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Abstract 
 
Background: Non-ST elevation myocardial infarction (NSTEMI) has only recently been included in the 
definition of acute myocardial infarction and literature is limited regarding the usefulness of echocardiography 
as a diagnostic tool in this setting. Since analysis of regional wall motion abnormalities (RWMAs) by standard 
echocardiography is highly reliant on observer experience, advanced modalities are suggested as possible 
complementary methods to perform quantitative RWMA assessment and observe underlying coronary artery 
disease (CAD); however, their utility has not been widely tested in a clinical setting.  
 
Aim: The aim of this thesis was to explore the usefulness of echocardiography for determining systolic and 
diastolic dysfunction post NSTEMI and compare the results to coronary angiography. The viability and 
accuracy of utilising the advanced echocardiography modalities of tissue velocity imaging and speckle tracking 
derived velocity, strain and strain rate as novel indices for quantifying regional dysfunction and determining 
underlying CAD was also explored.  
 
Method: A randomly selected data set of 55 patients admitted with NSTEMI to Christchurch Hospital, 
New Zealand, underwent standard echocardiography, advanced echocardiography analysis and angiography. 
 
Results: Of 55 patients, 76% were male while 20% had diabetes and 56% were current or previous 
smokers. Patients with diabetes and/or smoking history were more likely to have multiple coronary lesions and 
nine fold more likely to require coronary artery bypass grafting. 36% of patients had a left ventricular ejection 
fraction (LVEF) < 60% while 18% had an LVEF < 50%. A left anterior descending (LAD) coronary artery 
regional infarction resulted in the lowest LVEF (50+/- 6%). Mild diastolic dysfunction was present in 80% of 
patients, while moderate to severe diastolic dysfunction was present in 13%. For the advanced modalities, strain 
and strain rate derived by tissue velocity imaging were statistically significant for all regions, except for 
detecting underlying CAD in the RCA territory with strain rate and for RWMA identification in the RCA 
territory with strain – although there was a trend towards statistical significance. Velocity did not correlate well 
with the territories for identifying RWMAs and underlying CAD. Good correlation was noted in the LAD and 
Cx regions with speckle tracking derived strain and strain rate for identifying both RWMAs. Good correlation 
was noted in the LAD region with strain and strain rate for identifying underlying CAD. Although there was 
statistical significance within these results, there was also variation and overlap.   
 
Conclusions: The role of echocardiography in NSTEMI provides important information concerning 
systolic and diastolic dysfunction. We found excellent correlation between coronary angiography, clinical 
parameters and echocardiographic parameters. In general, the advanced imaging modalities correlated with both 
the presence of regional dysfunction and underlying CAD, however, there was overlap and variation within the 
data sets. With further technical and clinical refinement, these modalities may be useful supplementary tests to 
quantitatively evaluate RWMAs and to determine underlying CAD.  
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Introduction 
 
Non-ST elevation myocardial infarction (NSTEMI) is an acute coronary syndrome (ACS) 
involving acute coronary obstructions, which result in reduced oxygen to the myocardium.  In 2007, 
the American College of Cardiology and the European Society of Cardiology altered the 
definition of an acute myocardial infarction (AMI), traditionally incorporating only ST 
elevation myocardial infarction (STEMI), to include unstable angina and NSTEMI [1]. 
Echocardiography is a cost effective, bedside, adjunct diagnostic tool, which involves using 
ultrasound to assess the structure and function of a heart after such an event; however, it was only 
recently included in The New Zealand Medical Journal Guidelines as a recommended test with 
NSTEMI presentations. Literature regarding the use of echocardiography with NSTEMI presentations 
is limited. Most studies have been conducted in STEMI patient cohorts. Moreover, a New Zealand 
audit in this field has shown surprisingly low application rates of this easily accessible test.   
 
This study aims to describe the characteristics of NSTEMI presentation with echocardiography, 
specifically systolic and diastolic function. As echocardiography is highly subjective and requires an 
experienced operator, advanced imaging modalities such as tissue velocity imaging (TVI) and speckle 
tracking (ST) are suggested as modalities which provide quantitative assessment with reduced inter 
and intra-operator variation. These modalities, although well validated, have generally not been 
adapted by the clinical community (nationally nor internationally). Instead they are used mainly in the 
research environment. This study also aims to assess the validity and accuracy of performing these 
advanced modality techniques in a clinical setting.  
 
To achieve these aims, Chapter One provides an overview of the relevant background material 
and identifies areas that have yet to be explored. Based on Chapter One, Chapter Two outlines the 
methods used to study NSTEMI echocardiography characteristics and advanced imaging modalities. 
Chapter Three provides the results of echocardiography and NSTEMI presentation characteristics, 
while Chapter Four discusses the results of Chapter Three in light of the background material 
presented in Chapter One. Chapter Five provides the results of the advanced imaging modalities, 
while Chapter Six discusses the results of Chapter Five in light of the background material presented 
in Chapter One. In Chapter Seven limitations of the study are discussed, while in Chapter Eight, a 
summary of the thesis is presented and conclusions are drawn and related back to the aims in the 
introduction. 
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Literature Review 
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1 Chapter One: Literature Review 
 
1.1 Non-ST Elevation Myocardial Infarction – An Overview 
 
Non-ST elevation myocardial infarction (NSTEMI) has only recently been accepted as a 
form of acute coronary syndrome (ACS). In 2007, the American College of Cardiology and 
the European Society of Cardiology altered the definition of an acute myocardial infarction 
(AMI), traditionally incorporating only ST elevation myocardial infarction (STEMI), to 
include unstable angina and NSTEMI [1].  ACS is, therefore, an overarching term used to 
describe STEMI, NSTEMI and unstable angina. ACSs involve acute obstructions of coronary 
arteries, usually when an acute thrombus forms in an atherosclerotic artery. The aetiology of 
NSTEMI involves atheromatous plaque in coronary arteries becoming inflamed then 
rupturing exposing thrombogenic material [2]. This is mediated by a conformational change 
in membrane platelet glycoprotein receptors (IIb/IIIa), allowing aggregation of platelets, 
resulting in a thrombus, which interrupts blood flow (therefore oxygen) to the myocardium 
[3]. An AMI is myocardial necrosis from reduced blood flow to parts of the myocardium. 
Symptoms of NSTEMI include chest discomfort, dyspnoea, nausea and diaphoresis [4].   
 
Diagnosis of an AMI is with biomarker elevation and electrocardiogram (ECG) changes 
(the latter distinguishes NSTEMI from STEMI). A STEMI is myocardial necrosis with acute 
ST-segment elevation and possible Q wave development, while a NSTEMI is myocardial 
necrosis without ST-segment elevation, with possible ST-segment depression and/or T wave 
inversion. Of note, as many as 20% of patients admitted with NSTEMI may show no ECG 
changes; therefore, a lack of ECG changes in a patient presenting with chest pain is not 
enough to rule out ACS and further tests should be carried out [5]. The management and 
outcome of AMI patients depends on the degree and location of the obstruction. With a 
STEMI, the coronary artery is usually totally occluded and requires urgent pharmacological 
or interventional revascularisation (coronary angioplasty). With a NSTEMI, the coronary 
artery is usually partially blocked and patients require antithrombotic therapy and/or 
revascularisation reducing the coronary artery stenosis [6].  
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
18 
 
This literature review focuses on the current state of knowledge regarding the benefits of 
utilising echocardiography as a front-line diagnostic tool with NSTEMI presentations and the 
usefulness of echocardiography as a predictor of prognostic outcome. Gaps in the literature 
will be presented as possible paths for future investigation.  
 
 
1.1.1 NSTEMI versus STEMI Prognosis 
 
Various studies, such as Allen et al. [7] and Montalescot et al. [8], have found prognostic 
outcomes of NSTEMI patients similar to STEMI patients. Published in 2006, Allen et al. [7] 
studied 760 patients: 26% presented with NSTEMI, 17% with STEMI. Unadjusted mortality 
over 10 years was highest in patients with NSTEMI. NSTEMI patients were associated with 
higher co-morbidity rates and reduced utilisation of medical therapies when compared with 
STEMI patients. After statistically controlling for baseline differences, they found STEMI 
patients had the highest mortality. This study may indicate that prior to controlling for 
baseline differences, NSTEMI patients are at risk of adverse prognosis resulting in-part from 
individual patient co-morbidities and risk factors. Furthermore, this suggests that patients 
presenting with NSTEMI are more likely to have higher rates of co-morbidities than their 
STEMI counterparts. This study was based on retrospective research and although published 
in 2006, utilised patients hospitalised between 1991 and 1992. Thus, the data predates 
modern therapies. Modern medications and protocol changes may affect the results of this 
study if repeated today.  
 
In a more recent case series published in 2007, Montalescot et al. [8] compared STEMI 
with NSTEMI patient admissions on a large patient cohort of 2151, from multiple hospitals in 
France. They found STEMI patients were quicker to present to hospital (4 hours STEMI vs. 7 
hours NSTEMI), were more likely to undergo percutaneous coronary intervention (71% 
STEMI vs. 52% NSTEMI) and on discharge were more likely to receive secondary 
prevention therapies. This management was not supported with the differences found in 
disease severity. The study found rates of re-hospitalisation were equivocal (36.7% STEMI 
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vs. 41.5% NSTEMI), in-hospital mortality rates were equivocal (4.6% STEMI vs. 4.3% 
NSTEMI) and one year mortality rates were equivocal (9% STEMI vs. 11.6% NSTEMI). The 
study suggested heart failure and age were the highest one-year mortality predictors. This 
study is pivotal to understanding the similarities between STEMI and NSTEMI presentations. 
Although prognostic outcome between NSTEMI and STEMI is comparable, patients 
presenting with NSTEMI are often treated less effectively than their STEMI counterparts [9].  
 
 
1.1.2 Troponin I (TnI) 
 
NSTEMI diagnosis requires acute presentation of patients with ischemic symptoms (such 
as chest, upper extremity, jaw and/or epigastric pain, possibly accompanied by dyspnoea, 
nausea or syncope), ECG changes (T wave inversion or ST depression) and enzyme 
biomarker elevation. The biomarker troponin I (TnI), measured in μg/L, is primarily utilised 
at Christchurch Hospital, New Zealand as a marker of acute myocyte necrosis. It uses the 99
th
 
percentile as a reference limit of elevation [10]. TnI is regarded as the most sensitive and 
specific biomarker for myocardial damage with levels beginning to rise around 3-4 hours post 
event [11]. An increased TnI value suggests elevated acute risk and reduced long term 
prognostic outcome [12]; however, it does not reflect the mechanism for elevation, so further 
pathology such as aortic dissection or pulmonary embolism should be excluded [1]. 
Echocardiography allows for quick differentiation of these diagnoses in most patients, so 
should be considered as a diagnostic tool upon NSTEMI admission for this reason alone.  
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1.1.3 NSTEMI Patient Characteristics 
 
Risk stratification is an important part of the decision making process when a patient 
presents with NSTEMI [13]. Risk stratification involves analysing patient presentation 
symptoms, ECG tracings, biomarker elevations, patient characteristics, co-morbidities and 
risk factors. This process ensures adequate therapy is utilised on an individual patient basis, 
which reduces hospital stay, re-admission and, therefore, the cost to the public health system. 
Echocardiography is a quick and affordable diagnostic tool that assists in the risk 
stratification process, highlighting important individual characteristics of patients which may 
be useful for management.  
 
The average age of patients presenting with NSTEMI has been well documented as the 7
th
 
decade of life [7, 14, 15]. The New Zealand ACS audit, performed by Ellis et al. [15], studied 
all ACS patients admitted to New Zealand hospitals in 2007 over a 14-day period. They 
found the interquartile range was of aged between 56 and 78 years. It is well documented that 
a higher proportion of males (than females) present with NSTEMI [7, 8, 15, 16]. Gehrie et al. 
[16] found females were more likely to have non-obstructive coronary artery disease on 
angiography than men (15.1% vs. 6.8%), with better prognostic outcomes, although the 
underlying pathophysiology for this was not studied. Atypical NSTEMI presentations and 
complaints are more common in women, the elderly and patients with diabetes [17], often 
making diagnosis particularly challenging.  
 
Patient co-morbidities and risk factors such as diabetes and smoking, contribute to the 
prognostic outcome of individual NSTEMI presentations. Diabetes is a topical global disease 
due to its heavy demands on the health system [18]. Type II diabetes is due to high blood 
glucose levels - either the body does not make enough insulin or the body’s cells do not 
respond properly to insulin [19]. Diabetes affects the heart in numerous ways. This includes 
metabolic disturbances and increased vascular permeability, which result in myocyte 
apoptosis, left ventricular hypertrophy, decreased myocardial perfusion and systolic and 
diastolic dysfunction [20], [21]. The New Zealand ACS audit [15] performed in 2007 found 
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19% of patients had diabetes mellitus. The 2004 Global Registry of Acute Coronary Events 
[22] performed a prospective study on 5403 patients admitted with ACS from 94 hospitals. 
They found one quarter of the patients had diabetes. These patients were more likely to be 
older, female, have co-morbidities and were less likely to be treated with effective medical 
therapies. They also had an increased risk of heart and renal failure and all-cause mortality. 
Danahoe at al [23] performed an audit on patients with ACS from 11 independent clinical 
trials, published in 2007. Of a total 62,036 patients (46,577 were diagnosed with STEMI and 
15,459 were diagnosed with unstable angina/NSTEMI), 10,613 (17.1%) had diabetes. 
Mortality at 30 days for NSTEMI patients with diabetes was 2.1%, compared to 1.1% for 
non-diabetics, while the one-year mortality rate for NSTEMI patients with diabetes was 
significantly higher than that for non-diabetics (7.2 vs. 3.1%). They concluded that diabetes 
resulted in significant adverse prognosis, highlighting the need for aggressive strategies to 
manage this disease. 
 
Smoking has also been linked to an elevated risk of AMI [17], however, regardless of 
public awareness, it is still a common community burden. The New Zealand ACS audit [15] 
found 17% of patients admitted with NSTEMI were current smokers, while 39% had smoked 
in the past. Published in 2012, George et al. [24] reported a link between smoking and 
coronary artery disease (CAD) using a prospective cohort study of more than 91,5000 
patients. They found smokers were at higher risk of significant CAD than non-smokers when 
presenting with ACS. A limitation of this study was the failure to determine alternative risk 
factors such as diabetes, congestive heart failure or family history. It was also unclear 
whether ex-smokers qualified as non-smokers and what a significant smoking history would 
involve (i.e. cigarettes per day/packs per year). 
 
Patient in-hospital mortality rates after an AMI vary depending on the degree of heart 
failure present. This was demonstrated by a landmark study published in 1967 by Killip et al. 
[25], who studied 250 patients in a coronary care unit over a two year period. From the data 
retrieved the Killip classification was created, which grades the severity of heart failure 
symptoms post AMI. Killip et al. [25] found the in-hospital mortality rate was approximately 
10% and primarily determined by the severity of heart failure in NSTEMI and STEMI 
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presentations. Guidelines and clinical management have changed significantly since this 
study was published (1967), however, the trends between STEMI and NSTEMI admissions 
are still relevant. A global study [26], found the 30 day mortality rate overall was 6.2% for 
ACS patients and individually, was 7.4% for NSTEMI patients and 11.1% for STEMI 
patients, further supporting prognostic outcome similarities between the two syndromes. This 
study, however, was published in 2006. A repeat of the global study in 2009 by the same 
researchers found ACS 30 day mortality rates had decreased from 6.2% to 5.1%. This was 
thought to be the result of increased guideline adherence (as patient characteristics were 
similar in both studies), increased use of evidence based therapies/interventions and the 
availability of state-of-the-art cardiology departments [27].  
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1.2 Echocardiography and NSTEMI 
 
In current clinical practice, echocardiography is recommended when a patient presents 
with STEMI and NSTEMI. The New Zealand STEMI Guidelines suggest ‘…acute 
echocardiography demonstrating regional wall motion abnormalities (RWMAs) may be a 
useful adjunct for diagnosis and assessment of complications’ [28]. Similarly, the New 
Zealand NSTEMI guidelines recommend echocardiography “…in all patients with elevated 
troponin and those with ECG abnormalities to assess global and regional left ventricular 
function, assess the valves for defining differential diagnoses" [29]. The national audit [15] 
found 62% of patients admitted with STEMI received an echocardiogram, while only 22% of 
patients admitted with NSTEMI received an echocardiogram. This is surprising, as shown in 
previous studies, with current clinical management, STEMI and NSTEMI prognostic 
outcome is similar. This audit was performed in 2007, when the guidelines for NSTEMI did 
not include recommendations for echocardiography and modern clinical management of 
NSTEMI was still evolving.   
 
Echocardiography is an excellent real time diagnostic procedure with moderate temporal 
and spatial resolution [1], useful for assessing mechanical complications or cardiac 
abnormalities and variants. With NSTEMI presentations, echocardiography is highly useful 
when assessing myocardial contraction - differentiating areas of endocardium which are 
contracting normally from areas which are hypokinetic (reduced motion), akinetic (no 
motion) or diskinetic (dyssynchronous motion).  
 
Assessment of cardiac function by echocardiography may be split into two areas – 
systolic function and diastolic function. Echocardiographic indices helpful in the assessment 
of systolic dysfunction include left ventricular systolic volume, left ventricular ejection 
fraction (LVEF) - which represents the percentage of blood ejected from the left ventricle 
with each cardiac contraction, infarct size and location, mitral regurgitant jet severity and the 
presence of left ventricular hypertrophy [30]. Echocardiographic indices helpful in the 
assessment of diastolic dysfunction include grades of diastolic dysfunction, E/Em filling 
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pressures (early mitral inflow velocity to peak mitral annular velocity which is an estimate of 
left ventricular filling pressure), E:A ratio (mitral inflow Doppler ratio between early filling 
velocity and late filling velocity) and left atrial volume [31]. When compared with the vast 
pool of STEMI literature, there is a marked absence of studies assessing diastolic dysfunction 
in NSTEMI presentations. The available literature is limited to a small number of significant 
studies.  This study hopes to add to the small pool of NSTEMI literature by assessing the 
degree of diastolic dysfunction present in a sample of NSTEMI patients. 
 
 
1.2.1 Echocardiography and Systolic Function 
 
RWMAs often occur after an AMI and often result in global LVEF impairment, which is 
the most common form of systolic dysfunction in NSTEMI patients. RWMAs result in 
reduced myocardial contraction at the site of or downstream from the occlusion and are 
identified by visualising areas of reduced systolic endocardial thickening at the blood/tissue 
interface within the left ventricle. LVEF is generated from the difference in left ventricular 
end-diastolic and end-systolic volumes from two orthogonal planes of the left ventricle in the 
apical four chamber and apical two chamber views, using the Simpson’s Biplane method 
[32]. These views are generated from the apical window which is located in the fifth to sixth 
intercostal space in the median axillary line. With the cursor marker pointing to 
approximately one o’clock the apical four chamber view is visualised. A 60º-90 º anti-
clockwise rotation creates the apical two chamber view while a further 60 º anti-clockwise 
rotation creates the apical long axis view. RWMAs and global LVEF identified with 
echocardiography have been well-validated [33-36] and provide important information on the 
relationship between the location and extent of RWMAs present, ECG location and size, the 
status of the patient, complications and survival [37]. 
 
Infarct locations may be defined regionally: anterior, inferior or lateral or by afflicted 
coronary artery territory: left anterior descending (LAD), right coronary artery (RCA) or 
circumflex (Cx). Anterior infarcts and LAD occlusions are usually larger, associated with 
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lower LVEF and worse prognosis. A study published in 1987 by Hands et al. [38] assessed 42 
patients (19 with anterior infarction, 23 with inferior infarction) presenting with their first 
STEMI. They found for similar sized inferior and anterior infarcts, anterior infarcts were 
associated with a lower resting LVEF, increased extent and size of resting RWMAs and 
increased exercise induced ST-segment elevation which contributed to a poorer prognostic 
outcome. Future studies may determine whether ST depression and T wave inversion is more 
marked in anterior NSTEMI infarctions than inferior infarctions. A study published in 2000 
by McClements et al. [39] assessed 69 patients one week after AMI who received no 
thrombolytic therapy or revascularisation. They found a strong correlation between LVEF 
and the extent and size or RWMAs present. The LVEF was reduced most with an anterior 
infarction, suggesting that infarct size, location, severity and the extent of apical involvement 
were the most important predictors for LVEF. A study published in 1982 by Thanavaro et al. 
[40] assessed 1105 patients presenting with their first transmural AMI – 611 anterior and 494 
inferior. They found patients with inferior infarctions had lower in-hospital mortality (9.1% 
vs. 15.6%; p 0.0014), and congestive heart failure rates (39.4% vs. 47.6%; p 0.006) than 
patients with anterior infarctions. Many different mechanisms have been investigated as 
explanations for greater LVEF impairment in anterior infarcts. The internal mechanics of 
cardiac function are complex and not completely understood. There are several layers of 
muscle in the myocardium which travel in different directions. Rotation occurs in the left 
ventricle with the apex and base rotating in opposite directions. The image below shows ST 
B-mode interpretation of torsion angles of the myocardium (Figure 1).  
  
 
 
 
 
 
In the ejection phase (indicated by the number 2 at the top of the graph) the apex moves in a counter-clockwise rotation, while 
the base moves in a clockwise rotation, with torsion recoil apparent in the isovolumic relaxation phase (indicated by the number 3 at 
the top of the graph) and early diastolic filling phase (indicated by the number 4 at the top of the graph). Note that the LV base 
moves with a lower magnitude than that of the LV apex.  
Reproduced from Sengupta et al. [41]  
Figure 1: Torsion of the Myocardium with Speckle Tracking 
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Studies performed on dogs by LeWinter et al. [42] found regional differences within the 
myocardium. Fibres shortened more at the apex than the mid-ventricular or basal wall.  
Although the canine heart is similar in terms of physical mechanics to a human’s, it is not a 
perfect model, so results must be approached with a degree of caution [43]. It is also reported 
that as the apex is supplied blood by a single vessel (the LAD), if occluded, it will affect the 
entire apical region circumferentially resulting in the significant reduction of long axis 
shortening. Also, left ventricular minor axis shortening, the main contributor to left 
ventricular stroke volume, is also mainly dependent on blood supply from the LAD to the 
anteroseptal wall [39, 44]. A study published in 1986 by Tamaki et al. [45] utilised isotope 
ventriculography to determine variations in regional contractility in the first ten days post 
AMI. They found contractile improvements were greater in patients with single vessel 
disease in the Cx or RCA regions than LAD region. Furthermore, contractility improved 
more with single vessel disease than with multiple vessel disease.  
 
There is an absence of data regarding RWMAs associated with NSTEMI presentations 
and their relation to angiographic findings. One study published in 1998 by Weisman [37] 
determined the aetiology of chest pain presentations in an emergency department. He scanned 
175 patients, 88 (51%) had no RWMAs while 87 (49%) had RWMAs present. Of the 87 
patients with regional dysfunction, only 27 (31%) were diagnosed with an AMI. This study 
provides interesting information regarding the prevalence of RWMAs however does not 
differentiate between STEMI and NSTEMI nor does it state whether the RWMAs detected 
correspond to a specific occluded coronary artery. A retrospective audit was performed at 
Christchurch Hospital, New Zealand in 2007 utilising patients presenting with NSTEMI 
undergoing both echocardiography and angiography [46]. The study revealed 60% of 
NSTEMI patients had RWMAs on echocardiography, with 89% of the RWMAs correctly 
predicting the culprit artery identified with angiography.  
 
Further studies have described how left ventricular remodelling (adverse structural and 
functional changes in myocardium remote to the infarct zone) in response to myocardial 
infarction may be site specific and an important prognostic indicator of cardiovascular events 
in the future [47]. 
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There are gaps in existing NSTEMI literature with regards to identification of regional 
dysfunction and determining if the dysfunction visualised corresponds to a culprit coronary 
artery determined with coronary angiography.  This research project hopes to bridge the gaps 
in literature concerning NSTEMI admission and systolic function as addressed above, in a 
limited sample population of 55 patients. 
 
 
1.2.2 Echocardiography and Diastolic Function 
 
The diastolic phase of the cardiac cycle has historically been somewhat overlooked as a 
non-invasive, quick technique to further determine prognostic outcome. Diastolic dysfunction 
is the result of increased myocardial stiffness from a variety of factors including interstitial 
oedema, fibro-cellular infiltration and scar formation after an AMI [48]. A process termed the 
diastolic cascade (Figure 2), when diastolic dysfunction precedes systolic dysfunction [49-
51], has been validated as an early indicator of congestive heart failure after an AMI [52-54]. 
The diastolic cascade begins with an oxygen supply and demand imbalance, followed by 
metabolic alterations within the myocardium. The physiology is rather complex, however, 
remodelling of the left ventricle post infarction (such as reparative interstitial fibrosis and the 
development of scar tissue) leads to impaired left ventricular relaxation, hypertrophy and 
asynchrony. Pre-existing diabetes may also predispose to diastolic dysfunction. Left 
ventricular hypertrophy, the primary cause of chamber stiffness, leads to diastolic 
dysfunction [55]. 
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The diastolic cascade begins with perfusion abnormalities, which result in diastolic dysfunction, which then leads 
to systolic dysfunction (a reduction in left ventricular systolic function). 
Where: EKG = electrocardiogram  
Reproduced from Herzog et al. [56] 
 
The determination of diastology by echocardiography is based mainly upon transmitral 
and septal tissue Doppler interrogation; however pulmonary vein inflow and colour m-mode 
flow propagation may also be used. Diastolic dysfunction can be broken down into four main 
patterns/grades (Figure 3). Grade one is mildly impaired diastolic dysfunction, with an 
abnormal relaxation pattern. Grade two is moderately impaired diastolic dysfunction, with a 
pseudonormal relaxation pattern. Grades three and four are severely impaired diastolic 
dysfunction, with restrictive relaxation patterns, defined by an increased E wave and a short E 
deceleration time (<140ms). Grade three is reversible, while grade four is not [30]. 
Figure 2: Diastolic Cascade 
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Diastolic dysfunction patterns identified with echocardiography. In this diagram, Grade one is abnormal 
relaxation, grade two is pseudonormal relaxation and grade three is restrictive relation (grade four is not shown). 
The MVF (mitral inflow) and TDI (tissue velocity imaging) profiles were used for this study.  
Where: ECG = electrocardiogram; MVF = mitral inflow; PVF = pulmonary vein flow; TDI = tissue velocity 
imaging; colour m-mode = colour motion mode 
Reproduced from Roelandt et al. [57] 
 
A number of studies have examined whether restrictive diastolic dysfunction is useful in 
ACS presentations, to predict prognostic outcome, with have varied results. Occasionally 
studies have failed to demonstrate the value of these indices [58, 59]; however, the majority 
of studies find restrictive diastology to be an excellent predictor of clinical outcome, 
associated with higher left atrial filling pressures and increased rates of mortality post AMI 
[48, 58, 60-63]. A study published in 2010 by Hee et al. [64] validated restrictive diastolic 
Figure 3: Diastolic Dysfunction Patterns 
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dysfunction as a predictor of clinical outcome post STEMI in a long term (five year) study of 
100 patients. Restrictive diastolic dysfunction was defined as an E:A >2 and/or a mitral E 
deceleration time of <140ms. They found patients with restrictive diastolic dysfunction had 
higher myocardial enzyme levels (p<0.001), a high E:A ratio, lower tissue Doppler imaging 
septal Em, increased left atrial volume, decreased LVEF and a higher incidence of all-cause 
mortality. As this study was retrospective, echocardiography timings were variable (within a 
6 week range) and pre-existing diastolic dysfunction and co-morbidities (such as diabetes or 
heart failure) were not determined. Published in 2008, a large meta-analysis involving 3396 
patients from 12 prospective post infarction clinical trials found ~20% incidence of restrictive 
diastolic dysfunction. These patients were more likely to have diabetes, hyperlipidaemia, 
anterior myocardial infarction, increased left ventricular volume, decreased LVEF and a 
higher Killip Class [65]. Two interesting findings from this study were: that restrictive 
diastolic dysfunction predicted outcome even with preserved LVEF, and restrictive filling 
was associated with a three-fold increase in all-cause mortality. The large patient cohort of 
this study suggests it is reliable as an indicator of a true patient population.  
 
In the past, diastolic impairment with a preserved LVEF (defined as >50% [30]) was 
thought to be relatively benign in the setting of AMI, but this is now known not to be the case 
[65]. Although restrictive diastolic dysfunction has been fairly well studied and validated in 
ACS presentations, less is true for mildly impaired and pseudonormal diastolic dysfunction. 
A prospective study on 125 patients post AMI found patients with pseudonormal diastolic 
dysfunction (defined when mitral E deceleration time was normal: 140-240ms, while 
propagation velocity was decreased) had a high occurrence of in-hospital heart failure and a 
poor prognostic outcome [60]. These patients were older with greater heart failure 
complications than those with normal or mildly impaired diastolic dysfunction. Studies  
which have assessed mildly impaired diastolic dysfunction have yet found no significant 
correlation with mortality rates when adjustments are made for age, Killip Class and LVEF 
[66, 67]. The fact that pseudonormal diastolic function is associated with raised filling 
pressures, while mildly impaired diastolic dysfunction is not, may indicate a link between 
filling pressures and prognostic outcome. 
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A filling pressure (E/Em) of >15 has been associated with a worse prognostic outcome. A 
review in 2004 performed by Khouri et al. [68] stated E/Em >10 was abnormal, while E/Em 
was highly specific for raised left atrial filling pressures. This has been confirmed by other 
studies [69, 70].  A retrospective study in 2004 of 250 patients with AMI found filling 
pressure to be a predictor of all-cause mortality [71]. Filling pressure is, however, affected by 
a number of factors including loading conditions (i.e. heart rate, beta-blockers and cardiac 
remodelling), which must be taken into account before relying heavily upon an E/Em value 
[72].  
 
Left atrial dilatation is reported as a predictor of filling pressures and prognostic outcome. 
When a left atrium empties into a stiff left ventricle, left atrial pressures increase (as the walls 
of a left atrium are thin due to a normally low pressure environment) and dilatation occurs 
[73]. Left atrial dilatation has been associated with an increase in all-cause mortality [74, 75]. 
A prospective study was published in 2011 by Kuhl et al. [76] involving 384 patients 
presenting with NSTEMI. These patients underwent gated 64-slice coronary angiography to 
measure left atrial size and function and were then monitored over two subsequent years. 
Over two years, 9% of patients died. The left atrial minimal volume and fraction change were 
likely independent predictors of mortality, while left atrial maximal volume were likely not 
associated with increased mortality. Research published in 2004 by Beinart et al. [74] studied 
55 patients admitted with AMI. They found patients with a left atrial volume >32mL/m
2 
had 
higher rates of congestive heart failure, mitral regurgitation, larger left ventricular volumes 
and lower LVEF. These patients also had higher five year mortality rates than patients with a 
left atrial volume <32mL/m
2 
(35% versus 14%). These studies confirm important prognostic 
information may be extrapolated from the size/volume of the left atrium.  
 
The E:A ratio value is also recommended as an indicator of prognostic outcome. A meta-
analysis (as yet unpublished) performed by Whalley et al. [77] utilising 2344 patients found 
E:A <1 had a mortality rate of 12.3%, E:A 1-2 had a mortality rate of 21.3% while E:A >2 
had a mortality rate of 30.9%. The results showed that higher E:A ratios were related to 
increased rates of all-cause mortality. 
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1.3 Limitations of Current Clinical Echocardiography   
 
Echocardiography is an effective, affordable, bedside diagnostic tool, but it relies on 
accurate individual assessment and interpretation of indices by an experienced reader, 
specifically for assessment of RWMAs post AMI. Also, often there are minute changes in 
systolic function which are too small or too quick for the human eye to process. For this 
reason, ultrasound manufacturers have created different methodologies for semi-quantifying 
or quantifying RWMAs, enabling less reliance upon individual interpretation, thereby 
reducing bias. Two methods to be evaluated in our research are tissue velocity imaging (TVI) 
and speckle tracking (ST) from which velocity (v), strain (%) and strain rate (/s) data may be 
derived.   
 
 
1.4 Conclusion: Literature Review - Echocardiography Characteristics 
of NSTEMI Presentations 
 
In summary, previous literature has shown that the presence of diastolic dysfunction with 
echocardiography plays a vital role in determining the prognostic outcome of patients post 
AMI and may also indicate significant underlying CAD [78].  As diastolic dysfunction has 
been observed to precede systolic dysfunction, it may characterise disease earlier than 
visualisation of RWMAs or LVEF decline. Most studies showing echocardiography as a 
predictor of outcome post AMI have been conducted in patients with STEMI.  Data 
concerning the NSTEMI population is fairly limited in comparison and certainly warrants 
further investigation. It is likely that the more severe grades of diastolic dysfunction will 
occur in lower prevalence in this population, compared to the STEMI population. However, it 
has been shown in multiple clinical scenarios that once severe diastolic dysfunction is 
present, it carries poor prognosis, despite the underlying cause. Therefore, identification of 
diastolic dysfunction is an important adjunct to clinical information and may assist with 
management.  
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1.5 Advanced Imaging Modalities: Tissue Velocity Imaging and Speckle 
Tracking Derived Velocity, Strain and Strain Rate 
 
To overcome the limitations posed by conventional two-dimensional echocardiography, 
new advanced echocardiographic modalities now enable semi-quantitative and quantitative 
assessment of regional dysfunction as well as the ability to detect underlying CAD. The two 
modalities to be evaluated in this research are tissue velocity imaging (TVI) and speckle 
tracking (ST). From these modalities, values for velocity (v), strain (%) and strain rate (/s) 
may be derived.  
 
For TVI and ST derived velocity, normal segments (those with no RWMAs or CAD) will 
be positive in systole. Hypokinetic segments will be also positive in systole but of lower 
velocity. For TVI and ST derived strain and strain rate, normal segments (those with no 
RWMAs or CAD) will be high/increased negative waveforms in systole (further from the 
baseline). Hypokinetic segments will be negative; with lower/decreased strain values (will 
appear closer to the baseline). In the case of diskinesis, the waveforms of strain may be 
inverted (positive in systole when they should be negative). Studies determining normal 
values are discussed below, while normal TVI derived velocity, strain and strain rate values 
are shown in Table 21 in the appendix.  
 
 
1.5.1 Tissue Velocity Imaging Derived Velocity, Strain and Strain Rate 
 
TVI is a velocity based measurement which enables analysis (from time-interval 
calculations and myocardial contraction/relaxation velocities throughout the cardiac cycle) of 
signals from tissue which have high amplitude and low frequency [79]. TVI uses myocardial 
Doppler frequency shifts to quantify tissue motion [80], is relatively load independent and 
considered an accurate indicator of systolic and diastolic function [81]. TVI images were 
obtained from a GE Vivid 7 machine (software version 2.2.1., GE Vingmed Ultrasound 
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System, Horten, Norway) with data analysis performed on EchoPac (GE Vingmed 
Ultrasound System, Horten, Norway). The peak systolic myocardial velocity, strain and strain 
rate of all segments of the left ventricle is measured then trends are analysed and compared 
within the data set. A study published in 2010 by Dalen et al. [82] provided normal values for 
regional segmental assessment by measuring the peak systolic myocardial velocities in a 
large normal patient cohort (without prior cardiac history). TVI velocity traces are considered 
raw data as they are less processed than strain or strain rate traces and, therefore, the most 
reproducible [83].  
 
TVI is based on the principle of Doppler, which was originally used for blood flow and 
obeys the basic laws of physics concerning fluid motion. Tissue Doppler contends with the 
motion of the myocardium, which is complex - the segments within the myocardium are 
affected by tethering of adjacent segments and by the overall translational motion of the heart 
[84]. To overcome this problem, myocardial strain and strain rate can be derived from TVI 
velocity traces on the prospectively on the GE Vivid 7 machine (software version 2.2.1., GE, 
Horten, Norway) or retrospectively with EchoPac (GE Vingmed Ultrasound System, Horten, 
Norway), if prompted. Strain is a dimensionless value. It is deformation (stretching) of an 
object, relative to its length, which may be positive (fibre lengthening) or negative (fibre 
shortening) [85]. Strain and strain rate provide regional and global information on myocardial 
contraction [80]. Strain rate provides information which is too fast for the human eye to 
process in real time. Post-processing of the waveforms allows comparisons between different 
areas of the myocardium [80]. The equations for strain (Figure 4) and strain rate (Figure 5) 
are described by the equations below: 
Where: S = strain; l = instantaneous length; l0 = original length; ∆l = change in length; SR = strain rate; v = 
velocity; va-vb = difference in instantaneous myocardium at points a and b; d = distance in instantaneous myocardium 
at a specific time 
 Reproduced from GE Healthcare [80] 
Figure 4: Strain Figure 5: Strain Rate 
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Figure 6: Diagram of Longitudinal, Circumferential and Radial Strain 
TVI derived strain and strain rate imaging may be used to analyse longitudinal shortening 
- which is negative strain (apical views), transmural function - which is positive strain (apical 
and parasternal short axis views), or circumferential function - which is negative strain 
(parasternal short axis views) [86] (Figure 6). This research will focus on longitudinal 
(negative) strain and strain rate values obtained from the apical views, which studies suggest, 
are the most reproducible and the most accurate when assessing regional contraction and 
underlying CAD when compared with gold standard tests such as tagged magnetic resonance 
imaging (MRI) [86]. Transmural and circumferential strain indices are best proven for 
anterior and posterior segmental assessment and that is where their predominant clinical use 
lies.   
 
 
Reproduced from Leung et al. [87]  
The figure shows cardiac motion in the longitudinal (which is shortening and negative), circumferential aka 
transmural (which is shortening and negative) and radial (which is thickening and positive) directions.  
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Regional assessment is performed by analysing the peak systolic strain and peak systolic 
strain rate in 15 segments of the left ventricle. The values from each segment may be 
compared with normal values by myocardial level (basal, mid, distal) or between walls 
(anteroseptal, anterior, anterolateral, inferolateral, inferior, inferoseptal) as suggested by 
Dandel et al. [82].  TVI derived strain rate is the most processed method of TVI imaging, so 
is the least reproducible, however, it is the least affected by tethering and torsion of the heart 
[85].  
  
Various studies, including those of Urheim et al. [88] published in 2000 and Edvardsen et 
al. [89] published in 2002,  have validated the feasibility of myocardial strain by Doppler 
echocardiography. Urheim et al. [88] induced apical ischemia in 13 anesthetised dogs. While 
the apical myocardium became diskinetic (indicated by strain and Doppler velocities), the 
basal segment values for strain by Doppler and strain by sonomicrometry and velocity of 
shortening by sonomicrometry were unchanged. Doppler velocities at the base showed 
decreased values (4.2+/-0.7 to 2.7+/-0.4cm/s) suggesting that strain is less influenced by 
cardiac tethering and cardiac motion. The major limitations of this study were that it was 
performed on anesthetised dogs and the sample population (13) was small. The study did, 
however, indicate the general trends and benefits of utilising TVI derived strain.  
 
Edvardsen et al. [89] performed longitudinal and radial TVI strain and strain rate on 33 
normal patients and 17 patients with AMI. In the 33 normal patients, the longitudinal 
myocardial Doppler velocities decreased from the base to the apex, while the myocardial 
strain and strain rate indices remained uniform. In the 17 patients with AMI, the infarcted 
segments showed only 1.5+/-4.3% longitudinal strain compared with -15.0+/-3.9% in remote 
myocardial segments. A further comparison between myocardial strain and strain rate indices 
and tagged MRI revealed excellent correlation with longitudinal values (r=0.89).  Their study 
utilises a small patient population which is not indicative of a true population, therefore only 
trends should be analysed from this data. The frame rates used for TVI in their study ranged 
from 56-134 frames per second with a mean of 92. TVI involves the rapid analysis of 
increased velocity motion with very short duration, which means a high sampling rate is 
required. A study published in 2002 performed by Lind et al. [90] concluded frame rates with 
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a cut-off of 70 frames per second for E velocity analysis and 100 frames per second for all 
other systolic and diastolic analysis allowed an acceptable <10% deviation of results, with the 
optimal being between 141-203 frames per second (fps). This indicates that the frame rates 
used by Edvardsen et al. [89] were often lower than required (however, may conform to 
guidelines not stated in their research).  
 
A study published in 2003 by Hasegawa et al. [79] investigated the ability of myocardial 
strain to quantify regional myocardial contraction in patients with normal wall motion and 
patients with RWMA. The study found that peak systolic strain values of segments with 
differing contraction were significantly different to one-another – normokinetic -20.1 ± 5.5%; 
hypokinetic -11.9 ± 5.0%; akinetic -6.3 ± 3.4%. There was no significant overlap, suggesting 
myocardial strain agrees well with visually assessed wall motion. This study is limited by its 
small sample population of 13 patients with normal wall motion, and 18 patients with 
RWMA resulting in possible sampling/bias issues.  
 
Studies have also shown the ability of TVI to detect significant underlying CAD (>70% 
stenosis), with no visual RWMAs. A study published in 2008 by Choi et al. [91] showed mid 
and basal peak longitudinal strain cut off values of -17.9% to be indicative of detecting severe 
3 vessel disease or left main CAD (sensitivity 78.9%, specificity 79.3%), when there was an 
absence of RWMA with standard echocardiography. The sample population enrolled in this 
study was limited (189 patients with suspected angina and 110 patients with suspected CAD); 
however, important information regarding the diagnosis of underlying CAD was identified 
with this study. Future studies should employ a larger patient cohort to confirm these results.  
 
For TVI derived velocity, increased myocardial contraction results in higher systolic 
values. TVI derived strain and strain rate in systole result in negative values, therefore, better 
myocardial contraction results in values further away from the baseline (more negative), 
while abnormal or reduced motion is indicated by values closer to the baseline (less 
negative). In a heart with no diskinetic cardiac motion, strain and strain rate systolic values 
are always negative in systole. Although these methods appear to provide supplementary 
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quantifiable assessment of RWMA, TVI remains a Doppler based measurement. This means 
it is angle dependent and suffers from significant noise problems (especially at the apex), as 
well as difficulty in tracking the region of interest throughout the cardiac cycle and tethering 
from neighbouring segments [92]. 
 
 
1.5.2 Speckle Tracking Derived Velocity, Strain and Strain Rate 
 
ST overcomes the limitations of TVI by tracking speckles (which result from constructive 
and destructive interference of ultrasound backscatter from structures within the myocardium, 
smaller than the wavelength of the ultrasound beam) from frame to frame with the geographic 
shift corresponding to local tissue movement [93]. The resulting information is then post-
processed into traces showing the velocity, displacement, strain (a measurement of 
deformation) and strain rate (speed at which deformation occurs) of a specific myocardial 
segment [94]. ST is able to track the myocardium independently of cardiac translation and 
interrogation angle [95], with no significant base to apex gradient [85]. ST images were 
obtained from a GE Vivid 7 machine (software version 2.2.1., GE Vingmed Ultrasound 
System, Horten, Norway) with data analysis performed on EchoPac (GE Vingmed 
Ultrasound System, Horten, Norway). The peak systolic myocardial velocity, strain and strain 
rate of all segments of the left ventricle is measured then trends are analysed and compared 
within the data set. 
 
Studies have determined the validity of ST [92, 96-98]. A study published in 2009 by 
Amundsen et al. [92] compared TVI derived strain rate with ST derived strain rate using 
tagged MRI as a reference. They found ST may be used alone or combined with TVI, 
providing acceptable regional myocardial values. Also, that ST strain values were more 
reproducible than tagged MRI values. A study published in 2005 by Cho et al. [96] compared 
ST derived strain and TDI derived strain with tagged MRI. They found values for tagged 
MRI comparable with TDI and ST derived strain when assessing segments with dysfunction.  
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Global strain, the average of the individual segmental strain within an imaging plane 
(apical four chamber, two chamber of apical long axis view) has been associated with LVEF. 
A study published in 2004 by Reisner et al. [97] found global longitudinal strain and strain 
rate values were good indicators of global left ventricular function with high sensitivity and 
specificity. The study had a small sample population of 27 patients post AMI. The study 
attempted to reduce bias by using a non-echocardiographer to interpret the results but this 
calls into question the ability/competence of the non-echocardiographer. A study published in 
2006 by Becker et al. [98] suggested ST strain and strain rate assessment of regional LVEF, 
resulted in highly reproducible values with low intra-observer and inter-observer variation. 
The patient cohort was small (64). Frame rates were between 56-92 fps which is excellent as 
frame rates for speckle tracking should be around 40-80fps to maximise spatial resolution for 
frame-by-frame tracking of acoustic markers [99]. These studies confirm the feasibility of 
performing ST derived indices as accurate indicators of both regional and global systolic 
function.    
 
Various studies have validated the use of ST strain and strain rate when identifying 
RWMA. Decreased ST derived longitudinal segmental strain values imply a regional 
myocardial infarction with greater sensitivity and specificity than TVI. A study published in 
2007 by Gjesdal et al. [100] found peak systolic longitudinal strain values of -15% could 
identify an infarction (sensitivity 83%, specificity 93%) at the segmental level. The patient 
population sample was small (38) and the study only used the apical long axis window. A 
study published in 2010 by Eek et al. [101] found good correlation between infarct size, wall 
motion score index (r=0.74, p=<0.001) and global longitudinal strain (r=0.68, p<0.001) in 
patients with recent NSTEMI. The patient cohort was small (68), however, the study used 
tagged MRI, regarded as a gold standard test, as a reference. A study published in 2009 by 
Roes et al. [102] compared the ability of ST strain with contrast enhanced MRI to accurately 
assess the extent of endocardial scar tissue. Good correlation was found with cut-off values 
showing segments both without scar tissue (-10.4% +/- 5.2%) and with scar tissue (0.6% +/-
4.9%). They also found that a regional longitudinal strain cut off of -4.5% distinguished a 
non-transmural infarct from a transmural infarct (sensitivity 81.2%, specificity 81.6%). 
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1.5.3 Advanced Imaging Modalities: Current Lack of Clinical Utility 
 
Neither TVI nor ST derived velocity, strain nor strain rate have been adapted as routine 
tests post AMI at the Christchurch Hospital, New Zealand Echocardiography Department. 
From discussions with others in the field, it is noted that few hospitals have adapted these 
modalities into routine (non-research) clinical practice. They are, however, often utilised in 
echocardiography research laboratories. The author has noted a greater number of research 
protocols from national and international studies performed at Christchurch Hospital, New 
Zealand are requesting the images required for analysis with these modalities. However, 
discussions with people in the field of echocardiography yield negative comments towards 
the use of strain in a clinical (non-research) setting and literature regarding the use of these 
modalities in a clinical (non-research) setting is limited.  
 
Various literature reviews and studies, including those published in 2011 by Hoit et al. 
[103], in 2010 by Antoni et al. [104] and in 2005 by Ingul et al. [105], confirm the need for 
further research in this field. In their research conclusions, they state that, although their 
advanced imaging modality of choice was promising, more studies are required in the field to 
enable use of the modalities in a clinical (non-research) setting. Antoni et al. [104] found 
strain imaging a time consuming process, which means to use these modalities in a clinical 
setting, more time should be allocated for analysis, than that of a normal routine study. Choi 
et al. [91] studied the association between underlying CAD with no visible RWMA and strain 
imaging with the conclusion that the modalities ‘might’ be associated with CAD, indicating 
lack of surety. A literature review written by Marwick et al. [99]  in 2009 suggested that the 
modalities were susceptible to artefact, with the user requiring a significant understanding of 
both complex cardiac mechanics and the methodology behind the imaging techniques. They 
also mention that there are significant technical challenges with image acquisition, and 
interpretation of waveforms which result in high inter and intra observer variability with a 
need for further research.  
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A literature review written by Thomas, G. [106] in 2004 stated TVI imaging was a 
‘retrograde development’ based on ‘debatable research and publication’ with no clinical 
benefits. Furthermore, he stated that data obtained from any TVI method is flawed as it is an 
incorrect application of the Doppler technology. He argued that the four main flaws of TVI 
were as follows:  
 To make meaningful measurements, the line of motion must be known - this is 
possible in blood motion (i.e. blood flow within the left ventricle), however, not with 
the complex mechanics of the left ventricle.  
 Doppler was designed for fluid motion (i.e. the flow of blood within the left 
ventricular chamber), not tissue motion (i.e. the movement of the ventricle wall), 
which is slower than fluid motion. This may result in signals being eliminated on the 
basis of amplitude. 
 The Doppler method uses mathematical approaches to indirectly assess motion which 
cannot really be measured.  
 Also, the technique is ultra-sensitive, therefore, results in high rates of false positive 
waveforms. Furthermore, waveforms may be created when placing the sample volume 
outside of the cardiac region entirely.  
This review is a compelling argument against the clinical utilisation of specifically TVI 
derived analysis.  
 
These study conclusions and literature reviews offer insights into the current lack of 
clinical utilisation behind these advanced modalities. Limitations are often related to timing, 
technology, training constraints and the limited accuracy and reproducibility of clinical 
laboratory based strain. 
 
 
 
 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
42 
 
1.6 Conclusion: Literature Review – Advanced Echocardiography 
Techniques 
 
TVI and ST derived velocity, strain and strain rate have been well validated as modalities 
to assess regional myocardial motion and to determine underlying CAD. Despite positive 
validation studies, some literature reviews have debated the accuracy and importance of 
advanced modality imaging. It has been suggested that these are time consuming and possibly 
inaccurate techniques, best employed in the research lab. A very limited number of studies 
were found regarding the feasibility of utilising these new modalities in a clinical laboratory 
setting, on a randomly selected set of patients.  
 
This study attempts to determine whether strain imaging is useful in a clinical (non-
research) cardiac laboratory setting, and which modality is most accurate when identifying 
both regional dysfunction and underlying CAD.   
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2 Chapter Two: Experimental Design and Methodology 
 
The purpose of this chapter is to outline the overall aims of this thesis and describe the 
methods.  
 
 
2.1 Aims 
 
This study aimed to assess contemporary echocardiography in non-ST elevation 
myocardial infarction, and will be referred to as the CENSTEMI (Contemporary 
Echocardiography in Non-ST Elevation Myocardial Infarction) study/research throughout 
this thesis.  
 
This study aimed to determine the usefulness and characteristics of echocardiography 
with NSTEMI presentations. This study also aimed to determine whether TVI and ST derived 
velocity, strain and strain rate modalities are effective, appropriate and beneficial to a clinical 
routine examination. Specifically: 
- To describe the characteristics of patients presenting with NSTEMI at Christchurch 
Hospital, New Zealand 
- To determine the usefulness and effectiveness of echocardiography when evaluating 
patients who present with NSTEMI 
- To examine the correlation of abnormalities detected with new imaging modalities 
(TVI derived velocity, strain and strain rate, and ST derived velocity, strain and strain 
rate) with echocardiography and angiographic results in NSTEMI patients 
- To determine the validity of performing these advanced modalities (TVI and ST 
derived velocity, strain and strain rate) in a clinical setting. 
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2.2 Hypothesis 
 
- Echocardiography will be a useful adjunct imaging technique for assessing patients 
admitted with NSTEMI. 
- While the advanced imaging modalities may indicate trends towards regional 
dysfunction or underlying CAD, the limited reproducibility and accuracy of these 
modalities on a randomly selected set of patients in a clinical setting may preclude 
them from being useful for prognosis.  
 
 
2.3 Study Subjects 
 
This prospective study was conducted at Christchurch Hospital, New Zealand using 
patients presenting with NSTEMI between June 2011 and April 2012. The subject population 
consisted of patients admitted to Christchurch Hospital, New Zealand with a first diagnosis of 
NSTEMI. To be eligible for this study, patients were only included when referred on the days 
that the sonographer (the author) was working with in-patients, which was one to two slots (a 
morning or an afternoon slot) per week, because there was only one sonographer to perform 
the scans (the author) and there is only one GE Vivid 7  ultrasound machine (software version 
2.2.1., GE Vingmed Ultrasound System, Horten, Norway ) at Christchurch Hospital, New 
Zealand, which was solely used for this study to ensure consistency. Thus, 55 patients were 
recruited between June 2011 and April 2012 and included in this study. NSTEMI was defined 
as a chest pain presentation with an elevation in TnI over 0.03µg/L [29].  ECG changes did 
not necessarily have to be present for a diagnosis of NSTEMI.  If ST-segment elevation was 
present, the diagnosis was STEMI and, therefore, the patient was ineligible for the study.   To 
be eligible for the study patients had to be referred for an inpatient echocardiogram and also 
have in-patient coronary angiography planned. Approval for the study was obtained from the 
Upper South B Regional Ethics Committee of the Ministry of Healthy (ethics register 
number: URB/11/EXP/002).  
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2.3.1 Inclusion Criteria 
 
Patients were included in the study if they met the following criteria: 
- Presented to the hospital with a first diagnosis of NSTEMI 
- NSTEMI was defined as chest pain and TnI elevation over 0.03µg/L  
- Listed for both echocardiogram and angiogram during admission 
 
 
2.3.2 Exclusion Criteria 
 
Patients were excluded from the study for the following reasons: 
- evidence of STEMI (ST segment elevation on ECG);  
- any rhythm other than sinus (i.e. atrial fibrillation/flutter)  
- presence of significant (moderate or greater) valve disease  
- previous cardiac surgery/procedures 
 
 
Patients were not excluded for poor window quality as one of the goals of this study was 
to assess the utility of echocardiography and the advanced imaging modalities in a routine 
NSTEMI patient population.    
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2.4 Study Protocol 
 
A full echocardiogram according to the American Society of Echocardiography [107] 
standards was performed by the author on each patient to assess cardiac structure and 
function. Three to five minutes was added at the end of each scan to capture the images 
required for off-line advanced imaging analysis.  
 
Patient demographics (clinical details such as age and gender, smoker) were recorded 
prospectively at the time of the echocardiogram in an EXCEL spread-sheet. All patients were 
asked at the time of echocardiography if they had a history of diabetes mellitus and if they 
answered yes, details were recorded relating to duration and treatment. All self-reported 
clinical information was corroborated by the review of the patient’s clinical records.  
 
None of the patients required urgent revascularisation, and no patients required a 
coronary angiogram or echocardiography for the sole purpose of this study. All investigations 
were indicated as part of routine care. 
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2.5 Echocardiography 
 
This section will cover the methodology used for acquisition, analysis, measurements and 
calculations performed for echocardiography and coronary angiography. Statistical analysis 
of the data obtained will also be covered. 
 
 
2.5.1 Echocardiography Acquisition   
 
All echocardiographic images were acquired by the author, on a GE Vivid 7 ultrasound 
machine (software version 2.2.1., GE Vingmed Ultrasound System, Horten, Norway), with a 
matrix phased array M4S 1.5-4.0 MHz frequency transducer, using second harmonic imaging 
mode. All studies were performed in the echocardiography laboratory using a purpose built 
echocardiography bed with a mattress cut out to enable apical imaging in the left decubitus 
position. The author performed all of the echocardiography imaging.  
 
A standard echocardiography study was performed inclusive of standard 
echocardiographic imaging, m-mode, conventional and tissue Doppler imaging. Parasternal 
and apical images were performed with the patient in left lateral decubitus position with their 
left arm extended above their head, and their right arm along their side. Subcostal and 
suprasternal images were performed with the patient lying supine. The images were 
optimised ensuring clear delineation of the blood/endocardial interface by adjusting gains and 
compensation where required and ensuring on-axis orientation.  
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From the apical window, the apical four chamber, apical two chamber and apical long 
axis views were obtained by rotating the transducer. These views show the segments of the 
heart - inferoseptum, anterolateral, inferior, anterior and inferolateral (Figure 7).  
 
 
 
Reproduced from Lang et al. [32]  
Figure 7: Segment Analysis of Walls of the Left Ventricle in the Apical (1,2,3) and Parasternal Short Axis (4,5,6) 
Window 
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The segments of the left ventricle correspond to coronary artery territories – left anterior 
descending (LAD), circumflex (Cx) and right coronary artery (RCA) (Figure 8). Note: 
Definitive amendments to coronary artery territories were made for the purpose of this 
research from original image; mid inferoseptal and distal anterolateral (apical lateral) 
segments – LAD; Basal to mid anterolateral segments – Cx; Basal to mid inferolateral – 
RCA. 
Reproduced and altered (from the original image by the author) from Lang et al. [32]  
 
 
For TVI and ST derived modalities, gain was optimised and the sector was aligned to 
ensure the left ventricle filled the entire sector (inclusive of the mitral annulus/valve) - a 
narrow sector size, limiting the angle of insonation by ensuring the transducer was parallel 
with the cardiac walls, frame rates were optimised as much as possible (ST required 40-80 
frames per second) [99], TVI required 105-211 frames per second [90] and images were 
Figure 8: Coronary Distributions of the Left Ventricle in the Apical (1,2,3) and Parasternal Short Axis 
(4,5,6) Windows 
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captured during patient breath hold to minimise translation. A three beat loop of the apical 
four chamber view with one focal zone was captured for later off-line ST analysis. Then, 
three to four beat loops of each wall were captured with TVI overlay for later off-line 
analysis. The cine loops were stored digitally on the hospital’s ProSolv (ProSolv 
CardioVascular Client 4.0.2) archive system. 
 
 
2.5.2 Echocardiography and Angiography Analysis, Measurements and 
Calculations 
 
All echocardiography imaging and analysis was performed independently and without 
knowledge of the coronary artery angiography images or report. Analysis of RWMAs was 
performed by a single cardiologist, offline at a time separate to the image collection. All 
measurements were performed by the author, as recommended by the American Society of 
Echocardiography [107]. 
 
 
2.5.2.1  Regional Wall Motion Analysis  
 
Regional wall motion was assessed from the standard echocardiographic images obtained 
from the apical four chamber, apical two chamber, and apical long axis on Prosolv (ProSolv 
CardioVascular Client 4.0.2), by a single experienced echocardiologist. The echocardiologist 
determined the presence of RWMAs by assessing the degree of endocardial thickening of 
each of the cardiac walls. The independence of this analysis from the remaining 
echocardiography analysis was a critical component as this formed a comparative group.  
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2.5.2.2 All Other Echocardiography Analysis 
 
All other echocardiographic advanced imaging analysis was performed by the author, 
offline on EchoPac (GE Vingmed Ultrasound, Horten, Norway). TVI and ST derived 
velocity, strain, strain rate were performed and analysed by the author. This analysis was 
performed blind to the report from the echocardiologist and blind to the coronary 
angiography results.   
 
 
2.5.2.3  Two Dimension Measurements and Calculations 
 
2.5.2.3.1 Left Atria Area 
 
The left atrial area was obtained from the apical four chamber view (Figure 9). The left 
atrium was zoomed and frozen in end-systole (just prior to mitral valve opening). The blood-
tissue interface was traced from annulus to annulus. 
 
 
 
 
 
 
 
 
Figure 9: Left Atria Area 
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2.5.2.3.2  Left Ventricular Volumes and Ejection Fraction 
 
The left ventricular volumes and LVEF were obtained from the apical four chamber and 
apical two chamber views at breath hold using the Simpson’s Biplane method. The LVEF 
was calculated according to the following formula: 
 
EF (%) = (EDV-ESV/EDV) x 100 
 
The left ventricular endocardial border was traced manually at end-diastole and end-
systole (Figure 10) following the blood/tissue interface from annulus to annulus excluding the 
papillary muscles. The length was measured from the centre of the mitral annulus to the left 
ventricular apex. Left ventricular ejection fractions were calculated using the modified 
Simpson’s Biplane rule. A preserved LVEF was determined as higher than 50% (50-59% = 
low-normal systolic function), while a normal LVEF was determined as higher than 60%.  
 
Figure 10: Simpson’s Biplane Ejection Fraction: End Diastole (left) and End Systole (right) 
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2.5.2.4  Doppler Measurements and Calculations 
 
2.5.2.4.1 Transmitral Flow 
 
The transmitral flow trace was obtained from the apical four chamber view (Figure 11). 
Using pulsed wave Doppler, the sample volume (set at 1-2mm) was placed at the mitral valve 
leaflet tips, acquiring two to three beats. Early diastolic flow velocity (E), late diastolic flow 
velocity (A) and mitral E deceleration time were measured. 
 
 
Figure 11: Transmitral Inflow 
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2.5.2.4.1.1 Tissue Velocity Imaging at the Mitral Annulus 
 
TVI was obtained from the apical four chamber view of the left ventricle at breath hold. 
Tissue velocity was overlaid on the image. Using pulsed wave Doppler the sample volume 
(set at 3-5mm) was placed at the corner of the medial/mitral annulus, acquiring two to three 
beats. Early diastolic velocity (Em) and late diastolic velocity (Am) were measured (Figure 
12).  
  
 
 
 
Figure 12: Tissue Doppler Imaging Septal Annulus 
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2.5.2.5  Advanced Echocardiography Measurements 
 
 
2.5.2.5.1 Event Timing – Defining Systole 
 
Event timing enabled the identification of TVI and ST derived velocity, strain and strain 
rate waveforms and their relation to the cardiac cycle. To determine the length of systole 
using aortic valve opening and aortic valve closure, a left ventricular outflow tract trace was 
obtained.  
 
Pulsed wave Doppler was performed in the apical five chamber view, with a sample 
volume (set at 3-5mm) placed just proximal to the aortic valve in the left ventricular outflow 
tract, acquiring two to three beats. The time was measured between the R wave (on the ECG) 
and aortic valve opening, then between the R wave (on the ECG) and aortic valve closing 
(Figure 13).  
 
To determine the length of diastole using mitral valve opening and mitral valve closure a 
transmitral flow trace was obtained as described above. The time was measured between the 
R wave (on the ECG) and mitral valve opening, then between the R wave (on the ECG) and 
mitral valve closing (Figure 14). 
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Figure 13: Event timing of Aortic Valve Opening and Closure - Systole 
Figure 14: Event Timing of Mitral Valve Inflow Opening and Closure - Diastole 
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2.5.3 TVI Derived Velocity, Strain and Strain Rate 
 
The tissue velocity overlay images of the left ventricle optimised for the five walls (as 
described above) were selected individually.  A pulsed wave Doppler sample volume (5-
8mm) was placed at the basal (defined as the area between the mitral valve annulus and the 
tips of the papillary muscles), mid (defined as the area between the tips of the papillary 
muscles to the base of the papillary muscles) and distal (defined as the area between the base 
of the papillary muscles to the apex) segments, enabling analysis of 15 segments (Figure 15). 
The apex was excluded. The sample volume position was finely manipulated within the 
segment to avoid artefact, drop-out or nonsensical signals (Figure 15). Waveforms were 
acquired for TVI derived velocity, strain and strain rate. Traces were not performed or 
excluded if there was artefact (i.e. reverberation artefact from rib, etc.) or interference (i.e. 
from lung, etc.). 
 
 
 
 
 
 
 
 
 
Areas in red indicate 15 segments analysed, while black circles indicating approximate sample volume 
positioning when performing TVI analysis.  
Reproduced and altered (from the original image by the author) from [32] 
Figure 15: Segmental Analysis and Approximate Sample Volume Placement 
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From the resulting waveforms, the following measurements were performed: Systolic (S’) 
velocity – from the baseline up to the peak systolic waveform (Figure 16); peak negative 
strain – from the baseline down to the peak systolic waveform (Figure 17); and peak negative 
strain rate – from the baseline down to the peak systolic waveform (Figure 18). The data for 
each segment, for each modality, was averaged by the number of beats captured (three to four 
beats) then transferred to an EXCEL spread-sheet. In the EXCEL spread-sheet, the data of 
each modality (TVI and ST derived velocity, strain and strain rate) for each vessel territory 
(LAD, Cx and RCA) was averaged resulting in territorial velocity, strain and strain rate.   
 
 
 
 
 
 
 
 
 
 
 
 
Peak systolic velocities of the basal, mid and distal wall are positive and measured three times to ensure 
reproducibility 
Figure 16: TVI Derived Velocity 
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Peak systolic strain values of the basal, mid and distal walls are negative and measured three times to ensure 
reproducibility 
 
 
 
 
 
 
 
 
 
 
Peak systolic strain rate of the basal, mid and distal wall are negative and measured three times to ensure 
reproducibility 
Figure 17: TVI Derived Strain 
Figure 18: TVI Derived Strain Rate 
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2.5.4 ST Derived Velocity, Strain and Strain Rate 
 
The images with no TVI overlay, optimised for the left ventricle in the apical four 
chamber view were used for ST. The ST modality (also called 2D strain) was selected on 
EchoPac (GE Vingmed Ultrasound System, Horten, Norway) and the blood/tissue interface 
was manually traced around from the inferoseptal mitral annulus following the endocardium 
around to the anterolateral mitral annulus. The trace was analysed by EchoPac (GE Vingmed 
Ultrasound System, Horten, Norway) automatically showing the segments which were 
tracked well or tracked insufficiently, then approved manually by the author. The resulting 
waveforms were automatically displayed with calculated data on peak systolic velocity, peak 
systolic strain and peak systolic strain rate by the machine (Figure 19). Global strain was also 
calculated. The data was transferred to an EXCEL spread-sheet. In the EXCEL spread-sheet, 
the data of each modality for each vessel territory was averaged resulting in territorial 
velocity, strain and strain rate. 
 
 
The machine generates waveforms of the segments of the myocardium and provides measurements of velocity, 
strain and strain rate 
  
Figure 19: Speckle Tracking Derived Velocity, Strain and Strain Rate 
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2.6 Coronary Angiography 
 
The patients’ height (cm), weight (kg) and body surface area (m2) were calculated prior to 
the angiography procedure. Coronary angiography was performed using standard clinical 
techniques by the cardiologist assigned to angiography on the specific day. Images were 
stored in the hospital’s ProSolv (ProSolv CardioVascular Client 4.0.2) archive system. 
Standard diagnostic coronary artery angiography was undertaken according to clinical 
requirement, including contrast injections to all major vessels. 
 
 
2.6.1 Angiography Analysis 
 
The angiography images were analysed on Prosolv (ProSolv CardioVascular Client 4.0.2) 
by an experienced cardiologist. A single cardiologist determined the presence and severity of 
coronary artery stenosis in each of the major coronary artery territories (LAD, Cx and RCA). 
Significant coronary artery stenosis was defined as 70% or greater diameter stenosis. The 
cardiologist was blind to the echocardiography results including ST and TVI.  
  
 
2.7 Statistical Analysis 
 
Statistical analysis was performed using SAS JMP version 10 by a biostatistician at 
Christchurch Hospital, New Zealand. Linear regression fit was used to test for correlation 
between LVEF and the advanced echocardiography indices. A non-parametric Wilcoxon test 
was used for comparison of these indices between patient groups. Patients were grouped on 
the presence and absence of RWMAs in each territory and on the presence and absence of 
CAD in each territory. Statistical significance was taken as p<0.05. 
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2.8 Summary: Methodology 
 
Echocardiography is a quick, cost effective, bedside diagnostic tool which is useful in the 
assessment of both systolic and diastolic dysfunction when patients present with NSTEMI. 
From the background explored in Chapter One, it was noted there were gaps and shortages in 
the literature concerning the analysis of systolic and diastolic dysfunction with NSTEMI 
presentations. Particular areas which require further investigation include determining the 
prevalence of regional dysfunction visualised on NSTEMI admission and to determine 
whether the regional dysfunction correctly identified culprit coronary arteries (as identified 
by coronary angiography). 
 
Also, although well validated in literature, TVI and ST derived velocity, strain and strain 
rate are not utilised clinically at many national and international centres. This CENSTEMI 
methodology has been specifically formulated to show trends within the data set of TVI and 
ST derived velocity, strain and strain rate when compared to the three major coronary artery 
territories with RWMAs and underlying CAD. Also, it was important to determine the 
validity of performing these tests in a routine clinical (non-research) setting.  
 
Methodology has been specifically selected to investigate the aims (as above), as 
determined by gaps and shortages in literature (as outlined in the literature review).  
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3 Chapter Three:  Part I Results - NSTEMI Characteristics and 
Standard Echocardiography Features 
 
 
3.1 Introduction 
 
This chapter presents the results of an audit of the 55 randomly selected patients enrolled 
in this study who were admitted to Christchurch Hospital, New Zealand between the dates of 
June 2011 and April 2012 with NSTEMI who fulfilled the inclusion criteria.  
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3.2 Patient Characteristics 
 
Fifty-five patients with NSTEMI were included in this study. 76% were male with an 
average age of 66 years. 13% of the patients were smokers while 18% of the patients were 
ex-smokers (time since smoking ceased was not available). 20% of the patients had type II 
diabetes, with a mix of diet or medically controlled disease (Table 1).  
 
 
Table 1: NSTEMI Patient Characteristics of 55 Patients Admitted to Christchurch Hospital, New Zealand (June 
2011 and April 2012) 
 
Patient Characteristics of NSTEMI 
presentations (n=55) 
Variable Mean ± SD or n (%) 
Age (years) 65.9 ± 10.8 
Gender (male) 42 (76%) 
Height (cm) 171.7 ± 8.7 
Weight (kg) 85.6 ± 16.9 
BSA (m²) 2.0 ± 0.3 
Smoker 
7 (13%) 
Ex-Smoker  10 (18%) 
Type 2 diabetes  11 (20%) 
 
Where BSA = body surface area 
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3.3 Admission Characteristics 
 
All patients (100%) presented with chest pain; one patient had associated dyspnoea and 
one other associated vertigo. On admission, ECG in the Emergency Department showed 47% 
of the patients had no significant waveform changes, while the remaining patients had either 
T wave inversion, ST- segment (ECG) depression or a combination of the two. The peak TnI 
level ranged from 0.03µg/L to 31µg/L (Table 2).  
 
 
Table 2: NSTEMI Patient Admission Characteristics of 55 Patients Admitted to Christchurch Hospital, New 
Zealand 
 
Admission Characteristics of NSTEMI Presentations (n=55) 
Variable Mean ± SD or n (%) 
Main presenting symptoms 
55 (100%) Chest pain 
1 (2%) Dyspnoea 
1 (2%) Vertigo 
Main ECG changes  
(none or either 1 or both) 
26 (47%) none 
17 T wave inversion/14 ST 
segment depression (53%) 
Heart rate (beats per minute) 63 ± 10 
Peak TnI (µg/L) 2.53 ± 5.38 (range = 0.03-31) 
 
Where ECG = electrocardiogram and TnI - Troponin I 
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3.4 Event Timing: Admission, Echocardiography, Angiography and 
Discharge 
 
The timing of events was recorded for each patient from admission to echocardiography, 
angiography, and (if required) in-hospital coronary artery bypass grafting (CABG) to 
discharge. From admission, patients waited an average of 1.4 ± 1.1 days for an 
echocardiogram and 3.1 ± 1.4 days for angiography. Patients who were not referred for 
CABG were discharged an average of 4.1 ± 1.6 days after admission. The patients who were 
referred for in-hospital CABG were discharged an average of 19 ± 3.2 days after admission 
(Table 3).  
 
 
Table 3: Timing of Admission, Echocardiography, Angiography, Coronary Artery Bypass Grafting and 
Discharge 
 
Timing of Patient Events 
Variable Mean ± SD (days) 
Admission to Echocardiography (days) 1.4 ± 1.1 
Admission to Angiography (days) 3.1 ± 1.4 
Admission to Discharge – patients not requiring 
in-hospital CABG (days) 
4.1 ± 1.6 
Admission to Discharge – patient requiring in-
hospital CABG (days) 
19 ± 3.2 
 
Where: CABG - coronary artery bypass grafting 
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3.5 Echocardiography Results 
 
 
3.5.1 Echocardiography Systolic Results 
 
The mean LVEF for the sample population was 60 ± 9%. 35 had an LVEF greater than 
60%, 10 had an LVEF between 50-59%, 10 had an LVEF between 40-49% and 0 patients had 
an LVEF <40% (Table 4). 
 
 
Table 4: Systolic Function Characteristics of NSTEMI Presentations 
 
 
Where: SD = standard deviation and NSTEMI = non-ST elevation myocardial infarction 
  
Systolic Function Characteristics of NSTEMI Presentations (n=55) 
 Mean ± SD or n (%) 
Ejection Fraction (%) 
60 ± 9 
Ejection Fraction ≥ 60% 
35 (64%) 
Ejection Fraction  50-59% 
10 (18%) 
Ejection Fraction 40-49% 
10 (18%) 
Ejection Fraction <40% 
0 
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LVEF was compared with the presence and absence, of CAD as identified with 
angiography. Of the 55 patients, all of those with an LVEF 50-59% and 90% of those with an 
LVEF 40-49% had RWMAs present. 11% of patients with RWMAs had a normal systolic 
function (LVEF ≥60%); of these 75% had RWMAs in the RCA region. 60% of patients with 
an LVEF between 50-59% had an LAD RWMA and 40% had an RCA RWMA. CAD was 
present in 100% of the patients with an LVEF between 50-59%, and in 90% of patients with 
an LVEF between 40-49% (Table 5).  
 
Table 5: Left Ventricular Ejection Fraction Groups compared with Regional Wall Motion Abnormalities 
 
 
Where LVEF = left ventricular ejection fraction; RWMA = regional wall motion abnormalities; LAD = left 
anterior descending coronary artery; RCA = right coronary artery; Cx = circumflex coronary artery; TVD = triple 
vessel disease and CAD = coronary artery disease 
 
Left Ventricular Ejection Fraction Compared with Coronary Artery Disease 
 
LVEF ≥ 60% 
(n=35) 
LVEF 50-59% 
(n=10) 
LVEF 40-49% 
(n=10) 
RWMA Present 4 (11%) 10 (100%) 9 (90%) 
LAD RWMA 0 6 (60%) 5 (50%) 
RCA RWMA 3 (75%) 4 (40%) 0 
LAD + RCA RWMA 1 (25%) 0 0 
LAD + Cx RWMA 0 0 1 (10%) 
RCA + Cx RWMA 0 0 1 (10%) 
TVD RWMA 0 0 2 (22%) 
CAD Present  22 (63%) 10 (100%) 8 (80%) 
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3.5.2  Echocardiography Diastolic Results 
 
 
3.5.2.1  Diastolic Dysfunction Grading 
 
Of the 55 patients, 80% had mildly impaired diastolic function, 7% of patients had normal 
diastolic function, 11% had pseudonormal diastolic function and 2% had restrictive diastolic 
function. 7% of patients had an E:A ratio greater than 1.5, while 20% of patients had E/Em 
greater than 15 (Table 6).  
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Table 6: Echocardiography Derived Diastolic Function Indices 
 
Where: E = early filling velocity; A = late (atria) filling velocity; E DT = early filling velocity deceleration time; 
E:A ratio = mitral inflow Doppler ratio between early filling velocity and late filling velocity; E/Em = filling pressure; 
N/A = not available and TVI = tissue velocity imaging 
Diastolic Indices of NSTEMI Patients 
Variable Mean ± SD or n (%) 
E velocity 69.8 ± 22.2 
A velocity 80.6 ± 20.1 
E:A ratio 1.03 ± 1.04 
E:A ratio < 1 36 (65%) 
E:A ratio 1.0-1.5 13 (24%) 
E:A ratio > 1.5 4 (7%) 
E:A ratio N/A 2 (4%) 
E DT 265.8 ± 81.5 
TVI Em Velocity 6.59 ± 1.9 
TVI Am Velocity 10.4 ± 2.08 
E/Em 11.6 ± 5.2 
E/Em < 8 11 (20%) 
E/Em 8-14 32 (58%) 
E/Em >14 11 (20%) 
Undefined E/Em 1 (2%) 
Normal diastolic function (Grade 0) 4 (7%) 
Mildly impaired diastolic function (Grade 1) 44 (80%) 
Pseudonormal diastolic function (Grade 2) 6 (11%) 
Restrictive diastolic function  (Grade 3) 1 (2%) 
 Diastolic dysfunction grades were compared with patient age, TnI, LVEF, RWMA, CAD, CABG, E:A ratio and E/Em to determine trends 
within the data (Table 7).  
Table 7: Characteristics of Diastolic Function Grades in NSTEMI Patients 
 
Characteristics of Diastolic Function Grades in NSTEMI Patients 
Diastolic Function 
Classification 
Mean 
Age 
(years) 
TnI 
(µg/L) 
LVEF 
(%) 
RWMA 
Present 
CAD 
Present 
CABG 
E:A 
ratio 
E/Em 
Normal (n=4) 
50 ± 
5.3 
0.8 ± 
1.1 
65 ± 3 0 0 0 
1.3 ± 
0.3 
9.3 ± 
2.5 
Mildly Impaired  
 <65 years old  
(n=17) 
56 ± 5 
1.2 ± 
2.3 
59 ± 9 7 (41%) 
13 (76%) 
SVD 4 
DVD 4 
TVD 5 
4 
(24%) 
0.9 ± 
0.4 
9 ± 
3.2 
Mildly Impaired  
>65years old 
(n=27) 
73.9 ± 
6.3 
3.6 ± 
7.3 
61 ± 9 
11 
(41%) 
21 (75%) 
SVD 14 
DVD 5 
TVD 2 
2 (7%) 
0.8 ±  
0.2 
12 ± 
4.3 
Pseudonormal (n=6) 68 ± 8 
3.3 ± 
4.7 
54 ± 
10 
4 (67%) 
5 (83%) 
SVD 2 
DVD 2 
TVD 1 
2 
(33%) 
1.4 ± .2 
22 ± 
4.5 
Restrictive (n=1) 66 4 41 1(100%) 
1 
SVD 0 
DVD 0 
TVD 1 
0 1.2 9 
Where: TnI = Troponin I; LVEF = left ventricular ejection fraction; RWMA = regional wall motion abnormalities; CABG = coronary artery bypass grafting; SVD = Single 
vessel disease; DVD = Two vessel disease; TVD =Triple vessel disease; E:A ratio = mitral inflow Doppler ratio between early filling velocity and late filling velocity and E/Em = filling 
pressure; 
 3.5.2.2 Diastolic Dysfunction with Preserved Ejection Fraction 
 
The characteristics of patients with diastolic dysfunction were assessed. Diastolic 
dysfunction was defined as grade 1 (mildly impaired) or higher. A preserved LVEF was 
defined as >50% (Table 8).Of 55 patients, 40 had grade 1 or higher diastolic dysfunction with 
a preserved LVEF. 15 patients had mildly impaired diastolic dysfunction <65 years old, 22 
patients had mildly impaired diastolic dysfunction >65 years old and 3 patients had 
pseudonormal diastolic dysfunction.  
 
Table 8: Characteristics of Patients with Diastolic Dysfunction and Preserved Ejection Fraction (>50%) 
 
Diastolic Dysfunction with Preserved Ejection Fraction (>50%) 
 
Mean 
Age 
(years) 
TnI 
(µg/L) 
LVEF 
(%) 
RWMA CAD 
RVSP 
(>30mmHg) 
E:A 
ratio 
E/Em 
Mildly Impaired  
 <65 years old  
(n=15) 
57.5 ± 
5.3 
 
1.12 ± 
2.4 
 
62 ± 
6.6 
4 11 34 ± 5 
0.9 ± 
0.4 
9.9 ± 
3.3 
Mildly Impaired  
>65years old 
(n=22) 
74 ± 5.2 3.9 ± 8 
63 ± 
5.8 
8 18 32 ± 5 
0.74 ± 
0.2 
11.3 
± 3.8 
Pseudonormal 
(n=3) 
65 ± 5.7 2 ± 2.3 
63 ± 
8.5 
1 2 34 
1.2 ± 
0.2 
22 ± 
6.2 
 
Where: TnI = Troponin I; RWMA = regional wall motion abnormalities; CAD = coronary artery disease; RVSP 
= right ventricular systolic pressure; E:A ratio = mitral inflow Doppler ratio between early filling velocity and late 
filling velocity and E/Em = filling pressures 
  
  
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
75 
 
3.5.2.3 Diastolic E:A ratio > 1.0 in Patients with Pseudo-normal and Restrictive 
Diastolic Dysfunction 
 
E:A ratio > 1.0 was assessed in patients with pseudonormal and restrictive diastolic 
dysfunction. The mean age was 68 ± 9 years old, the mean LVEF was 52 ± 12% and the 
mean E/Em was 20 ± 6 (Table 9).  
 
Table 9: Characteristics of Patients with E:A ratio >1.0 in Patients with Pseudo-normal and Restrictive Diastolic 
Dysfunction 
 
Patients with E:A ratio >1.0 and Pseudonormal or 
Restrictive Diastolic Dysfunction (n=7) 
Variable 
Mean ± SD or n (%) 
E:A ratio distribution 
1.4 ± .4 
Age (years) 
68 ± 9 
Ejection Fraction (%) 
52 ± 12 
Coronary Artery Disease Present 
6 (86%) 
E/Em  
20 ± 6 
Pseudonormal Diastolic Dysfunction 
6 (86%) 
Restrictive Diastolic Dysfunction 
1 (14%) 
 
Where: E:A ratio = mitral inflow Doppler ratio between early filling velocity and late filling velocity and  E/Em 
= filling pressures 
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3.5.3 Assessment of Regional Wall Motion Abnormalities with 
Echocardiography 
 
Out of the 55 patients admitted with NSTEMI, 23 were noted to have RWMAs on 
echocardiography. 48% of RWMAs were in the LAD region and 30% in the RCA region. 
Multiple RWMAs were noted in 22% of patients. No RWMAs were solely in the Cx region. 
Of the 4 groups, RCA infarcts had an LVEF 58 +/- 6%, LAD 50 +/- 6%. Patients with 
multiple RWMAs had an LVEF 46 +/- 4% (Table 10).  
 
 
Table 10: Regional Wall Motion Abnormalities Assessment 
 
Regional Wall Motion Abnormalities Present 
RWMA (n=23) 
RWMA 
Present 
Ejection fraction 
(%) 
LAD 11(48%) 50 ± 6 
Cx 0 N/A 
RCA 7 (30%) 58 ± 6 
Multiple 5 (22%) 46 ±4 
 
 
Where: RWMA = Regional wall motion abnormalities; LAD = Left anterior descending coronary artery; Cx = 
Circumflex coronary artery; RCA = Right coronary artery and Multiple = Two or three region regional wall motion 
abnormalities noted 
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3.5.4 Correlation of Troponin I with Ejection Fraction 
 
Troponin I (TnI) and LVEF were assessed to determine whether peak TnI correlated with 
RWMAs (i.e. myocardial necrosis) or systolic dysfunction, which would result in a reduced 
LVEF. Graph 1 shows there was no correlation between TnI and LVEF (p value was 0.8698). 
Of note, whilst the LVEF showed a slightly left skewed normal distribution, TnI was clearly 
not normally distributed and heavily skewed to the left. 
 
 
 
 
 
  
Graph 1: Bivariate Fit of Ejection Fraction (%) by Troponin I (μg/L) 
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3.5.5 Further Echocardiography Pathologies 
 
The routine echocardiography examination was reviewed to detect further significant 
pathologies.  
 
All (100%) patients had tricuspid regurgitation, while mitral regurgitation was also found 
in 46 patients (83%). Aortic regurgitation was noted in 15 patients (27%).  
 
A minority of patients had right ventricular or right atrial dilatation (4% and 5% 
respectively). While, a raised right ventricular systolic pressure (>30mmHg) was noted in 
45% of the patients.  
 
A degree of left ventricular hypertrophy (wall thickness greater than 12mm) was detected 
in 40% of patients while 22% of patients had proximal descending aorta dilatation (diameter 
greater the 37mm). 
 
These results are displayed below, in Table 11.  
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Table 11: Pathologies Noted With Echocardiography 
 
Other Pathologies Noted with Echocardiography 
Pathology 
Number of Patients with 
pathology (n=55) 
Aortic regurgitation (n=15 (27%)) 
13 (23%) mild 
2 (4%) moderate 
Mitral regurgitation (n=46 (83%)) 
43 (78%) mild 
3 (5%) moderate 
Tricuspid regurgitation (n=55 (100%)) 
52 (95%) mild 
3 (5%) moderate 
RVSP above 30mmHg 25 (45%) 
RV dilatation 2 (4%) 
LA dilatation  8 (15%) 
RA dilatation 3 (5%) 
Left ventricular hypertrophy (n=22 (40%)) 
20 mild (36%) 
2 moderate (4%) 
Descending aorta dilatation 12 (22%) 
 
Where: RVSP = Right ventricular systolic pressure (mmHg); RV=– Right ventricle; LA = Left atrium; RA = 
Right atrium; LVH = Left ventricular hypertrophy 
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Patients presenting with NSTEMI were divided into five groups: those discharged 
following angiography, those requiring CABG, those with a re-admission, those requiring 
CABG and who re-admitted and those who had CABG then died. These variables were 
compared to patient echocardiography characteristics and TnI (Table 12).  
 
Table 12: Patient Events Post NSTEMI Compared with Echocardiography Characteristics 
Patient Events Post NSTEMI 
 
No event after 
angiography / 
angioplasty 
(n=39) 
CABG 
(n=6) 
Re- 
Admission 
(n=8) 
CABG + 
Re- 
Admissio
n (n=1) 
CABG + 
Deceased 
(n=1) 
Ejection 
Fraction 
(%) 
61 ± 8 57 ± 9 61 ± 8 71 48 
TnI  3 ± 6 2.6 ± 4.2 0.6 ± 1.1 0.4 10.7 
Left atria 
dilatation 
6 (15%) 2 (33%) 1 (14%) 0 0 
Aortic 
dilatation 
9 (23%) 2 (33%) 1 (14%) 0 1 
Diastolic 
function 
Grade 0 4 
Grade 1 31 
Grade 2 3 
Grade 3 1 
 
Grade 
1 
4 
Grade 
2 
1 
 
Grade 
1 
8 
 
Grade 
1 
1 
 
Grade 
2 
1 
 
E:A ratio 1.1 ± 1.2 1.1 ± 0.6 0.82 ± 0.4 0.8 1.19 
E/Em 11 ± 4.9 14 ± 6.2 13 ± 5.5 - 22 
 
Where: CABG =Coronary artery bypass grafting and TnI = Troponin I; E:A ratio = mitral inflow Doppler ratio 
between early filling velocity and late filling velocity and E/Em = filling pressures 
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3.6 Angiography Results 
 
This section will look at the results of angiography to determine the presence and absence 
of CAD in patients presenting with NSTEMI. Of the 55 patients, 40 had significant disease 
present. For 37% of patients the LAD was the culprit coronary artery and for 13% of patients 
the RCA was the culprit coronary artery. The Cx was not deemed a significant single culprit 
artery in any of the 40 patients with significant CAD. Prevalence of two vessel disease 
(where two of the three main coronary artery vessels were deemed culprit arteries) and triple 
vessel disease (where all three of the main coronary arteries were deemed culprit arteries) 
was 27% and 23% respectively (Table 13).  
 
 
Table 13: Angiography Results – Culprit Coronary Arteries 
 
Culprit Coronary Arteries 
Coronary Artery 
Patients with significant disease 
present (n=40) 
LAD 15 (37%) 
Cx 0 
RCA 5 (13%) 
Two vessel disease 11 (27%) 
Triple vessel disease 9 (23%) 
 
 
Where: LAD = Left anterior descending coronary artery; Cx = Circumflex coronary artery; RCA = Right 
coronary artery 
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3.6.1  Agreement between RWMA with Echocardiography and the Presence 
and Absence, of CAD with Angiography 
 
The correlation between RWMA assessment with echocardiography and CAD with 
angiography was assessed. There were 63 possible regions in 21 patients with both RWMA 
present on echocardiography and CAD present on angiography. Two of the 55 patients with 
RWMA but no CAD, were excluded from this comparison. Of the patients with RWMA, 
74% of the regions were correctly identified by echocardiography as having either normal or 
abnormal (hypokinetic/akinetic) function associated with CAD, while 21% of the segments 
were not identified/missing (deemed normal when in fact they were abnormal) and 5% of the 
segments were incorrectly identified (deemed abnormal when in fact they were normal - 
RWMAs were noted when there was no associated CAD). The 13 regions with no identified 
RWMAs, where CAD was present, were from patients with multiple vessel disease, with at 
least one of the culprit arteries in each case correctly identified with echocardiography (Table 
14).  
 
Table 14: Regional Wall Motion Abnormalities Identified with Echocardiography: Comparison with 
Angiography Results 
Regional Wall Motion Abnormalities Identified with Echocardiography: Comparison 
with Angiography Results 
Correlation of wall motion assessment 
with angiography 
Regions identified (regions n=63) 
Identified a correct CA (correct) 
47 (74%) 
No RWMA identified but CAD present 
(missing) 13 (21%) 
RWMA identified does not match culprit 
coronary artery (wrong) 3 (5%) 
 
Where: CA = coronary artery; CAD = coronary artery disease and RWMA = regional wall motion abnormality 
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RWMAs present on echocardiography were compared with CAD detected with 
angiography to determine the prevalence of a false negative or false positive diagnosis. Of the 
55 patients, 40 had CAD and 23 patients had RWMAs. Of the 55 patients, 2 showed RWMAs 
on echocardiography with no evidence of CAD on coronary angiography suggestive of false 
positive results. Of the two patients, one had type II diabetes and an LVEF of 43% (Table 
15).  
 
 
 
Table 15: Specificity versus Sensitivity of Regional Wall Motion Abnormality Analysis with Echocardiography 
 
Specificity versus Sensitivity of RWMA Analysis with 
Echocardiography 
 Coronary Artery Disease Present 
 
RWMA 
Present on 
Echo 
 Yes No Total 
Yes 21 2 23 
No 19 13 32 
Total 40 15 55 
 
Where: RWMA = regional wall motion abnormalities 
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 The distribution of CAD in patients with no evidence of RWMAs with echocardiography 
and the number of patients from each category requiring CABG was assessed. Angiography 
showed 19 (48%) of patients with CAD had no identifiable RWMAs. CAD with no 
reciprocal RWMA was noted in the LAD territory (37%) and the RCA territory (16%). As 
noted earlier, the Cx was not identified as a single culprit coronary artery in any of the 55 
patients (Table 16).  
 
Table 16: Coronary Artery Disease with no Corresponding Regional Wall Motion Abnormalities 
 
Coronary Artery Disease with No Visual Regional Wall Motion Abnormalities 
Coronary Artery Patients (n=19) Require CABG (n=4) 
TVD 4 (21%) 3 (75%) 
DVD 5 (26%) 1 (25%) 
LAD 7 (37%) 0 
RCA 3 (16%) 0 
Cx 0 0 
 
 
Where: CABG = coronary artery bypass grafting; TVD = triple vessel disease; DVD = double vessel disease; 
LAD = left anterior descending coronary artery; RCA = right coronary artery and Cx = circumflex coronary artery 
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3.7 Re-admission and Mortality 
 
Re-admission was assessed up to, and including August 13
th
 2012. Of the 55 patients, 
nine patients represented to hospital (Table 17). Re-admission times varied greatly (49 +/- 60 
days). Eight of the nine patients readmitted with chest pain, while one was re-admitted with 
syncope after taking glyceryl trinitrate spray for angina. Four of the patients had diabetes and 
only one of the patients had undergone CABG. Tests and treatments for these patients were 
not assessed. As of 13
th
 August 2012, one of the 55 patients has died. No further survival 
analyses have been conducted as the event rate is so low. 
 
Table 17: Re-admission Characteristics 
Re-admission Characteristics 
Re-admission timings (days) 49 ± 60 
Sex 78% male 
Troponin I 0.6 ± 1.1 
Reason 
8 Chest Pain 
1 Syncope post GTN 
Smoker 
1 Current 
2 Ex-smokers 
Diabetes 4 
Ejection Fraction (%) 62 ± 8 
Coronary artery disease 7 
Coronary artery bypass grafting 1 
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4 Chapter Four: Part I Discussion - NSTEMI Characteristics and 
Standard Echocardiography Features 
 
4.1 Introduction 
 
In 2007 the American College of Cardiology and the European Society of Cardiology 
altered the definition of a myocardial infarction, traditionally incorporating only STEMI, to 
include unstable angina and NSTEMI presentations [108], which have since been updated 
[1]. The New Zealand 2012 NSTEMI management guidelines [29] state “an echocardiogram 
is recommended in all patients with elevated TnI and those with electrocardiogram 
abnormalities to assess global and regional left ventricular function, to assess the valves, 
defining all differential diagnosis”. It is therefore surprising that the New Zealand ACS audit 
[15] found echocardiography was only performed in 22% of patients who presented with 
NSTEMI. This chapter explores the benefits of utilising echocardiography as a diagnostic 
tool in NSTEMI presentations, detailing characteristics of admission, echocardiography and 
angiography for a randomly selected set of 55 patients admitted to Christchurch Hospital, 
New Zealand between June 2011 and April 2012.  
 
 
4.2 Patient Characteristics 
 
The ‘average NSTEMI’ patient from this research data set was aged 66 years old (±10.8) 
and male (76%). Current literature in this field varies in thought regarding the prevalence of 
male and female NSTEMI presentations. The Global Registry of Acute Coronary Events 
2004 [22] included 11,543 patients from 14 countries. They found 53% of the patients were ≥ 
65 years of age and around two thirds of the patients were male (inclusive of all acute 
coronary events). A study published in 2010 by Ellis et al. [15] found the mean age of 
patients presenting with NSTEMI was 67 years, while 58% of patients were male. This 
CENSTEMI study revealed a similar average age to the two studies mentioned above, but the 
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higher prevalence of male patients agreed more with the Global Registry of Acute Coronary 
Events study [22]. A higher percentage of male patients could be due to chance alone, owing 
to the small sample size or it could be the result of entry criteria that required coronary 
angiography to be planned. It is possible that males are more likely to be referred for 
angiography than females. Also, females often present with atypical symptoms and a less-
severe past medical history. Literature suggests that females, are therefore, often treated less 
aggressively due to misdiagnosis resulting in poorer prognostic outcomes [109]. 
 
One fifth of the patients presenting with NSTEMI in this study had type II diabetes 
(20%), while over half the patients (56%) were current or former smokers. Similar numbers 
were found in New Zealand ACS audit [15] with 19% and 59% respectively. In this 
CENSTEMI study, overall, those who were current or former smokers, and/or those who had 
diabetes, had a higher incidence of significant coronary artery lesions than patients who had 
neither diabetes nor ever smoked (79% versus 67% respectively). Interestingly, patients who 
smoked and/or were diabetic (n=24) were associated with a nine-fold requirement for CABG 
than patients who had neither diabetes nor smoked (n=31) (29% versus 3% respectively). The 
decision to proceed to CABG was clinical and was required if cardiologists were unable to 
successfully unblock culprit lesions with angioplasty or if the coronary disease was 
significantly diffuse. These figures are consistent with our understanding that diabetes and 
smoking predispose a patient to a significantly increased burden of cardiovascular disease 
[110-115]. 
  
 
4.3 Admission Characteristics 
 
NSTEMI diagnosis requires acute presentation of patients with ischemic symptoms (such 
as chest, upper extremity, jaw or epigastric pain, possibly accompanied by dyspnoea, nausea 
or syncope [1], biomarker elevation (Troponin I (TnI)), measured in μg/L, is primarily 
utilised at Christchurch Hospital, New Zealand as a marker of acute myocyte necrosis, using 
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the 99
th
 percentile as a reference limit of elevation) and ECG changes (T wave inversion or 
ST depression).  
All patients presented with chest pain, 53% of patients had ECG changes (T wave 
inversion and/or ST depression), and all patients had an elevated peak TnI. Patients with 
myocardial necrosis, which results in visual endocardial damage, will have RWMAs. This is 
where regions of endocardium fail to contract normally (defined as hypokinetic, akinetic or 
diskinetic), and, therefore, will have reduced LVEF (as measured by the Simpson’s Biplane 
method).  
 
Peak TnI values were compared to LVEF. We did not find any correlation between TnI 
elevation and LVEF impairment. Although peak TnI is an effective indicator of acute 
myocyte necrosis [1], this CENSTEMI study shows that TnI elevation does not correlate with 
the extent of endocardial damage identified with echocardiography. A study published in 
2009 by Piotrowska-Kownacka et al. [116] assessed 34 patients presenting with STEMI. TnI 
was measured on admission and cardiac MRI was used to determine regional dysfunction and 
LVEF. They found TnI on admission could not predict infarct size or early LVEF. The 
outcomes of the Piotrowska-Kownacka study [116] and this CENSTEMI research suggest 
that TnI will only indicate the event of an acute coronary process, not the extent of LVEF 
impairment whether considering TnI on admission or at peak respectively. Therefore, this 
CENSTEMI study argues against using peak TnI to select patients for echocardiography. 
 
The average time from admission to echocardiography was 1.4 days (±1.1) and from 
admission to angiography was 3.1 days (±1.4). A study published in 2012, performed by 
Theile et al. [117] assessed the outcome of NSTEMI patients following early (<2 hours), 
intermediate (10-48hours) or selective (67.2 hours) angiography using both peak creatine 
kinase myocardial banding activity during hospitalisation with death, non-fatal infarction, 
refractory ischemia and re-hospitalisation within six months as endpoints. The study found 
that intermediate or selective angiography did not significantly alter patient prognosis. In this 
CENSTEMI study, the average time from admission to angiography was calculated at 74.4 ± 
33.6 hours suggesting that the selective strategy of angiography is utilised most commonly at 
Christchurch Hospital, New Zealand. The Theile et al. [117] study provides reassuring data 
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about the time from admission to angiography at Christchurch Hospital, New Zealand, 
suggesting that while in hospital, the selective strategy of angiography does not affect the 
prognostic outcome of patients. However, the Theile et al. [117] study did not test any 
echocardiographic parameters. Echocardiographic parameters may have assisted in 
diagnosing the severity of the event (e.g. RWMA size/severity and LVEF both short and long 
term). It would be interesting to repeat the study, including echocardiography, to determine 
whether early, intermediate or selective revascularisation affects the severity of regional 
dysfunction or results in further LVEF impairment. A study published in 2012 by DeWinter 
et al. [118] suggested early intervention for high risk ACS patients was a safe and practical 
approach resulting in reduced mortality. A study published in 2010 by Sami et al. [119] found 
high rates of adverse cardiovascular events result from unstable angina and NSTEMI 
admissions, furthermore, an early-invasive strategy would benefit high risk patients, while an 
early-conservative strategy would benefit low risk patients.  
 
In this study, the average time from admission to discharge was 4.1 days (±1.6). It was 
not possible to compare this data to the New Zealand ACS Audit as they did not assess 
hospital length of stay following NSTEMI. This is surprising as important information is 
gained regarding the cost and utilisation of public hospital resources. The New Zealand 
NSTEMI guidelines do, however, suggest that an invasive approach is cost effective as it 
reduces hospital stay [29]. This approach is limited by time and staffing constraints and the 
need to prioritise acute cardiac presentations.  
  
 In the study the average time from admission to in-hospital CABG was 19 days (±3.2). 
Again, it was not possible to compare this data to the New Zealand ACS Audit [120], as they 
did not assess hospital length of stay following NSTEMI. 
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4.4 Echocardiography  
 
4.4.1 Systolic Function 
 
Systolic function is the function of the heart in systole, or the contraction and ejection 
phase of the cardiac cycle. Systolic function may be determined by echocardiography, both 
regionally (visual assessment of the degree of contraction of regions in the heart), or globally 
(by estimation of left ventricular volumes using the Simpson’s Biplane method). 
 
LVEF was assessed in the 55 patients using the Simpson’s Biplane method. LVEF was 
most preserved in patients with regional dysfunction in the RCA territory (58±6%); LAD 
regional dysfunction resulted in the lowest single region LVEF (50±6%), while patients with 
multiple regions of dysfunction had the lowest overall LVEF (46±5%). As covered in the 
literature review, multiple studies have reported anterior infarcts result in greater LVEF 
impairment with a worse prognostic outcome than other regional infarcts [121-125]. In 
patients with an anterior infarction and LVEF impairment, peak circumferential strain at the 
apex is decreased. This results in reduced magnitude of apical rotation in the ejection phase 
and delays torsion recoil in the early diastolic phase. Inferior infarcts do not affect the apex of 
the heart (as blood supply is via the RCA coronary artery) so, presumably, have a lesser 
effect on the severity of systolic dysfunction present after an AMI. Further explanations of 
pathophysiology regarding the effect of regional dysfunction on LVEF were covered in the 
literature review.  
 
For this study, LVEF was separated into ≥60%, 50-59%, 40-49% and <40%. 90% of 
patients with an LVEF between 40-49% had CAD.  The two patients with no CAD and a 
LVEF between 40-49% was reassessed to determine the cause of systolic dysfunction. On 
review, the patient had global systolic impairment and a dilated right ventricle with raised 
right sided pressures (57mmHg before right atrial pressure), so NSTEMI may have been a 
secondary diagnosis for this patient, a co-incidental diagnosis or an incorrect diagnosis. All of 
the patients with an LVEF between 50-59% had CAD.  
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Apart from the two patients with LVEF impairment and no CAD, the results suggest 
regional dysfunction and reduced LVEF result from significant CAD due to myocardial 
necrosis as explained earlier. 67% of the patients with an LVEF ≥60% had CAD, suggesting 
that these patients had minor (mild hypokinesis, or hypokinesis in a region such as the RCA 
which affect LVEF less than that of a LAD regional infarction) or no regional dysfunction. 
Of all 55 patients, 36% had a LVEF <60%, while 18% had a LVEF <50%. These results 
show the advantages of utilising echocardiography as a tool to determine the degree of 
systolic dysfunction, which would alter post medical/clinical management of the patient.  
 
Medical therapies such as beta-blockers and angiotensin-converting-enzyme inhibitors are 
often under-prescribed in New Zealand [9, 120], so the knowledge of cardiac dysfunction 
may reinforce the requirement for prescribing these readily available, often subsidised 
medications. Patients with regional dysfunction or LVEF impairment are often routinely re-
examined with echocardiography after discharge from hospital to determine improvement. 
The results of the echocardiogram often effect the management of the patient (alterations in 
medication and follow up consultations with cardiologists as required). If echocardiography 
is not performed after an AMI, then left ventricular dysfunction may not be identified and 
subsequently not followed-up.  Furthermore, the New Zealand Transport Authority [126]  
requires a LVEF of ≥ 40% to deem someone fit to drive. This has repercussions for the wider 
community, both in terms of safety and the loss of income for families for whom driving is a 
profession. In this CENSTEMI research, no patients had a LVEF below 40%; however, a 
significant infarct (such as in the LAD region) may impair the ventricular function below 
40% (which has been seen in cases at Christchurch Hospital, New Zealand). Alternatively, a 
significant infarct may also result in an ischaemic cardiomyopathy. Without the aid of 
echocardiography, a small number of patients with an LVEF <40% may be un-diagnosed. 
This has far-reaching repercussions.  The data from this CENSTEMI study would suggest 
there are enough diagnostic benefits to warrant performing echocardiography as part of most 
ACS admissions.  
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4.4.2 Diastolic Function 
 
Diastolic dysfunction is the abnormal function of the heart during the diastolic filling or 
relaxation phase of the cardiac cycle [127]. Very few (4%) of this cohort had normal diastolic 
function (grade 0); 80% had mildly impaired diastolic dysfunction (grade 1), 11% had 
pseudonormal diastolic function (grade 2), and 2% had restrictive diastolic dysfunction 
(grade 3). This is perhaps not surprising given the average age of this patient cohort (66 
years) and the natural decline in diastolic function (seen as E:A <1) is demonstrated in people 
over 65 years [78, 128, 129]. 
 
 
4.4.2.1  The Diastolic Dysfunction Cascade  
 
The process of the diastolic cascade, which has been well validated, describes how 
diastolic dysfunction precedes systolic dysfunction. This provides an early warning sign of 
congestive heart failure [30, 130]. Diastolic dysfunction may also indicate the presence of 
underlying CAD (even when no visual RWMAs are present on standard echocardiography) 
and provides valuable information on prognostic outcome regarding mortality, re-infarction 
and congestive heart failure [51, 131]. Diastolic dysfunction with a preserved LVEF may be 
the only indication of  underlying damage to the myocardium from a NSTEMI event and may 
present within a very short time frame [132]. Diastolic dysfunction has been associated with 
cardiac remodelling, which results in progressive left ventricular dilatation, the development 
of heart failure and death following an AMI event, irrespective of the presence of systolic 
dysfunction [133]. Diastolic heart failure describes a clinical syndrome defined by the 
European Society of Cardiology [134] as the presence of signs or symptoms of heart failure 
with a preserved LVEF (>50%) and evidence of abnormal relaxation. It has been suggested 
that up to 40-50% of patients display this phenomena [135]. Heart failure symptoms were not 
evaluated in this CENSTEMI patient cohort so the presence of diastolic heart failure cannot 
be assessed in this study.  
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In this study, 40 patients presented with at least mild diastolic dysfunction and a 
preserved LVEF. 37 (84%) patients had mildly impaired diastolic dysfunction (out of the 
original 44 patients with mildly impaired diastolic dysfunction) with preserved LVEF, and 3 
(5%) patients had pseudonormal diastolic dysfunction (out of the original 6 patients with 
pseudonormal diastolic dysfunction) with preserved LVEF. A higher proportion of patients 
with preserved LVEF had mild diastolic dysfunction (84%) than with pseudonormal diastolic 
dysfunction (50%). The results of this CENSTEMI study agree with literature in this field as 
pseudonormal dysfunction is essentially a progressively worse form of mildly impaired 
diastolic dysfunction. This means patients with pseudonormal diastolic dysfunction are more 
likely to have systolic dysfunction (LVEF impairment) than patients with mildly impaired 
diastolic dysfunction.  
 
In this study, two of the three patients with pseudonormal diastolic dysfunction and a 
preserved LVEF, had CAD identified by coronary angiography. This confirms that diastolic 
dysfunction may be the result of a remodelling process [132].  
 
Of the 51 patients with diastolic dysfunction (44 mildly impaired; 6 pseudo-normal; 1 
restrictive diastolic dysfunction), 11 (28%) had no CAD. In these cases, the NSTEMI event 
may not be the cause of diastolic dysfunction; however, even in the patients with CAD, the 
NSTEMI event cannot be concluded as the cause of diastolic dysfunction. Diastolic 
dysfunction may be a pre-existing condition, which can be caused by a number of conditions 
including hypertension, age, obesity, aortic stenosis, myocardial disorder/disease and diabetes 
[136], all of which may result in CAD. Understanding the pathological process that leads to 
diastolic dysfunction, and subsequently systolic dysfunction is complex and beyond the scope 
of this thesis. But this research highlights the multi-faceted echocardiography abnormalities 
that co-exist in patients with ACSs and especially in this group who present with NSTEMI. 
Previously, these were an almost ignored group of patients and there is little research about 
the implications of such findings.  
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4.4.2.2  Normal Diastolic Function 
 
Very few patients displayed true normal diastolic function (n=4). These patients were the 
youngest in age, had an average LVEF within normal limits, the lowest peak TnI, neither 
RWMA nor CAD present, an acceptable average E:A ratio and an E/Em within normal limits. 
Normal diastolic dysfunction post AMI is associated with lower rates of cardiac death [48], 
suggesting a better prognostic outcome than patients with a degree of diastolic dysfunction. 
The average values obtained in this study agree with reference limits of normal diastolic 
function [78]. This was a very small group of patients in the study and, it is therefore, 
difficult to draw inferences from. It is interesting in itself, however, that a very small number 
of NSTEMI presentations have normal diastolic function, and also, all of the patients with 
normal diastolic function in this study had no CAD. This would suggest that patients 
presenting with NSTEMI who have normal diastolic function, are often likely to have no 
CAD. Further testing is required on a larger patient cohort to confirm this.  
 
One patient with normal diastolic function had a peak TnI elevation of 2.4 with lateral 
ischemia (ST depression in leads I/aVL) on ECG. However echocardiography and coronary 
angiography results were normal. Reasons other than ischemia for TnI elevations are 
discussed below – Angiography Results. There are a number of possible explanations for the 
misinterpretation of lateral ischemia with ECG. These include: the patient may have another 
unknown pathology causing ST segment depression (such as left ventricular hypertrophy, 
digitalis effect, metabolic or a non-ACS injury i.e. contusion [137]), a degree of ST 
depression may be normal for this particular patient or the ECG may have been misread in 
the Emergency Department. Further testing would be required to determine the cause.  
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4.4.2.3  Mildly Impaired Diastolic Dysfunction 
 
Abnormal filling is best determined by Doppler and is identified by a decreased early 
filling velocity (E), longer E deceleration time (DT), increased late filling (A) and a 
prolonged isovolumic relaxation time [78]. The patients with mild diastolic impairment were 
split into two groups (<65years of age and ≥65 years of age). This is because diastolic 
dysfunction has been associated with an age dependent decline affecting the left ventricular 
filling in a normal patient population due to the age related process of fibrosis of cardiac 
tissue [78, 128]. 
 
 
Mildly Impaired Diastolic Dysfunction <65 years of age 
The patients with mildly impaired diastolic dysfunction and aged <65years (n=17) were 
older, and had higher TnI and E/Em than those with normal diastolic function. The LVEF and 
E:A ratio were lower, 41% had RWMA and 76% had significant CAD. These results fit well 
with the expected parameters of mildly impaired diastolic dysfunction [78], and are indicative 
of the milder end of diastolic dysfunction.  
 
 
Mildly Impaired Diastolic Dysfunction ≥65 years of age 
The patients with mildly impaired diastolic dysfunction and aged ≥65 (n=28) had higher 
TnI and E/Em than those with normal or mildly impaired diastolic function <65 years of age, 
and a similar LVEF. The E:A ratio was lower in this patient group. 39% of these patients had 
RWMA, while 75% had CAD. Published in 2011, Kane et al. [138] performed a study on 
2042 patients aged >45 years to determine the age related changes in diastolic dysfunction 
and the relationship between these changes and the risk of developing heart failure. One 
examination was performed between 1997 and 2000, with surviving patients returning for a 
second examination between 2001 and 2004. They found diastolic dysfunction of any grade 
increased from 24% prevalence on first examination to 39% on second examination. They 
also found age was predictive of the development of diastolic dysfunction (especially in 
patients >65years) and was the greatest predictor of heart failure [129, 138]. This 
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CENSTEMI study shows that echocardiography parameters between the two age groups (<65 
and ≥65 years of age), are similar. Perhaps it did not have a population size large enough to 
show significant differences between the groups. However, differences are minimal between 
the age groups and more evident between the degrees of diastolic dysfunction, which is what 
this CENSTEMI research found.  
 
 
4.4.2.4  Psuedonormal Diastolic Dysfunction 
 
The six patients with pseudonormal diastolic dysfunction were older, had the highest E:A 
ratio and E/Em, 67% with RWMA and 83% had CAD. Diagnosing pseudonormal diastolic 
dysfunction is important as it has a prognosis similar to that of restrictive diastolic 
dysfunction: a meta-analysis published in 2009 by Somartne et al [139] included 887 patients 
from seven studies. They found a 4-fold increase in the rate of mortality in patients with 
pseudonormal diastolic dysfunction, compared with mildly impaired diastolic dysfunction. 
This further confirms that patients with pseudonormal and restrictive diastolic dysfunction 
have similar risks of death. An E/Em >15 has been associated with elevated left atrial and left 
ventricular diastolic pressures, which are predictors of cardiac mortality [41, 69, 140, 141]. 
An Em <3cm/s is associated with ‘significant excess mortality’ [141]. Two of the patients 
had both E/Em >20 and Em ≤3cm/s, which would suggest a very poor long-term prognostic 
outcome. One of these two patients required in-hospital CABG and subsequently died, which 
correlates with the literature described. It is interesting that a small number of NSTEMI 
presentations had pseudonormal diastolic dysfunction, with LVEF impairment and high 
filling pressures. It would be interesting to follow these patients with serial echocardiograms 
to assess whether the diastolic dysfunction declines further and to determine the prognostic 
outcome of these patients. However, for a reliable study, a larger patient cohort would be 
required. 
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4.4.2.5  Restrictive Diastolic Dysfunction 
 
The one patient with restrictive diastolic dysfunction in this study had a short E velocity 
deceleration time, a high peak TnI and the lowest LVEF. These indices agree with literature 
in this field, which suggest patients with restrictive diastolic dysfunction have significantly 
abnormal cardiac filling profiles which result in poor prognostic outcomes [64, 142].  
 
A study performed by Hee et al. [64] published in 2010, assessed the prognostic outcome 
in patients with restrictive filling patterns (defined as an E:A ratio of >2 and E DT of 
<140ms). They found that a restrictive filling pattern was a good predicator of all-cause 
mortality, regardless of left ventricular systolic function. The patient in our research had both 
restrictive diastolic dysfunction and LVEF impairment. A study published in 2011 by Prasad 
et al. [142] assessed 20 patients with restrictive diastolic dysfunction post STEMI and found 
association with the duration of AMI, the infarct size and the prognostic outcome. The patient 
in this CENSTEMI research with restrictive diastolic dysfunction did indeed have a very 
large LAD RWMA with an LVEF of 41%; these results agree with findings in the Prasad et 
al. study [142]. The E/Em (9) in this patient was lower than expected.  
 
A higher E/Em (E/Em >15) is associated with restrictive filling profiles as it relates to the 
left ventricular filling pressures, therefore, stiffness of the left ventricle resulting in restrictive 
diastolic dysfunction [69]. As the echocardiogram was performed a matter of hours after the 
event, perhaps the remodelling process of the left ventricle, which ultimately results in 
stiffness and therefore raised filling pressures, has yet to take place. Filling pressures are, 
however, reliant upon a number of factors including heart rate, loading conditions and the use 
of certain medications, while Doppler interrogation of the septal mitral annulus is affected by 
cardiac translation and motion affecting the accuracy of the measurement [66]. These may be 
the reasons for the low E/Em in this patient.  
 
  
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
99 
 
4.4.2.6  E:A Ratio 
 
The average E:A ratio for patients with pseudonormal and restrictive filling profiles was 
elevated 1.4±0.5 and 1.2 respectively. Patients with pseudonormal or restrictive diastolic 
dysfunction and an E:A ratio >1 were assessed. All seven patients who met this criteria had 
TnI elevation, systolic impairment and CAD. 
 
 A study (unpublished data) performed by Whalley et al. [77] found E:A ratio was a 
powerful predictor of all-cause mortality and prognostic outcome. In an analysis of 3128 
patients, E:A ratio <1 was associated with 127 deaths, E:A ratio 1-2 was associated with 143 
deaths and E:A ratio >2 was associated with 197 deaths. One of the patients in this 
CENSTEMI study required in-hospital CABG and subsequently died. This correlates with the 
prognostic outcomes identified in the study performed by Whalley et al. [77]. 
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4.4.3 Other Pathologies 
 
Along with RWMA assessment, echocardiography is used clinically to assess many 
aspects of cardiac structure and function. Coexistent pathologies from the patients admitted 
with NSTEMI were assessed.  
 
 
4.4.3.1  Valve Regurgitation 
 
The prevalence of valvular regurgitation was determined with echocardiography using 
colour pulsed wave Doppler. All patients had a tricuspid regurgitation, the majority (83%) 
had mitral regurgitation and a minority (27%) had aortic regurgitation. Studies published in 
1987 by Akasaka et al. [143], and in 1990 by Klein et al. [144], assessed the age-related 
prevalence of valvular regurgitation in normal, healthy volunteers. Prevalence of aortic 
regurgitation for a normal population aged between 60 and 69 years was 24%, which 
correlates well with the findings in this CENSTEMI study.  The data obtained with this 
CENSTEMI study found a slightly higher prevalence of both mitral and tricuspid 
regurgitation (83 vs. 67% and 100 vs. 81% respectively) than those found by Akasaka et al. 
[143] and Klein et al. [144]. There are at least two plausible explanations for the increased 
prevalence of mitral and tricuspid regurgitation. The first, there may be a degree of valvular 
dysfunction post infarction (functional regurgitation - regurgitation secondary to the 
infarction which may be timing related) and, secondly, as these studies were performed in 
1988 (Akasaka et al. [143]) and 1990 (Klein et al. [144]), colour Doppler technology may 
have improved somewhat since then resulting in better visualisation of smaller or eccentric 
regurgitant lesions.  
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4.4.3.2  Right Ventricular Systolic Pressures 
 
Nearly half of the patients in this study had at least mildly raised pulmonary pressures. A 
study published in 2008 and performed by Weeks et al. [145] showed right ventricular 
systolic pressure was an indicator of left ventricular end diastolic pressure and, therefore, a 
predictor of heart failure. Left ventricular end diastolic pressure was determined in 25 heart 
failure patients with preserved LVEF (56% of whom had CAD) following administration of 
Nesiritide. Right ventricular systolic pressure was found to correlate most with left 
ventricular filling pressures, pulmonary capillary wedge pressures, pre-A wave and left 
ventricular end diastolic pressure. 
 
 This prevalence of elevated right ventricular systolic pressure in this CENSTEMI study 
may allude to the presence of heart failure in these patients; however, further testing is 
required.  
 
 
4.4.3.3  Left Atrial Dilatation 
 
The prevalence of left atrial dilatation was not common in this study (15%). Other studies 
have assessed left atrial size and its contribution to mortality in NSTEMI patients [146] [76].  
 
A study published in 2010 by Boyd et al. [146] found when compared with age-matched 
normal controls, left atrial volumes were larger within 48 hours of presentation for NSTEMI, 
and continued to enlarge up to 12 months post NSTEMI (27.6±7.4 vs. 30.2±8.9mL/m² 
respectively). It may be that the CENSTEMI study echocardiography was performed too 
early in the time course of AMI to detect significant left atrial enlargement; perhaps the 
patient cohort was too small to show these changes; also in this CENSTEMI study, left atrial 
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area (which may underestimate the size of the left atrium) was measured instead of left atrial 
volume.  
 
A study published in 2011 by Kuhl et al. [76] studied a cohort of 385 patients admitted 
with NSTEMI and found that reduced left atrial fractional change and left atrial ejection 
fraction predicted a poor prognosis in low-risk NSTEMI patients. Longer term follow-up 
would be required to confirm these findings.  
 
However, this CENSTEMI study did find a small group of patients with left atrial 
dilatation, and for this group, this may be an important finding. Left atrial dilatation has been 
consistently linked to long-term diastolic dysfunction and poor prognosis. Although the 
prevalence of left atrial dilatation may be low, its prognostic significance in patients with 
NSTEMI warrants further investigation. 
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4.5 Angiography Results 
 
Of the 55 patients admitted with NSTEMI, 40 (73%) patients had significant CAD. A 
study published in 2002 by Koyma et al. [147] found CAD present in 90% of 125 patients 
admitted with NSTEMI. Lower prevalence of culprit coronary lesions in this CENSTEMI 
study may be due to small sample size, which may not be indicative of a true population. Or, 
NSTEMI diagnosis criteria may have affected the results. The Koyma et al. [147] study did 
not require TnI elevation as a determinant of NSTEMI, whereas this CENSTEMI study did. 
This suggests that patient selection criteria may be a reason for the different results.   
The LAD was the most common single vessel culprit artery (37%), followed by the RCA 
(13%). The remaining 50% comprised of double vessel and triple vessel lesions. The Cx was 
not the sole culprit artery in any of the 55 patients.  
 
The patients with significant CAD were older, had higher peak TnI and lower LVEF. A 
study published in 2010 by Hong et al. [148] determined the differences in culprit lesions 
between STEMI and NSTEMI patients. Of 185 patients admitted with NSTEMI, culprit 
coronary lesion prevalence was as follows: LAD 52%, RCA 28% and Cx 18%. A similar 
trend was noted in this CENSTEMI study: the LAD was the most common culprit lesion, 
followed by RCA and lastly Cx. Hong et al. [148] used only single vessel CAD in their study 
to determine the culprit coronary distribution, hence the values for each vessel are higher than 
those found in this CENSTEMI study. An audit published in 2008,- by Dixon et al. [149] 
included 30,386 NSTEMI patients to determine the distribution of culprit lesions with related 
prognostic clinical outcome. Culprit coronary lesion prevalence was as follows: LAD 38%, 
RCA 34% and Cx 28%. The LAD values are similar between the Dixon et al. [149] research 
and this CENSTEMI study with familiar trends of culprit coronary artery prevalence noted – 
LAD prevalence > RCA prevalence > Cx prevalence. In the Dixon et al. [149] study, the 
culprit artery was determined by the first attempted coronary artery re-vascularised during 
coronary angiography. This is in comparison to this CENSTEMI research, where culprit 
lesions were identified as >70% stenosis, and any region with significant stenosis (>70%) 
was included as a culprit coronary artery (enabling inclusion of double and triple vessel 
culprit coronary arteries). Dixon et al. [149] concluded that the Cx coronary artery was the 
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least likely culprit lesion, due in part to its geometry (resulting in different shear wall stress) 
and/or due to probability. These studies support the trends noted in this CENSTEMI research.   
 
Of the 55 patients, 13 (24%) patients had no significant CAD noted with angiography. 
Previous studies have assessed the prevalence of false-positive AMI diagnosis, determined by 
coronary angiography in the STEMI population [150-152] , however, little research has been 
performed in the NSTEMI population. Perugini et al. [152] suggested the main causes for a 
false-positive STEMI diagnosis prior to coronary angiography were ‘absent or minimal 
coronary lesions, Tako-Tsubo, or chronic ischaemic heart disease without culprit lesion, 
repolarisation, left bundle branch block, pericarditis, left ventricular hypertrophy and 
myocarditis’. These syndromes may explain the 24% of patients in this study diagnosed with 
NSTEMI who had no significant coronary lesions identified with coronary angiography. 
Similarly, a study published in 2010 by Larson et al. [150] found of 1335 patients with 
suspected STEMI who underwent coronary angiography, 14% had no culprit coronary lesion 
while 9.5% had no significant CAD. Differential biomarker elevation provides another 
explanation for ‘false-positive’ NSTEMI diagnosis. Guidelines suggest the use of the 99th 
percentile as a reference limit of an elevated TnI level [1], however, TnI is not exclusive for 
ACS. Possible cardiac causes include acute heart failure, aortic dissection, 
pericarditis/myocarditis or tachycardia.  
 
Of the 24% of patients with no CAD, 11 had mitral regurgitation (all cases were mild), 
while six patients had raised RVSP. No other obvious cardiac causes for TnI elevation level 
were identified with echocardiography, which provides a quick, non-invasive, diagnostic tool 
to rule out many those alternate diagnoses. Causes for non-cardiac TnI elevation include 
pulmonary embolism, stroke, sepsis or renal failure [153]. It is rare that a TnI elevation 
cannot be explained; further testing is required to elucidate the condition behind a significant 
biomarker elevation.  
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4.5.1 RWMA Assessment and CAD 
 
Regional wall motion assessment was possible in all 55 patients. 23 (42%) patients had 
regional dysfunction noted on echo. A retrospective study published in 2007 by Bridgman et 
al. [46] utilising NSTEMI patients at Christchurch Hospital, New Zealand found 60% of 
patients had RWMA identified with echocardiography. Of these patients, 89% correctly 
identified the culprit coronary lesion. This CENSTEMI research had a marginally lower 
number of patients with regional dysfunction visualised with echocardiography, and a 
marginally lower number of correctly identified culprit lesions (74%) which may be due to 
the small patient cohort, patient window quality or chance.  
 
Of the 23 patients with regional dysfunction, two had no associated CAD. Of the 
remaining 21 patients, the cardiologist correctly identified 47 of 63 regions with abnormal 
function corresponding to CAD. Three regions from three patients were identified as 
abnormal (RCA in all cases) when there was no corresponding CAD - while another region in 
the heart was affected by a culprit coronary artery (LAD in all cases) with no corresponding 
regional dysfunction. Coronary artery anatomy variations between patients, difficulty in 
interpreting the cardiac myocardial thickening (due to artefacts, motion etc.) and patient 
window quality may explain these misinterpretations.  
 
Of the 55 patients, 19 had CAD, but no corresponding regional dysfunction. This means 
that there was no visual necrosis of cardiac tissue around or downstream of the culprit 
coronary lesion. Regional wall motion assessment is a subjective measure that requires 
significant expertise and experience. It is often complicated by difficult echocardiography 
windows and a lack of “baseline” for comparison. The presence of RWMAs is, however, in 
itself an interesting finding in an echocardiography examination as it is likely indicative of a 
degree of cardiac necrosis from the NSTEMI event itself. 
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4.5.2 Sensitivity versus Specificity 
 
Of the 55 patients, RWMAs were identified in two male patients, both of whom had no 
significant CAD identified with angiography. In patient A, a RWMA was identified in the 
RCA region with no corresponding CAD: LVEF was 68% and there was a minor TnI rise, 
with no other significant echocardiography abnormalities. On re-review of the 
echocardiogram, mild hypokinesis in the RCA territory is confirmed, suggesting there may be 
an underlying, undiagnosed disease process present, or perhaps this is a normal variant for 
this patient.  
 
Patient B had an LVEF of 43% and a small peak TnI rise. On review of the 
echocardiogram, the left ventricle was dilated, with mild-moderate mitral regurgitation, and 
raised filling pressures. Appearances suggest overall heart failure. The sensitivity and 
specificity of using echocardiography to determine RWMA association to CAD using 
coronary angiography was assessed by Medina et al. in 1985 [154]. They found that the 
predictive accuracy of detecting RWMA in patients with a dilated left ventricle had a 
sensitivity of 83% and a specificity of 57%, while the accuracy of RWMA detecting 
significant CAD had a sensitivity of 95%, a specificity of 100% and a predictive accuracy of 
95%. This suggests that echocardiography is highly suited for detecting RWMA.  
 
The risk of a false positive RWMA identified by echocardiography is a diagnostic 
angiogram to investigate the cause. Angiography is regarded as a semi-invasive procedure 
and carries increased patient risk. The risk of a false-positive diagnosis is out-weighed by the 
benefit of performing coronary angiography. The risk of performing a coronary angiogram in 
a non-compromised patient and finding nothing outweighs the risk of not performing the test 
at all, with the risk of missing something important.  This mantra is echoed in previous 
literature [150-152], all of which determined the prevalence of false-positive STEMI 
diagnosis with coronary angiography. Perugini et al. [152] found a false-positive diagnosis 
was an ‘acceptable and unavoidable price to pay to guarantee the lowest possible frequency 
of false negatives’. These studies are reassuring when faced with the possibility of false-
positive RWMA diagnoses with echocardiography.   
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4.6 Re-admission Rates 
 
Of the 55 patients, only nine (16%) were re-admitted. There were no outstanding 
characteristics noted within this group. Seven of the patients underwent coronary angioplasty 
for culprit coronary stenosis. Research published in 2012 by Khawaja et al. [155] studied 30 
re-admission rates in 15,498 patients who underwent percutaneous coronary intervention. 
9.4% re-admitted within 30 days. The researchers found that the patients who re-admitted 
were more likely to be female and have less high school education, unstable angina, 
cerebrovascular disease, transient ischaemic attack, renal dysfunction and/or chronic 
obstructive pulmonary disease.  
 
In this CENSTEMI study, as only nine patients were re-admitted, the patient cohort was 
too small to make assumptions from. Furthermore, social and alternative reasons for re-
admission were not determined.  However, a review written in 2012 by Hernandez et al. 
[156] suggested that future prediction, regarding re-admission was difficult and that a certain 
degree of vulnerability presents itself after an acute cardiac hospitalisation.  
 
It is possible that there are no obvious explanations, patient characteristics or features 
which would predict nor explain re-admission rates in this CENSTEMI study and that it is 
due to chance alone. 
 
 
4.7 Advanced Imaging Modalities 
 
Of the patients with CAD, the culprit coronary artery was correctly identified by 
associated RWMAs in 74% of patients. 21% of patients had no RWMA identified but CAD 
present while in 5% of patients RWMAs did not match the culprit coronary artery. This, as 
discussed above, could be due to a number of reasons, such as image quality; perhaps there 
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were no RWMA to be visualised; or perhaps the changes in the myocardium are so subtle that 
they are undetectable to the human eye.  
 
Recent studies suggest TVI and ST derived velocity, strain and strain rate imaging may 
provide valid, quantitative global and regional assessment. Furthermore, these tests are 
suggested to possess the ability to identify early and subtle changes in systolic function, as 
well as the presence of underlying CAD, all while reducing the subjective nature of 
echocardiography.  Although well validated, advanced modality imaging has failed to be 
integrated into a standard routine examination in a clinical (non-research) laboratory.  
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4.8 Conclusion: NSTEMI Characteristics and Echocardiographic 
Features  
 
In conclusion, the role of echocardiography in patients presenting with NSTEMI remains 
under-utilised. Yet, it is recommended in the 2012 ACS guidelines and this CENSTEMI 
study found it an invaluable tool for detecting structural and functional abnormalities.  
 
The patients studied in this thesis represent a fairly typical NSTEMI group, presenting to 
a public hospital in New Zealand. The data obtained in this study has shown the usefulness of 
echocardiography when identifying systolic and diastolic dysfunction. The usefulness of 
using echocardiography as a diagnostic tool for assessing co-cardiac pathologies was also 
assessed. Echocardiography was efficiently used to determine cardiac pressures (right 
ventricular systolic pressure), dilatation of chambers (left atrial chamber) and regurgitant 
lesions.  
 
This study has also shown that the degree of TnI elevation cannot be used to select a 
subset of patients for echocardiography. 
 
There were patients with CAD and an absence of visual RWMAs. There were also a very 
small number of patients who were possibly misdiagnosed (misdiagnosed as a NSTEMI or 
incorrect RWMA identification). Utilisation of advanced imaging modalities such as TVI and 
ST may provide additional information to determine underlying CAD. Literature suggests 
using advanced modalities (TVI and ST derived velocity, strain and strain rate) to determine 
or confirm regional dysfunction and/or underlying CAD. Therefore, these advanced 
echocardiography modalities were tested (TVI and ST derived velocity, strain and strain rate) 
in a standard, clinical (non-research) environment on the same randomly selected set of 55 
NSTEMI patients.   
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5 Chapter Five: Results Part II – Advanced Echocardiography 
Techniques 
 
5.1 Introduction 
 
This chapter explores the ability of advanced echocardiography imaging modalities to 
detect RWMAs and CAD with NSTEMI presentations. The values for TVI and ST derived 
velocity (υ), strain (є ) and strain rate (sˉ¹) were grouped and averaged into the three major 
vessel territories – LAD, Cx, RCA resulting in territorial velocity, strain and strain rate. 
Comparisons were made between velocity, strain and strain rate and the presence, and 
absence, of RWMAs and underlying CAD. Statistical significance was taken as p<0.05. 
 
 
5.2 Patient Characteristics 
 
This is an extension of the study previously described in Results I/Discussions I and 
includes the same 55 randomly selected patients. TVI was possible in all patients; ST was 
possible in 53 patients. As discussed in methods, there were 15 possible segments (basal, mid 
and distal segments of the inferoseptal, anterolateral, inferior, anterior and inferolateral walls) 
available for interrogation by TVI from the three imaging views (apical four chamber, two 
chamber and long axis). There were 6 possible segments (basal, mid and distal segments of 
the inferoseptal and anterolateral walls) available for interrogation by ST from the apical four 
chamber view.  Out of 825 segments available for interrogation with TVI, assessment was 
possible in 754 (91%). Out of 330 segments available for interrogation with ST, assessment 
was possible in 305 (92%) (Table 18). 
  Table 18: Segmental Assessment with TVI and ST in 55 Patients 
 
The total number of TVI segments for available for interrogation was 825 (15 segments x 55 patients); the total number of ST segments available for interrogation was 330 (6 
segments x 55 patients); 3 segments of each cardiac wall x 55 patients = 165 segments available for interrogation on each cardiac wall and where: S = septal; AL = anterolateral; I = 
inferior; A = anterior; IL= inferolateral; Indices – velocity, strain and strain rate, TVI = tissue velocity imaging 
Segmental Assessment with TVI and ST in 55 Patients 
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TVI  
Indices 
55 55 55 53 43 50 55 54 55 51 43 36 53 49 47 
Total TVI 
(n/825) 
Total segments deemed 
suitable for interrogation 
n = 165 
Total segments deemed 
suitable for interrogation 
n = 146 
Total segments deemed 
suitable for interrogation 
n = 164 
Total segments deemed 
suitable for interrogation 
Total n = 130 
Total segments deemed 
suitable for interrogation 
Total n = 149 
ST 
Indices 
51 53 53 48 51 49 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Total ST 
indices 
(n/330) 
Total segments deemed 
suitable for interrogation 
Total n = 157 
Total segments deemed 
suitable for interrogation 
Total n =148 
N/A N/A N/A 
 5.3 RWMA Assessment 
 
Univariate correlations between territorial strain from the advanced echo imaging 
modalities - TVI and ST derived velocity (cm/s), strain (%) and strain rate (/s) - and the 
presence and absence, of RWMAs in the three major vessel territories - LAD, Cx and RCA - 
were assessed. The p-values are grouped in Table 19 (after the graphs: p. 140) for quick 
comparison, while statistical significance is shown in Table 21 (after the graphs: p 141).   
 
 
5.3.1 Tissue Velocity Imaging 
 
Below are the results from analysis between RWMAs and TVI derived velocity, strain 
and strain rate. For each modality a comparison was made between the group of patients with 
and without RWMAs present on standard echocardiography. In general, there was overlap 
between the groups, although significant group mean differences were observed.  
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5.3.1.1 TVI Derived Velocity for RWMA assessment 
 
TVI derived velocity (cm/s) was not different with the presence and absence of visual 
RWMAs on standard echocardiography imaging, in any of the three major vascular 
territories: p= 0.36 for LAD territory (Graph 2), p=0.58 for Cx territory (Graph 3) and p=0.50 
for RCA territory (Graph 4). No regions were statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: TVI = tissue velocity imaging; LAD = left anterior descending coronary artery; RWMA = regional wall 
motion abnormality 
  
Graph 2: One-way Analysis of TVI LAD territory (cm/s) By RWMA LAD territory 
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Where: TVI = tissue velocity imaging; Cx = circumflex coronary artery territory and RWMA = regional wall 
motion abnormality 
 
 
 
 
 
 
 
 
 
 
 
Where: TVI = tissue velocity imaging; RCA = right coronary artery territory; RWMA = regional wall motion 
abnormality 
Graph 3: One-way Analysis of TVI Cx territory (cm/s) By RWMA Cx 
territory 
Graph 4: One-way Analysis of TVI RCA territory (cm/s) By RWMA RCA 
territory 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
116 
 
Graph 5: One-way Analysis of Strain LAD territory (%) By RWMA LAD territory 
5.3.1.2 TVI Derived Strain for RWMA assessment 
 
TVI derived strain (%) correlated with the presence and absence, of RWMAs on standard 
echocardiography in the LAD and Cx regions. Values were decreased (closer to the baseline), 
in territories where a RWMA was present: p=0.0002 for LAD territory (Graph 5), p=0.002 
for the Cx territory (Graph 6), p=0.06 for the RCA territory (Graph 7). The RCA region 
showed a trend towards statistical significance. The LAD and Cx regions were statistically 
significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD = left anterior descending coronary artery territory; RWMA = regional wall motion abnormality 
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Where: Cx = circumflex coronary artery territory; RWMA = regional wall motion abnormality 
 
 
  
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery territory; RWMA = regional wall motion abnormality 
 
Graph 6: One-way Analysis of Strain Cx territory (%) By RWMA Cx 
territory 
Graph 7: One-way Analysis of Strain RCA territory (%) By RWMA 
RCA territory 
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5.3.1.3  TVI Derived Strain Rate for RWMA Assessment 
 
TVI derived strain rate (/s) correlated with the presence and absence, of RWMAs on 
standard echocardiography. Values were decreased (closer to the baseline), in territories 
where a RWMA was present: p=0.0007 for LAD territory (Graph 8), p=0.01 for Cx territory 
(Graph 9), and p=0.01 for RCA territory (Graph 10).  All the regions were statistically 
significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD =left anterior descending coronary artery territory; RWMA = regional wall motion abnormality 
  
Graph 8: One-way Analysis of Strain rate LAD territory (/s) By RWMA LAD territory 
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Where: Cx = circumflex coronary artery territory; RWMA = regional wall motion abnormality 
 
 
 
 
Where: RCA =right coronary artery territory; RWMA = regional wall motion abnormality 
  
Graph 9: One-way Analysis of Strain rate Cx territory (/s) By RWMA Cx 
territory 
Graph 10: One-way Analysis of Strain rate RCA territory (/s) By RWMA RCA 
territory 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
120 
 
5.3.2 Speckle Tracking 
 
Below are the results from analysis between RWMAs and TVI derived velocity, strain 
and strain rate. For each modality a comparison was made between the group of patients with 
and without RWMAs present on standard echocardiography. In general, there was overlap 
between the groups, although significant group mean differences were observed.  
 
5.3.2.1 ST Imaging Derived Velocity for RWMA Assessment 
 
ST derived velocity (cm/s) was not different with the presence and absence of visual 
RWMAs on standard echocardiography imaging, in any of the three major vascular 
territories: p=0.23 for LAD territory (Graph 11), p=0.78 for Cx territory (Graph 12), and 
p=0.46 for the RCA territory (Graph 13). No regions were statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
Where: v = velocity; ST = speckle tracking; LAD = left anterior descending coronary artery territory; RWMA = 
regional wall motion abnormality 
Graph 11: One-way Analysis of LAD Speckle tracking Velocity (cm/s) By RWMA 
LAD territory 
 
ST LAD 
v (cm/s) 
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Where: v = velocity; ST = speckle tracking; Cx = circumflex coronary artery territory; RWMA = regional wall 
motion abnormality 
 
 
 
 
 
 
 
 
 
 
 
Where: v = velocity; ST = speckle tracking; RCA = right coronary artery territory; RWMA = regional wall 
motion abnormality 
Graph 13: One-way Analysis of RCA Speckle tracking velocity (cm/s) By 
RWMA RCA territory 
 
RCA ST  
v (cm/s) 
Graph 12: One-way Analysis of Cx Speckle tracking velocity (cm/s) By RWMA 
Cx territory 
 
ST Cx  
v (cm/s) 
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5.3.2.2  ST Imaging Derived Strain for RWMA Assessment 
 
ST strain correlated less well than TVI strain (%) in territories where RWMAs were 
evident on standard echocardiography imaging in the RCA and Cx territories. Values were 
decreased (closer to the baseline) when RWMAs were visualised with standard 
echocardiography: p=0.01 for LAD territory (Graph 14), p=0.001 for Cx territory (Graph 15), 
and p=0.25 for RCA territory (Graph 16). The LAD and Cx regions were statistically 
significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD =left anterior descending coronary artery territory; RWMA = regional wall motion abnormality 
  
Graph 14: One-way Analysis of Speckle tracking strain LAD (%) By RWMA LAD territory 
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Where: Cx = circumflex coronary artery territory; RWMA = regional wall motion abnormality 
 
 
 
 
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery territory; RWMA = regional wall motion abnormality 
  
Graph 16: One-way Analysis of Speckle Tracking Strain RCA territory (%) By 
RWMA RCA territory 
Graph 15: One-way Analysis of Speckle tracking strain Cx (%) By RWMA Cx 
territory 
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5.3.2.3 ST Imaging Derived Strain Rate for RWMA Assessment 
 
ST strain rate correlated less well than TVI strain rate (/s) in territories where RWMAs 
were evident on standard echocardiography imaging. Values were decreased (closer to the 
baseline) where a RWMA was visualised with standard echocardiography: p=0.002 for LAD 
territory (Graph 17), p=0.03 for Cx territory (Graph 18), and p=0.97 for RCA territory 
(Graph 19). The LAD and Cx regions were statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD = left anterior descending coronary artery territory; RWMA = regional wall motion abnormality 
  
Graph 17: One-way Analysis of LAD Speckle tracking strain rate (/s) By RWMA LAD territory 
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Where: Cx = circumflex coronary artery territory; RWMA = regional wall motion abnormality 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery territory; RWMA = regional wall motion abnormality 
Graph 18: One-way Analysis of Cx Speckle tracking strain rate (/s) By RWMA 
Cx territory 
Graph 19: One-way Analysis of RCA Speckle tracking strain rate (/s) By RWMA 
RCA territory 
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5.4 Coronary Artery Territory Disease 
 
Univariate correlations between territorial strain from the advanced echocardiography 
imaging modalities - TVI and ST derived velocity (cm/s), strain (%) and strain rate (/s) - and 
the presence and absence, of CAD in the three major vessel territories - LAD, Cx and RCA - 
were assessed. Correlations were reduced compared to those for RWMA. Of the advanced 
echocardiography modalities, strain and strain rate performed generally equivocally.  
 
 
5.4.1 Tissue Velocity Imaging 
 
Below are the results from analysis between CAD and TVI derived velocity, strain and 
strain rate. For each modality a comparison was made between the group of patients with and 
without CAD identified with coronary angiography. In general, there was overlap between 
the groups, although significant group mean differences were observed. 
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5.4.1.1 TVI Derived Velocity for CAD  
 
TVI derived velocity (cm/s) was not different between those with or without CAD 
(determined by angiography), in any of the three major vascular territories: p=0.17 for LAD 
disease (Graph 20), p=0.27 for Cx disease (Graph 21), and p=0.71 for RCA disease (Graph 
22). There was no statistical significance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: TVI = tissue velocity imging; LAD = left anterior descending coronary artery  
  
Graph 20: One-way Analysis of TVI LAD territory (cm/s) By LAD disease 
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Graph 22: One-way Analysis of TVI RCA territory (cm/s) By RCA disease 
 
 
 
 
 
 
 
 
 
 
 
Where: TVI = tissue velocity imaging; Cx = circumflex coronary artery 
 
 
 
 
 
 
 
 
 
 
 
 
Where: TVI = tissue velocity imaging; RCA = right coronary artery 
Graph 21: One-way Analysis of TVI Cx territory (cm/s) By Cx disease 
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5.4.1.2  TVI Derived Strain for CAD 
 
TVI derived strain (%) correlated the presence and absence, of CAD (identified by 
coronary angiography) in all three of the major vascular territories. TVI derived strain (%) 
obtained the highest correlation. Strain values were decreased (closer to the baseline), in 
territories where CAD was evident on a coronary angiogram: p<0.0001 for LAD disease 
(Graph 23), p=0.03 for Cx disease (Graph 24), and p=0.001 for RCA disease (Graph 25). All 
territories were statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD = left anterior descending coronary artery 
  
Graph 23: One-way Analysis of Strain LAD territory (%) By LAD disease 
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Where: Cx = circumflex coronary artery 
 
 
 
 
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery 
 
Graph 24: One-way Analysis of Strain Cx territory (%) By Cx disease 
Graph 25: One-way Analysis of Strain RCA territory (%) By RCA disease 
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5.4.1.3  TVI Derived Strain Rate for CAD 
 
TVI derived strain rate (/s) correlated with the presence and absence, of CAD (identified 
by coronary angiography) in two of the major vascular territories. Strain rate values were 
decreased (closer to the baseline), in territories where CAD was evident on a coronary 
angiogram: p=0.0003 for LAD disease (Graph 26), p=0.01 for Cx disease (Graph 27), and 
p=0.21 for RCA disease (Graph 28). The LAD and Cx territories were statistically 
significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD = left anterior descending coronary artery 
  
Graph 26: One-way Analysis of Strain rate LAD territory (/s) By LAD disease 
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 Where: Cx = circumflex coronary artery 
 
 
 
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery 
 
Graph 27: One-way Analysis of Strain rate Cx territory (/s) By Cx disease 
Graph 28: One-way Analysis of Strain rate RCA territory (/s) By RCA disease 
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5.4.2 Speckle Tracking Imaging 
 
Below are the results from analysis between CAD and ST derived velocity, strain and 
strain rate. For each modality a comparison was made between the group of patients with and 
without CAD identified with coronary angiography. In general, there was overlap between 
the groups, although group mean differences were observed.  
 
5.4.2.1  ST Imaging Derived Velocity for CAD 
 
ST derived velocity (cm/s) was not different between those with or without CAD 
(identified with angiography) in the RCA and Cx territories. However, correlation was noted 
between the presence and, absence of CAD (identified by coronary angiography) in the LAD 
territory: p=0.008 for LAD disease (Graph 29), p=0.30 for Cx disease (Graph 30), and p=0.64 
for RCA disease (Graph 31). The LAD territory was statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
Where: ST = speckle tracking; v = velocity; LAD = left anterior descending coronary artery  
Graph 29: One-way Analysis of LAD Speckle tracking derived velocity 
(cm/s) By LAD disease 
 
ST LAD 
v (cm/s) 
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Graph 30: One-way Analysis of Cx Speckle tracking TVI (cm/s) By Cx 
disease 
 
 
 
 
 
 
 
 
 
Where: ST = speckle tracking; v = velocity; Cx = circumflex coronary artery 
 
  
 
 
 
 
 
 
 
 
 
 
Where: ST = speckle tracking; v = velocity; RCA = right coronary artery 
  
Graph 31: One-way Analysis of RCA Speckle tracking TVI (cm/s) By 
RCA disease 
 
ST Cx 
v (cm/s) 
 
ST RCA  
v (cm/s) 
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5.4.2.2  ST Imaging Derived Strain for CAD 
 
ST derived strain (/s) was not different between those with or without CAD (identified 
with angiography) in the Cx territory. However, correlation was noted between the presence 
and, absence of CAD (identified by coronary angiography) in the LAD and RCA territories: 
p=0.006 for LAD disease (Graph 32), p=0.14 for Cx disease (Graph 33), and p=0.007 for 
RCA disease (Graph 34). The LAD and RCA territories were statiscally significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD = left anterior descending coronary artery 
  
Graph 32: One-way Analysis of Speckle tracking strain LAD (%) By LAD disease 
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Where: Cx =circumflex coronary artery 
 
 
 
 
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery 
Graph 33: One-way Analysis of Speckle tracking strain Cx (%) By Cx disease 
Graph 34: One-way Analysis of Speckle tracking strain RCA (%) By RCA disease 
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5.4.2.3 ST Imaging Derived Strain Rate for CAD 
 
ST derived strain rate (/s) correlated less well than TVI derived strain rate (/s). ST derived 
strain rate (cm/s) was not different between those with or without CAD (identified with 
angiography) in the RCA and Cx territories. However, correlation was noted between the 
presence and absence, of CAD (identified by coronary angiography) in the LAD territory: 
p=0.0001 for LAD disease (Graph 35), p=0.23 for Cx disease (Graph 36), and p=0.33 for 
RCA disease (Graph 37). The LAD territory was statistically signficant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Where: LAD = left anterior descending coronary artery 
 
  
Graph 35: One-way Analysis of LAD Speckle tracking strain rate (/s) By LAD disease 
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Where: Cx = circumflex coronary artery 
 
 
 
 
 
 
 
 
 
 
 
 
Where: RCA = right coronary artery 
 
Graph 37: One-way Analysis of RCA Speckle tracking strain rate (/s) By 
RCA disease 
Graph 36: One-way Analysis of Cx Speckle tracking strain rate (/s) By Cx 
disease 
 Table 19: Quick Reference Table: Vascular Territory Distribution and the Correlation Between Advanced Imaging Modalities and the Presence and Absence of RWMA or CAD 
(p values) 
 
Vascular Territory Distribution and the Correlation Between Advanced Imaging Modalities and the Presence and Absence of RWMA or CAD 
 
LAD Cx RCA 
RWMA CAD RWMA CAD RWMA CAD 
 
TVI 
Velocity (p) 0.36 0.17 0.58 0.27 0.50 0.71 
Strain (p) 0.0002 <0.0001 0.002 0.03 0.06 0.001 
Strain Rate (p) 0.0007 0.0003 0.01 0.01 0.009 0.21 
 
ST 
Velocity (p) 0.23 0.008 0.78 0.30 0.46 0.64 
Strain (p) 0.01 0.006 0.001 0.14 0.25 0.007 
Strain Rate (p) 0.002 0.0001 0.03 0.23 0.97 0.33 
 
Where: TVI = tissue velocity imaging; RWMA = regional wall motion abnormalities; CAD = coronary artery disease; LAD – left anterior descending coronary artery; RCA = 
right coronary artery; Cx = circumflex and p = p value (statistical significance was taken as p<0.05)  
 Table 20: Quick Reference Table of Statistical Significance: Vascular Territory Distribution and the Correlation between Advanced Imaging Modalities and the Presence and 
Absence of RWMA or CAD 
 
 
 
 
 
 
 
 
 
 
 
Where: TVI = tissue velocity imaging; ST = speckle tracking; LAD = left anterior descending; Cx = circumflex; RCA = right coronary artery; SS = statistically significant; N = 
not statistically significant and trend SS = trend towards statistical significance
Table of Statistical Significance: Vascular Territory Distribution and the Correlation Between 
Advanced Imaging Modalities and the Presence and Absence of RWMA or CAD 
  LAD Cx RCA 
  RWMA CAD RWMA CAD RWMA CAD 
TVI Velocity N N N N N N 
Strain SS SS SS SS N  
(trend SS) 
SS 
Strain 
rate 
SS SS SS SS SS N 
ST Velocity N SS N N N N 
Strain SS SS SS N N SS 
Strain 
rate 
SS SS SS N N N 
 5.5 Global Strain 
 
Global strain was assessed from the ST modality (also called 2D strain), in the apical four 
chamber view, as an indicator of overall left ventricular systolic function (Graph 38). The 
bivariate fit of ejection fraction to the global strain R square value was 0.2 (20% of the 
variation can be explained), which suggests there is a weak correlation between global strain 
and LVEF.  
 
Graph 38: Bivariate Fit of Ejection fraction (%) By Global strain (%) 
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5.6 Summary: Advanced Echocardiography Results  
 
In summary, TVI derived velocity did not significantly correlate with any of the three 
major vascular territories and the presence, nor absence, of RWMA or CAD.   
 
TVI derived strain and strain rate was statistically significant for RWMA and CAD in all 
territories, apart from strain rate in the RCA territory to determine underlying CAD and strain 
in the RCA territory to determine RWMA. However strain in the RCA territory did trend 
towards statistical significance (p value = 0.06).  
 
There was good correlation noted in the LAD territory with strain and strain rate (with 
both TVI and ST modalities) with the presence and absence, of RWMA (identified with 
standard echocardiography) and CAD (identified with angiography). There was also good 
correlation noted with TVI derived strain and strain rate and the presence and absence of 
RWMA and CAD in the Cx territory.  
 
ST derived strain and strain rate were statistically significant with the presence and 
absence of RWMA in the Cx territory. The RCA was only statistically significant with ST 
derived strain when determining the presence and absence of CAD.   
 
The bivariate fit of ejection fraction to global strain R square value was 0.2 (20% of the 
variation can be explained), which suggests there was a weak correlation between global 
strain and LVEF.  
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6 Chapter Six: Discussion Part II – Advanced Echocardiography 
Techniques 
 
6.1 Introduction 
 
Echocardiography, although a quick, affordable and effective diagnostic tool, relies upon 
individual interpretation of wall motion (contraction) to determine systolic dysfunction of a 
left ventricle after an AMI. This makes the test reasonably observer dependent (even though 
standardised training and guidelines attempt to minimise the effects of inter-observer 
variability). Furthermore, there may only be very subtle changes to systolic function, 
invisible to the human eye. For these reasons, the advanced echocardiographic modalities of 
tissue velocity imaging (TVI) and speckle tracking (ST) derived velocity, strain and strain 
rate are proposed as sensitive, quantitative, less observer dependent determinants of regional 
dysfunction, with the ability to detect significant underlying CAD.  
 
This chapter determines the viability and accuracy of utilising TVI and ST derived 
velocity, strain and strain rate as a diagnostic tool in a clinical (non-research) setting. This 
study was performed with the same set of 55 NSTEMI patients as used in Results 
I/Discussions I, admitted to Christchurch Hospital, New Zealand between June 2011 and 
April 2012. Using territorial strain of the three major vascular territories (LAD, RCA and 
Cx), trends between the presence and absence, of RWMAs (with echocardiography) and 
CAD (with coronary angiography) and their correlation with TVI and ST derived velocity, 
strain and strain rate values were assessed.   
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6.2 Validity of Performing and Analysing TVI and ST in a Non-Research 
Clinical Laboratory  
 
 
6.2.1 Acquisition 
 
The process of performing, analysing and interpreting TVI and ST waveforms is time 
consuming. This is especially so, for a routine (non-research) clinical laboratory in a public 
hospital where there are restraints on the length of an echocardiography examination due to 
high demand for the procedure. The acquisition of images for advanced modality analysis 
took approximately five minutes (described in detail in Chapter Two: Methodology).  The 
images were stored digitally and sent to EchoPac (GE Vingmed Ultrasound System, Horten, 
Norway). A disadvantage of using the 2007 version of EchoPac (GE Vingmed Ultrasound 
System, Horten, Norway) was the need for its own workstation. The new version of EchoPac 
(GE Vingmed Ultrasound System, Horten, Norway) may be uploaded and combined with 
ProSolv (ProSolv CardioVascular Client 4.0.2), which would significantly speed up the 
process (announced in 2009 [157]) – this is not currently used at Christchurch Hospital, New 
Zealand. Production and analysis of TVI and ST derived velocity, strain and strain rate 
waveforms may be performed on the GE Vivid 7 (GE Vingmed Ultrasound System, Horten, 
Norway) machine itself; however, this method was not used for this research due to 
procedure time constraints for each patient.  
 
All patients admitted with NSTEMI underwent additional imaging. From the additional 
images, advanced imaging modality analysis was performed to determine the usefulness of 
these tests in a routine clinical (non-research) setting. The patient images (windows) ranged 
from borderline to excellent (as a result of individual patient image quality) and although 
Simpson’s Biplane was possible in all patients, not all segments were perfectly visualised due 
to various factors (drop-out, reverberation artefact, etc.). No patients were excluded for poor 
acoustic window quality. If required, segments or entire walls were discarded. This study 
population, therefore, resembles a normal patient population in a clinical (non-research) 
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setting. A study published in 2011 by Marcon et al. [158] determined the accuracy of using 
longitudinal strain with ST in patients with suboptimal window quality (defined as three or 
more suboptimal segments). They found that longitudinal strain data was still accurate and 
reproducible. This suggests, that in this CESTEMI study, although some segments of 
suboptimal quality were discarded, the final data set should be accurate and reproducible, and 
moreover, representative of a true clinical population in a routine (non-research) cardiac 
clinical setting.     
 
 
6.2.2 Analysis 
 
Offline analysis of the five walls with TVI and two walls with ST derived velocity, strain 
and strain rate took approximately 20-40 minutes. Angiography for this patient cohort was 
performed on average 1.4 ± 1.1 days after the echocardiogram. This means that time permits 
for advanced modality analysis and interpretation prior to angiography if required.  
 
TVI velocity waveforms were used to determine the suitability for segmental 
interpretation as they represent primary, least processed data [85, 159]. Waveforms with 
excessive noise or aliasing were excluded as they precluded further analysis with strain and 
strain rate.  
 
For this study, territorial ‘strain’ was utilised as a method for determining RWMAs and 
underlying CAD correlation with the advanced modalities. This method was used instead of 
analysing individual segmental values. The segments were averaged for each theoretical 
vascular distribution (as described in the methods section), resulting in territorial data 
(velocity, strain and strain rate) for the LAD, RCA and Cx coronary artery territories 
according to established recommendations [160]. Studies have used this method in the past 
with favourable results [100, 161]. Research published in 2010 by Grenne et al. [161] found, 
of 105 patients presenting with NSTEMI, territorial circumferential strain was reduced in 
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those with significant CAD. A study published in 2007 by Gjesdal et al. [100] found 35 
STEMI patients displayed reduced territorial strain values, which correlated with significant 
CAD, infarct size and infarct mass. The territorial strain method used in this CENSTEMI 
study enabled the assessment of trends within the data set between the presence and absence 
of RWMAs and CAD and their correlation with velocity, strain and strain rate values (at the 
level of the theoretical coronary artery distribution). The averaged territorial strain value may, 
therefore, reflect a mixture of normal and diseased myocardium, hence, territorial strain 
values containing infarcted segments may not be as low as that measured from a single 
infarcted segment. This means that the resulting territorial strain value variations may not be 
as obvious as those found with single segmental analysis, with the possibility of greater 
overlap.  This method may not be suitable for a clinical setting as it is time consuming to 
average the data from each vascular distribution, although if required, the data may be 
collected then analysed retrospectively when time permits (which was performed in this 
study).  
 
Territorial strain provided the necessary information required to analyse and determine 
trends within the data set of this study. Greater or more obvious trends may be observed if a 
larger patient cohort was used; however, the modalities must work on an individual basis in a 
clinical (non-research) setting, not as a collective. Therefore, if the modalities were to work 
well, we would see promising results in a majority of the patients in this study. Individual 
coronary artery distribution was not accounted for in this study; however, in a clinical setting, 
this information is also unknown so it reflects real life practise. 
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6.2.3 TVI Analysis 
 
The sample volume was positioned, blinded to any RWMAs present and moved 
marginally if artefact was noted (reverberation/drop out etc.) or if the trace was obviously 
nonsensical. Of 825 possible segments for interrogation, 754 (91%) were found suitable for 
analysis.  
 
A study published in 2001 by Stoylen A. [162] determined the viability of using TVI 
derived strain rate to determine regional dysfunction in 30 patients. Of 480 possible 
segments, 473 (98%) could be analysed with standard echocardiography, while 454 (95%) 
could be analysed with strain rate. Stoylen A. [162] did not comment on the quality of 
segments in their study, however, did mention that the patients were randomly selected and 
not excluded for poor window quality. The proportion of segments suitable for analysis in the 
Stoylen A. study [162], was equivalent to the number determined suitable for analysis in this 
CENSTEMI study.  
 
In this study, the inferoseptal and inferior walls were most suitable for interrogation (165 
and 164 of 165 possible segments respectively). The author found that these segments aligned 
best with the cursor, reducing the angle of insonation. The anterior and anterolateral segments 
were found least suitable for interrogation (130 and 146 of 165 possible segments 
respectively).  Reverberation artefacts and drop-out were often noted in regions of the 
anterior and anterolateral walls. This, as well as the pronounced curve of the anterolateral 
wall (which increased the angle of insonation, a limitation of TVI [85]) reduced the potential 
segments available for interrogation/analysis.   
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6.2.4 ST Analysis 
 
Of 330 segments for possible interrogation, 305 (92%) were suitable for analysis. The 
septal wall was the most suitable for analysis (157 of a possible 165 segments), followed by 
the anterolateral wall (148 of a possible 165 segments). Stoylen A. [85] suggests discarding 
the entire wall if reverberation artefact or drop-out is noted. This was not performed in this 
CENSTEMI study. 
 
 A feasibility study performed by Sagberg et al. [163], published in 2004 found 
reverberation artefacts were noted in up to 80% of patients. They suggested that studies 
reporting 80% of segments for analysis may be feasible, but those reporting 90% or greater 
may have a high number of artefacts in their data. 92% of segments were determined feasible 
for analysis in this CENSTEMI study which raised the possibility of a small number of 
artefacts within the data set. Information obtained from the Sagberg et al. study [163] 
suggests that, when performing ST imaging, more emphasis should be placed on the 
determination of segment quality with consideration of discarding the whole segment/wall if 
artefact is noted.  
 
When performing Simpson’s Biplane ejection fraction with standard echocardiography it 
is recommended to start the trace at the mitral annulus, follow the anterolateral wall to the 
apex, along the inferoseptal wall to the opposite mitral annulus [107]. This is because there is 
reduced delineation of the anterolateral endocardial border, which makes tracking of the 
blood/tissue interface difficult when the image is frozen. This means that both standard 
echocardiography and advanced imaging modalities are influenced by window quality.    
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6.2.5 Coronary Angiography Analysis 
 
Analysis with coronary angiography was performed by averaging segmental data into the 
respective coronary artery territories - LAD, Cx and RCA - resulting in territorial values as 
described earlier. Significant correlations in the data set were observed when trends were 
noted between decreased values (of no particular arbitrary value) in the coronary artery 
territories when related to the presence and absence of RWMAs or underlying CAD. A study 
published in 2004 by Maniar et al. [164] used this method to assess ventricular function after 
CABG with myocardial strain imaging using MRI. Average regional circumferential strain 
for each region was determined with favourable results. They found this approach suitable for 
their research as it enabled detection of trends within the data. As this CENSTEMI study also 
wished to assess trends within the data, to determine whether the modalities actually worked 
or not in a clinical (non-research) laboratory setting, this method was, therefore, decided 
suitable for use.  
 
This CENSTEMI study did not determine, nor take into consideration normal nor 
abnormal values for the presence and absence of significant CAD as these have been shown 
and well validated in previous studies [86, 165] – see Appendix: Table 21 p.186.   
 
The analysis of underlying CAD by TVI and ST did not take into account RWMAs 
identified with echocardiography. The resulting data, therefore, represents patients with 
RWMAs and CAD, not just underlying CAD. When Choi et al. [91] examined correlation 
between strain and underlying CAD, they recruited patients with suspected ACS who had no 
visual RWMAs as determined by standard echocardiography. This reduced the possibility of 
segments with hypokinetic contraction biasing the results. In future studies, if the presence of 
underlying CAD is to be evaluated, the patient cohort should have no visible RWMAs with 
standard echocardiography.  
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6.3 Interpretation 
 
6.3.1 Tissue Velocity Imaging 
 
TVI derived velocity involves interrogating the motion between two points (the sample 
volume and the transducer), moving toward or away from each other [86]. In this study, 
territorial TVI derived strain and strain rate values were superior to velocity when correlating 
with RWMAs or CAD. Territorial TVI derived velocity did not correlate (was not statistically 
significant) with the presence of RWMAs and CAD for any of the coronary regions. There 
was high statistical significance and excellent correlation noted between the LAD region and 
TVI derived strain and strain rate. There was statistical significance and good correlation 
noted between the Cx region and TVI derived strain and strain rate. Statistical significance 
was not noted with the presence of CAD determined by strain rate in the RCA territory. Nor 
with the presence of RWMA determined by strain in the RCA region, however, a trend 
towards statistical significance was noted here.  Although there was correlation between 
strain/strain rate and RWMAs/CAD, there was also variation and overlap. This is significant 
in a clinical setting as it would reduce the validity of performing the test routinely - refer to 
the graphs (Chapter Five: Results II) for visual cues as to the spread of the data with the 
modalities and indices for the 55 patients.  
 
While TVI derived velocity is well validated and provides least processed waveforms and 
data [166-168], there are significant regional level differences in the distribution of 
myocardial velocities. A study published in 2000 by Palmes et al. [169] performed TVI on 20 
healthy patients, and 16 patients with AMI analysed waveforms from the basal, mid and 
apical segments. They found decreased S and E velocities correlated with regional 
dysfunction, velocity differences between walls (the lateral and septal walls in healthy 
subjects showed lower velocities) and at different levels of the myocardium (the apical 
velocities were lower than the basal velocities). Animal based studies have related these 
variances to non-homogenous contraction of longitudinal, circumferential and radial fibres 
with an apex which is thickening, yet stationary, hence the low velocities [170].  
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6.3.1.1 Explanations for the Reduced Statistical Significance between TVI Derived 
Velocity and RWMAs/CAD  
 
Velocity is indicative of tissue motion and is position dependent [86]. TVI derived 
velocity involves interrogating the motion between two points (the sample volume and the 
transducer) moving toward or away from each other [171]. For this reason, TVI derived 
velocity is influenced by translational motion and tethering of adjacent tissue and indicative 
only of a single point not fully capturing intricate myocardial mechanics. As velocity 
increases from apex to base, contraction at the apex of the heart may affect passive segments 
at the base resulting in motion shown when there is none [86]. These issues may contribute to 
the low correlation and lack of statistical significance noted between TVI derived velocity 
and the presence and absence of RWMAs or CAD. The method used for this study – 
obtaining territorial data – may possibly be incorrect for analysis of trends with TVI derived 
velocity. In a normal examination, values will differ slightly from the base (lower values) to 
the apex (higher values) because of the gradient, as explained above. Because this research 
involved averaging segments from theoretical coronary distributions, data was gathered from 
these theoretical coronary distributions at the base, mid and apex of the left ventricle. The 
averaged values are, therefore, incorporating a normal gradient of difference between the 
levels of the heart, which is not distributed normally for the coronary territories. This may 
result in values which appear incorrectly significant or insignificant.  
 
 
6.3.1.2  Reasons for Improved Statistical Significance between TVI Derived Strain 
and Strain Rate and RWMA/CAD 
 
While velocity is indicative of wall motion, strain and strain rate are measures of tissue 
deformation [86]. Strain is a measure of tissue deformation; the change in length during 
myocardial contraction and relaxation normalised to the original length; an estimate obtained 
from paired velocity points along a single scan line separated by a fixed distance [172]. Strain 
rate is the rate at which the deformation occurs; the rate to which paired velocity points along 
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a scan line move toward or away from one another [173] and has been well validated in 
literature as a method superior to that of TVI derived velocity as it is angle independent  
[174-176]. Data is now compared between paired internal velocity points, rather than an 
internal point (sample volume) and an external point (the transducer). This principle 
overcomes the issues that overshadow TVI derived velocity. Strain and strain rate data, 
although still angle dependent, overcome the effects of tethering and translation and provide 
greater correlation with the presence and absence of RWMAs or CAD as shown in literature 
[85, 86, 171].  
 
A study published in 2001 by Stoylen, A. [162] used 20 patients admitted with AMI for 
coronary angiography to compare strain rate values to standard echocardiography regional 
analysis. The presence and absence, of CAD with angiography correlated well with strain rate 
peak S data (p<0.001), confirming the feasibility of this method. Stoylen, A. [162] did also 
not correct for patients with pre-existing RWMAs so perhaps there is also an element of bias 
in their study. However, Stoylen, A. [162] concluded that although correlations were present, 
significant overlap and wide standard deviations meant strain rate analysis was not sufficient 
for standard clinical laboratory use. The CENSTEMI study agrees with the above research, as 
significant correlations and trends within the CENSTEMI data sets were noted; however, 
equally significant overlap between the data sets suggests these values may be unreliable for 
clinical (non-research) laboratory use.  
 
 
6.3.1.3  Limitations of TVI Derived Velocity, Strain and Strain Rate 
 
TVI derived velocity, strain and strain rate is observer dependent and requires an 
experienced user with extensive training in the field. Interpretation of waveforms is often not 
black and white and there is occasional difficulty in correctly identifying waveforms as 
multiple peaks may be present [177]. Stoylen, A. [85] has previously described 
echocardiography as a craft, not an exact science, which concisely sums TVI analysis. As 
stated earlier, the sample volume was placed in pre-defined locations and moved marginally, 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
154 
 
if required. The author noted very minor movements often drastically changed the waveforms 
for analysis. A user more experienced in the field may feel comfortable altering the 
positioning of the sample volume to an extent not carried out in this study resulting in more 
accurate waveforms. However protocol was followed in this study by putting the sample 
volume in the pre-defined locations ensuring consistency and reproducibility.   
 
Echocardiography performed on NSTEMI patients can often be challenging. These 
patients are acute admissions, often older with increased body habitus. These factors often 
result in difficult acoustic images, which make interpretation of cardiac function and 
advanced modality imaging challenging.  Because no patient was excluded from this study 
for poor image quality, this was a frequent problem faced. This may also contribute to the 
variation noted within these modalities.  
 
Strain and strain rate data are derived from velocity based measurements which are one 
dimensional, whereas cardiac tissue deforms in three dimensions [86]. The modality of three 
dimensional strain (speckle tracking) may overcome this issue in the future, however, current 
state of knowledge results is significant differences between manufacturers so further clinical 
validity is required. Moreover, studies of inter-observer variability with the advanced 
imaging modalities in previous literature were variable. Some found TVI derived indices 
highly reproducible [178, 179], others suggest variability ranges 10-15% [86], while further 
studies suggest that TVI derived indices have low reproducibility rates [86, 171]. 
 
6.3.1.4  TVI Summary 
 
This study shows that TVI derived strain and strain rate are more promising modalities 
than TVI derived velocity for identifying the presence of RWMAs and CAD. However, 
although there is significant correlation within the data sets, there is also significant overlap 
which reduces the validity of using this modality in a clinical (non-research) laboratory 
setting.   
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6.3.2 Speckle Tracking Imaging 
 
ST involves tracking natural acoustic markers frame by frame throughout one cardiac 
cycle and has been well validated [105, 180-182]. ST overcomes the angle of insonation and 
the effects of cardiac translation by applying the sum of absolute differences algorithm [178]. 
Territorial ST derived velocity did not correlate well with the presence of RWMAs, or CAD 
in the Cx or RCA territories therefore was not statistically significant. ST derived velocity 
was only statistically significant with the presence and absence of CAD in the LAD region. 
Territorial ST derived strain and strain rate values correlated well with the presence of 
RWMAs and CAD in the LAD region, therefore, were statistically significant and 
outperformed analysis with ST in both the Cx and RCA. The remaining values were varied; 
while territorial strain and strain rate correlated well and were statistically significant with 
RWMAs in the Cx region, there was no correlation (no statistical significance) noted in the 
RCA region; and while territorial strain correlated well with the presence of CAD in the RCA 
region (there was statistical significance), no correlation was noted with velocity and strain 
rate in the RCA or Cx region (there was no statistical significance) for CAD.  
 
 
6.3.2.1  Reasons for Reduced Statistical Significance between ST and RWMAs/CAD 
 
This study used ST to assess velocity, strain and strain rate in the apical four chamber 
view. Territorial strain was determined (as described earlier) by averaging velocity, strain and 
strain rate data from the three coronary regions - LAD, Cx and RCA. The apical four 
chamber view receives coronary flow from all three arteries; one segment via the RCA (basal 
inferoseptal), three via the LAD (mid and distal inferoseptal and the distal anterolateral 
segment), and two via the Cx (basal and mid anterolateral segments). The Cx (represented by 
two segments) and moreover the RCA (represented by one segment) are the least represented 
regions in the apical four chamber view. The RCA segment is likely misrepresented in this 
study. Using the technique of averaging data sets to obtain territorial velocity, strain and 
strain rate data (average values for the theoretical coronary distribution) may be an incorrect 
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method of analysis when using only the apical four chamber view as in this study. Individual 
segmental analysis would be the best method for analysis when using only the apical four 
chamber view. If territorial strain is to be used in the future, this study suggests that all three 
imaging planes (apical four chamber, apical two chamber and apical long axis) should be 
analysed. However, as explained earlier, the aim of this study was to ascertain trends within 
the data set. If there were significant correlations between the RCA and the presence and 
absence of RWMAs and CAD, these trends would show in the data. This, in general, was not 
the case.  
 
It is surprising that the RCA region did not (in general) correlate well with RWMAs and 
underlying CAD as the inferoseptal wall was found to align with the transducer most of all 
the cardiac walls (reducing the angle of insonation) and there were never any significant 
artefacts in the region.  
 
Moreover, a study published in 2009 by Gustafsson et al. [183] further confirmed the 
complexity of the intrinsic mechanics of the left ventricle. Using 40 healthy patients, they 
used circumferential ST to assess left ventricular motion. They found that the basal 
inferoseptum segments rotated significantly more clock-wise than both the basal anterolateral 
segments and the segments at the mid and distal levels of the myocardium. They also noted 
significant differences concerning the duration of twist within the left ventricle (the basal 
segments duration of un-twisting was much longer than that of the apical segments). These 
differences in regional contraction play important roles in left ventricular filling and function. 
The motion of the basal inferoseptum noted in the above study with circumferential ST may 
further explain the lack of statistical significance noted between ST and the presence/absence 
of RWMAs/CAD in the RCA segment in this CENSTEMI study. It is possible, that the 
accentuated motion of the basal inferoseptum counteracts a hypokinetic myocardium to some 
extent. Future studies may confirm this.  
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6.3.2.2  Limitations of ST Derived Velocity, Strain and Strain Rate 
 
Although ST is a quicker and less observer dependent process than TVI [184], there are 
various pitfalls to this technique which could contribute to the varied correlations and overlap 
noted in this study. ST relies upon a high frame rate (50-70 fps [99]) which can be difficult in 
individuals with borderline image quality. 
 
The author found frame rates were often difficult to perfect, due to the reduced quality of 
patients individual images (frame rates ranged from 36 to 109 frames per second). An 
increased frame rate reduces under-sampling, however, results in decreased spatial resolution 
(the ability of a system to distinguish two points as separate in space), which results in less 
than optimal tracking of the region of interest [185]. Decreased frame rates, increase spatial 
resolution. But, because the software searches and tracks individual speckles frame-by-frame, 
this may mean that, owing to the low frame rate, a speckle is outside of the search area, once 
again resulting in less than optimal tracking of the region of interest [181]. There is a chance, 
therefore, that variations in frame rates may contribute to underestimated or overestimated 
values. However, Edvasden et al. [89] used frame rates ranging from 56-134 fps with 
excellent results, furthermore, studies have suggested that frame rates >30fps allow for 
reliable and reproducible software operation [186, 187]. This means that the frame rates used 
in this CENSTEMI study were acceptable.  
 
ST is a two dimensional measurement, whereas cardiac motion is three dimensional [99]. 
This means that the modality may not capture the full motion of the left ventricle. Therefore, 
areas may be under or over estimated. Values are variable with age and sex, so there is a 
possibility that a normal value for one patient may be borderline or abnormal for another 
[188, 189]. This study was looking for trends in a predominantly older subset of 
predominantly male patients, so these factors, although still relevant, should be minimised.  
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6.3.2.3 Statistical Significance between the LAD Territory and ST Derived Velocity 
Strain and Strain Rate 
 
The strain and strain rate values for the LAD region correlated best (were statistically 
significant) with the presence and absence of RWMAs and underlying CAD for both the TVI 
and ST modalities. This may be due to a large number of LAD infarcts in this research (15 
patients had LAD single vessel CAD, compared with 5 patients with RCA single vessel CAD 
and no patients with Cx single vessel CAD). It may also be explained by less individual 
variation in the LAD coronary artery distribution [190]. Good cursor alignment and 
visualisation of LAD regional segments may also have assisted with the favourable results.  
 
 
6.3.2.4  Benefits of the Utilising of Speckle Tracking over Tissue Velocity Imaging  
 
Unlike TVI, which requires user to determine sample volume positioning and waveform 
measurement, ST requires only a user defined region of interest which is optimised to follow 
the endocardium throughout one cardiac cycle. The result is automated analysis of segments 
which are less influenced by the user. Although, an average of three measurements is 
recommended to ensure reproducibility. 
 
This CENSTEMI study found ST much quicker to perform, which agrees with literature 
in the field [105, 191]. When the region of interest was optimised, automated analysis 
resulted in velocity, strain and strain rate waveforms. Values for peak velocity, strain and 
strain rate were analysed, pre-measured and displayed automatically in a box below the 
waveforms. Although a high frame rate was required for ST analysis, only one cardiac cycle 
was required. The need for just one cardiac cycle meant that the traces were less likely to 
contain incidental movement or inspiration. Hoyt et al [103] suggested ST to be less time 
consuming as it is a semi-automated process, beneficial over TVI as studies suggest increased 
reproducibility, increased signal to noise ration and no angle dependency.    
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6.3.2.5  ST Summary 
 
This study shows that ST of the apical four chamber view correlated well with strain and 
strain rate with the presence of both RWMAs and underlying CAD in the LAD region. 
However, less correlation was noted in the Cx region, and lesser still in the RCA region.  
 
This may be due to limitations with the study methodology such as theoretical coronary 
artery distribution assumptions, difficult patient image quality, the complex mechanics of the 
left ventricle, or perhaps reflects the real-world application of ST.  
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6.4 Inter-Observer Variability 
 
No inter-observer or test re-test variation assessment was performed for this research, 
which is a limitation to the reproducibility of TVI and ST derived velocity, strain and strain 
rate values obtained in this study. Future studies would benefit from adding the calculation of 
inter-observer variability to their methodology to ensure the reproducibility of their obtained 
values.  
 
 
6.5 Global Strain 
 
Global strain is an average of all segmental values (six segments) in the apical four 
chamber views. Global strain was assessed by ST, resulting in an automated value. An r
2
 of 
0.22 suggested weak correlation between LVEF and global strain. Studies such as Brown et 
al. [192] and Mistry et al. [193] found that global strain an effective quantifier of LVEF, 
especially in patients with extensive RWMAs. However, in this CENSTEMI study, the 
correlation between LVEF and global strain was weak, suggesting that in a clinical (non-
research) laboratory setting, Simpson’s Biplane ejection fraction is superior to ST derived 
global strain when determining LVEF.  
 
A study published in 2010 and performed by Eek et al. [101] identified 61 patients with 
NSTEMI, and performed echocardiography prior to angiography. They found good 
correlation between global strain and infarct size (r=0.68 and p<0.001), with a global strain 
>-13.8% identifying patients with significant infarction, who may benefit from urgent 
angioplasty. The results of the above study were compared to the raw CENSTEMI global 
strain data set on EXCEL. Nine patients had a global strain values >-13.8%, with average 
LVEFs of 49 ± 7%. In comparison, 42 patients had global strain values of ≤-13.8%, with 
average LVEFs of 59 ± 11%. This raw data agrees with that obtained in the Eek et al [101] 
study, as global strain values in the CENSTEMI data set >-13.8% also had lower LVEFs 
suggestive of significant infarction.  
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In this CENSTEMI study, as global strain showed only weak correlation, it is unlikely to 
be clinically useful. Above all, the advanced imaging modality of real-time three-dimensional 
echocardiographic quantification is regarded as an excellent indicator of LVEF. It is rapid, 
accurate and reproducible [194] and especially useful for patients with asymmetrical 
ventricles [195, 196]; however, also remains highly reliant on patient image quality.   
 
 
6.6 Clinical Application 
 
On the basis of this study, and existing literature, it is doubtful whether the addition of 
TVI and ST derived information to a clinical report would alter the clinical pathway of an 
ACS patient at Christchurch Hospital, New Zealand. This is because although correlation and 
statistical significance was noted, there was also significant overlap and variation - refer to 
the graphs (Chapter Five: Results II) for visual cues as to the spread of the data with the 
modalities and indices for the 55 patients. It is unlikely that including data such as this into a 
clinical report would alter the patient’s requirement for stress echocardiography and/or 
angiography when the patient had otherwise normal left ventricular function and an absence 
of RWMAs.  
 
However, these modalities may, with further refinement, detect underlying CAD that may 
otherwise be overlooked, in patients with no regional or global dysfunction, both within the 
NSTEMI population and the general population. Further testing with adjusted methodologies 
would clarify this. As novel indices, there is hope that in the future these will prove useful for 
quantifying RWMAs and detecting underlying CAD. The author will continue to use these 
modalities, when time permits, in clinical (non-research) situations in an attempt to further 
refine the technique, with the aim to provide supplementary information to future routine 
echocardiography studies.   
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Conclusion: Advanced Echocardiography Discussion  
 
Velocity derived from TVI was not statistically significant with the presence and absence 
of RWMAs and underlying CAD in any of the coronary regions. In general, strain and strain 
rate imaging derived from both TVI and ST modalities were statistically significant with the 
presence and absence of RWMAs and underlying CAD. There was especially excellent 
correlation noted between the LAD region and strain and strain rate derived indices. There 
was, however, overlap between patients with and without RWMAs/CAD, such that it is 
unlikely that the additional information from the new modalities would currently be clinically 
useful for the management of individual patients.  
 
 
This study found that TVI was generally superior to ST when assessing the presence of 
RWMAs and CAD in all of the coronary regions. However, ST was quicker and less operator 
dependent. The clinical use of these modalities would be useful if there was less variation and 
overlap noted within the data sets. ST would be the method of choice as it was much quicker, 
less observer dependent and provides a lot of additional information, however, in this study 
TVI generally portrayed greater correlation with the presence and absence of RWMAs abd 
underlying CAD.  
 
 
Further refinement is required both technically and clinically. This study found the results 
were highly reliant on patient window quality, which was considered a significant limitation 
of these modalities clinically. TVI (specifically of the LAD territory) and ST (specifically 
strain and strain rate of the LAD territory for both RWMAs and CAD and strain and strain 
rate of the Cx territory for RWMAs) derived indices give quantifiable values which would be 
useful for future comparison to determine contractile improvement.  
 
 
There was weak correlation between global strain and LVEF, suggesting that global strain 
is unlikely to be useful clinically. Moreover, real-time three-dimensional LVEF 
quantification is now suggested as an excellent indicator of LVEF.  
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7 Chapter Seven: Study Limitations 
 
 
7.1 Clinical Limitations 
 
This research was conducted in one hospital with a small randomly selected sample 
population (n=55), suggesting the resulting data may not be statistically indicative of a true 
population. Several values in the TVI and ST derived velocity, strain and strain rate chapter 
overlapped and were not statistically different. Increasing the patient sample size may reduce 
the effects of a Type I error (incorrect rejection of the null hypothesis). There may also be 
failure to identify a true difference due to the small sample size (Type II error – failure to 
reject the false null hypothesis). However, data heterogeneity and overlap in this study 
between patients suggests that increasing the patient sample size would have no significant 
effect on the results. The main aim of this research was to provide further information on 
NSTEMI characteristics and management. This is a relatively under studied area compared to 
that of STEMI.  
 
Note should also be made that a GE echocardiography machine was used for this study. 
The results may not extrapolate to other manufacturers machines, hence clinical relevance 
may be limited to centres with GE machines.  
 
A limitation of this research was the exclusion criteria, suggesting the results may not be 
indicative of a true population. However, the exclusion criteria provided consistency between 
patients. Furthermore, the patients were randomly recruited (as discussed in the Chapter Two: 
Methodology).   
  
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
165 
 
7.1.1 Technical Limitations 
 
Observer variability is an important issue in echocardiography because all of the 
measurements are generally observer-dependent. To minimise this variability, the 
echocardiography images and advanced imaging modality analysis was performed by one 
sonographer, but the possibility of intra-observer variation remains. For this research, a single 
operator provided consistency between patients with any bias likely to be systematic rather 
than random. We did not formally assess intra-observer variability, but the sonographer 
employed holds appropriate qualifications (trained formally through Queensland University 
of Technology - Post Graduate Diploma of Cardiac Ultrasound) and has experience in 
obtaining images for advanced modality analysis in occasional national and international 
research projects based at Christchurch Hospital, New Zealand.  
 
An attempt was made to minimise these technical limitations by initiating a prospective 
study of patient data collection after developing a clear echocardiographic protocol. All 
images, analysis and interpretations were performed according to this protocol, and clinical 
interpretation, RWMA and coronary angiography assessment was performed by a single 
cardiologist. Other studies in this field have used a retrospective approach with multiple 
researchers performing images and analysis. The methodology used in this CENSTEMI study 
ensured consistency between patients. 
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8 Chapter Eight: Conclusion 
 
Although echocardiography is a valuable tool in the setting of ACS management for 
detecting structural and functional cardiac abnormalities, and it is recommended in the 2012 
ACS guidelines, it remains under-utilised. The cohort studied in this thesis was a randomly 
selected set of 55 NSTEMI patients, typical of a New Zealand hospital setting. We have 
demonstrated the usefulness of echocardiography for identification of systolic and diastolic 
dysfunction, also, that the degree of TnI elevation cannot be used to select a subset of patients 
for echocardiography. 
 
In this study, we examined the characteristics of 55 NSTEMI presentations with 
echocardiography. One fifth of the patients had diabetes, while over fifty per cent were 
current or prior smokers. These patients had a higher incidence of CAD and were nine fold 
more likely to require CABG.  
 
There was no correlation between LVEF and TNI elevation, suggesting that TNI 
elevation should not be used to determine AMI severity, or the extent of myocardial damage.  
 
The highest incidence of single vessel CAD was noted in the LAD territory, followed by 
the RCA. No Cx arteries were single vessel culprits. Over one third of the patients had low-
normal LVEFs (<60%), while just under one fifth of the patients had at least mild systolic 
impairment (<50%), which substantially affects patient medical management.  
 
Just over one eighth of patients had moderate to severe diastolic impairment. They were 
more likely to have impaired LVEFs and CAD. Moderate to severe diastolic dysfunction has 
been associated with poor prognostic outcome in previous literature, despite the underlying 
cause. 
 Almost one quarter of the patients admitted with NSTEMI had no CAD. This may be the 
result of false positive diagnosis on admission, or perhaps symptoms and TnI elevations 
which align with other conditions.  Of the patients with CAD, just over two fifths had 
RWMAs, with around three quarters correctly identifying the culprit artery.  
 
This study found that echocardiography, which is cost effective and quick, plays a very 
useful role in identification of systolic and diastolic dysfunction with NSTEMI presentations. 
Systolic and diastolic dysfunction are useful indicators for patient management and 
prognostic outcome.   
 
We also examined the feasibility of utilising the advanced imaging modalities TVI and 
ST derived velocity, strain and strain rate to quantitatively determine regional function and 
detect underlying CAD. The process of performing TVI was time consuming, while 
performing ST was very quick in comparison.  
 
This study found, that of the modalities TVI derived strain and strain rate were superior to 
velocity when identifying RWMA and underlying CAD, especially in the LAD region, and to 
a lesser extent, the Cx region. However, noted that, when placing the sample volumes, minor 
movements often significantly altered the waveforms and waveforms could be created by 
placing the sample volume outside the cardiac region. Furthermore, interpretation of the 
waveforms was often difficult. ST derived strain and strain rate was highly statistically 
significant and correlated best with the LAD segment when identifying RWMAs and 
underlying CAD. 
 
This study found ST had an advantage over TVI because it was quick and after defining 
the region of interest, the waveforms were created and measured by the machine, making 
analysis easier. However, it did not correlate as well with the presence and absence of 
RWMAs and underlying CAD as the TVI derived indices. Both TVI and ST were highly 
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reliant on patient image quality which, along with the utilisation of territorial strain analysis, 
may have been limitations of this study.  
 
From this study, it is therefore recommended that patients require good to excellent image 
quality for both TVI and ST. Territorial strain was useful in this study for identifying overall 
trends in the data, however, for clinical use, individual analysis of segments is likely quicker. 
Individual analysis of segments is more efficiently performed with ST as the waveforms for 
each imaging plane (apical four chamber, apical two chamber and apical long axis) are 
displayed on one graph, with peak velocity, strain and strain rate values automatically 
measured allowing comparisons between segments and walls.  
 
These advanced modalities, with further technical and clinical refinement, may prove 
useful in clinical situations. Furthermore, the author will continue to use these modalities, 
especially ST, in the hope of further refining both technical and clinical technique, as 
quantification of RWMAs would supplement future echocardiographic comparisons while a 
novel, non-invasive approach to identifying underlying CAD with no visual RWMAs would 
be of interest in a clinical laboratory.    
 
 
 
 
  
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
170 
 
 
References 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
171 
 
9 References 
 
1. Thygesen, K., Alpert, JS., Jaffe, AS., Simoons, ML., Chaitman, BR., White, HD, 
Third universal definition of myocardial infarction. Eur Heart J, 2012. 33(20): p. 
2551-67. 
2. The Merck Manuals. [Internet].  Acute Coronary Syndromes (ASC). USA: c2013. 
Available from: 
www.http://www.merckmanuals.com/professional/cardiovascular_disorders/coronary
_artery_disease/acute_coronary_syndromes_acs.html 
3. Gawaz, M., F. Neumann, and A. Schomig, Evaluation of platelet membrane 
glycoproteins in coronary artery disease : consequences for diagnosis and therapy. 
Circulation, 1999. 99(1): p. E1-E11. 
4. The Merck Manuals. [Internet].  Acute Coronary Syndromes (ASC). USA: c2013. 
Available from: 
www.http://www.merckmanuals.com/professional/cardiovascular_disorders/coronary
_artery_disease/acute_coronary_syndromes_acs.html 
5. Griffin, B., Callahan, T., Menon, V., Wu, W., Caurhen, C., Dunn, J, editors. Manual 
of Cardiovascular Medicine. 4th Edition. USA: Lippincott Williams & Wilkins; 2013. 
p. 42.  
6. Kumar, A. and C. Cannon, Acute coronary syndromes: diagnosis and management, 
part I. Mayo Clin Proc, 2009. 84(10): p. 917-38. 
7. Allen, L., O'Donnell, CJ., Camargo, CA., Giugliano, RP., Lloyd-Jones, DM, 
Comparison of long-term mortality across the spectrum of acute coronary syndromes. 
Am Heart J, 2006. 151(5): p. 1065-71. 
8. Montalescot, G., Dallongeville, J., Van Belle, E., Rouanet, S., Baulac, C., 
Degrandsart, A., Vicaut, E., STEMI and NSTEMI: are they so different? 1 year 
outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the 
OPERA registry). Eur Heart J, 2007. 28(12): p. 1409-17. 
9. Ellis, C., Devlin, G., Elliott, J., Matsis, P., Williams, M., Gamble, G., Hamer, A., 
Richards, M., White H., Acute Coronary Syndrome patients in New Zealand 
Experience signficant delays to acess cardiac investigations and revascularisation 
treatment especially when admitted to non-interventional centres. The New Zealand 
Medical Journal, 2010. 123: p. 1-17. 
10. Thygesen, K., Mair, J.,Giannitsis, E.,Mueller, C., Lindahl, B., Blankenberg, S., 
Huber, K., Plebani, M., Biasucci, L. M., Tubaro, M., Collinson, P., Venge, P., Hasin, 
Y., Galvani, M., Koenig, W., Hamm, C., Alpert, JS, Katus, H., Jaffe, AS, How to use 
high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J, 2012. 33(18): p. 
2252-7. 
11. Singh, V., Martinezclark, P., Pascual, M., Shaw, ES., O'Neill, WW., Cardiac 
biomarkers - the old and the new: a review. Coron Artery Dis, 2010. 21(4): p. 244-56. 
12. Jaffe, A., Ordonez-Llanos, J., High sensitivity troponin in chest pain and acute 
coronary syndromes. A step forward? Rev Esp Cardiol, 2010. 63(7): p. 763-9. 
13. Anderson, J., Adams, CD., Antman, EM., Bridges, CR., Califf, RM., Casey, DE., 
Chavey, WE., Fesmire, FM., Hochman, JS., Levin, TN., Lincoff, AM., Peterson, ED., 
Theroux, P., Wenger, NK., Wright, RS., Smith, SC., 2011 ACCF/AHA Focused 
Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of 
Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
172 
 
the American College of Cardiology Foundation/American Heart Association Task 
Force on Practice Guidelines. Circulation, 2011. 123(18): p. e426-579. 
14. Boersma, E., Pieper, KS., Steyerberg, EW., Wilcox, RG., Chang, WC., Lee, KL., 
Akkerhuis, KM., Harrington, RA., Deckers, JW., Armstrong, PW., Lincoff, AM., 
Califf, RM., Topol, E., Simoons, ML., Predictors of outcome in patients with acute 
coronary syndromes without persistent ST-segment elevation. Results from an 
international trial of 9461 patients. The PURSUIT Investigators. Circulation, 2000. 
101(22): p. 2557-67. 
15. Ellis, C., Gamble, G., Hamer, A., Williams, M., Matsis, P., Elliott, J., Devlin, G., 
Richards, M., White, H., Patients admitted with an acute coronary syndrome (ACS) in 
New Zealand in 2007: results of a second comprehensive nationwide audit and a 
comparison with the first audit from 2002. N Z Med J, 2010. 123(1319): p. 25-43. 
16. Gehrie, E., Reynolds, HR., Chen, AY., Neelon, BH., Roe, MT., Gibler, WB., Ohman, 
EM., Newby, LK., Peterson, ED., Hochman, JS. , Characterization and outcomes of 
women and men with non-ST-segment elevation myocardial infarction and 
nonobstructive coronary artery disease: results from the Can Rapid Risk 
Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early 
Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement 
initiative. Am Heart J, 2009. 158(4): p. 688-94. 
17. Bolooki, H., Askari, A. . Acute Myocardial Infarction. 2011; Available from: 
http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/a
cute-myocardial-infarction/. 
18. Todd, T. [Internet]. Diabetes 'tsunami' predicted. New Zealand: The Press; 2010. 
Available from: http://www.stuff.co.nz/national/health/4209719/Diabetes-tsunami-
predicted 
19. New Zealand: Ministry of Health. [Internet]. Diabetes Information. 2010. Available 
from: http://www.moh.govt.nz/moh.nsf/indexmh/diabetes-information 
20. Shang, Q., Yip, G. Diabetic Heart Disease: The Story Continues. Journal of Human 
Hypertension. 2010. 25: p. 141-143. 
21. Nardi, E., Palermo, A., Mule, G., Cusimano, P., Cottone, S., Cerasola, G., Impact of 
type 2 diabetes on left ventricular geometry and diastolic function in hypertensive 
patients with chronic kidney disease. J Hum Hypertens, 2011. 25(3): p. 144-51. 
22. Franklin, K., Goldberg, RJ., Spencer, F., Klein, W., Budaj, A., Brieger, D., Marre, M., 
Steg, PG., Gowda, N., Gore, JM., Implications of diabetes in patients with acute 
coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern 
Med, 2004. 164(13): p. 1457-63. 
23. Donahoe, S., Stewart, GC., McCabe, CH., Mohanavelu, S., Murphy, SA., Cannon, 
CP., Antman, EM., Diabetes and mortality following acute coronary syndromes. 
JAMA, 2007. 298(7): p. 765-75. 
24. George, J., Herrett, E., Denaxas, S., Rapsomaniki, S., Timmis, A., Smeeth, L., 
Hemingway, H. , The Hazard of Smoking for Specific Coronary Disease Phenotypes: 
An Electronic Health Records Study with Linked Data in 915,000 Patients. Epidemiol 
Community Health, 2012. 66: p. 34-35. 
25. Killip, T., Kimball, J., Treatment of myocardial infarction in a coronary care unit: a 
two year experience with 250 patients. American Journal of Cardiology, 1967. 20: p. 
457–465 
 
26. Mandelzweig, L., Battler, A., Boyko, V., Bueno, H., Danchin, N., Filippatos, G., Gitt, 
A., Hasdai, D., Hasin, Y., Marrugat, J., Van de Werf, F., Wallentin, L., Behar, S., The 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
173 
 
second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, 
and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. 
Eur Heart J, 2006. 27(19): p. 2285-93. 
27. Danchin, N., Battler, A., Bueno, H., Fox, K., Hamm, C., Lindahl, B., Schiele, F., 
Simoons, M., Tendera, M., Tubaro, M., Euro Heart Survey on ACS, 2009, Euro Heart 
Survey. 
28. ST-elevation myocardial infarction: New Zealand management guidelines. N Z Med 
J, 2005. 118(1223): p. U1679. 
29. New Zealand 2012 guidelines for the management of non ST-elevation acute coronary 
syndromes. N Z Med J, 2012. 125(1357): p. 122-47. 
30. St John Sutton, M., Quest for diastolic prognostic indicators of clinical outcome after 
acute myocardial infarction. Circulation, 2008. 117(20): p. 2570-2. 
31. Nagueh, S., Appleton, CP., Gillebert, TC., Marino, PN., Oh, JK., Smiseth, OA., 
Waggoner, AD., Flachskampf, FA., Pellikka, PA.  and A. Evangelisa, 
Recommendations for the evaluation of left ventricular diastolic function by 
echocardiography. Eur J Echocardiogr, 2009. 10(2): p. 165-93. 
32. Lang, R., Bierig, M., Devereux, RB., Flachskampf, FA., Foster, E., Pellikka, PA., 
Picard, MH., Roman, MJ., Seward, J., Shanewise, JS., Solomon, SD., Spencer, KT., 
Sutton, MS., Stewart, WJ., Recommendations for chamber quantification: a report 
from the American Society of Echocardiography's Guidelines and Standards 
Committee and the Chamber Quantification Writing Group, developed in conjunction 
with the European Association of Echocardiography, a branch of the European 
Society of Cardiology. J Am Soc Echocardiogr, 2005. 18(12): p. 1440-63. 
33. Ko, S., Kim, YJ., Park, JH., Choi, NM., Assessment of left ventricular ejection 
fraction and regional wall motion with 64-slice multidetector CT: a comparison with 
two-dimensional transthoracic echocardiography. Br J Radiol, 2010. 83(985): p. 28-
34. 
34. Squeri, A., Gaibazzi, N., Reverberi, C., Caracciolo, MM., Ardissino, D., Gherli, T., 
Ejection fraction change and coronary artery disease severity: a vasodilator contrast 
stress-echocardiography study. J Am Soc Echocardiogr, 2012. 25(4): p. 454-9. 
35. Fleming, R.M., A tete-a-tete comparison of ejection fraction and regional wall motion 
abnormalities as measured by echocardiography and gated sestamibi SPECT. 
Angiology, 2002. 53(3): p. 313-21. 
36. Erbel, R., Schweizer, P., Krebs, W., Meyer, J., Effert, S., Sensitivity and specificity of 
two-dimensional echocardiography in detection of impaired left ventricular function. 
Eur Heart J, 1984. 5(6): p. 477-89. 
37. Weissman, N. Transthoracic echocardiography for the evaluation of chest pain in the 
emergency department. 1998; Available from: 
http://cmbi.bjmu.edu.cn/uptodate/echocardiography%20and%20imaging/Echocardogr
aphy/Transthoracic%20echocardiography%20for%20the%20evaluation%20of%20ch
est%20pain%20in%20the%20emergency%20department.htm. 
38. Hands M, A.V., Thompson P, Hung J, Robinson J, Lloyd B., Differences in left 
ventricular function between anterior and inferior myocardial infarction of equivalent 
enzymatic size. International Journal of Cardiology, 1987. 17(2): p. 155-167. 
39. McClements, B., Weyman, AE., Newell, JB., Picard, MH., Echocardiographic 
determinants of left ventricular ejection fraction after acute myocardial infarction. 
Am Heart J, 2000. 140(2): p. 284-9. 
40. Thanavaro, S., Kleiger, RE., Province, MA., Hubert, JW., Miller, JP., Krone, RJ., 
Oliver, GC., Effect of infarct location on the in-hospital prognosis of patients with 
first transmural myocardial infarction. Circulation, 1982. 66(4): p. 742-7. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
174 
 
41. Sengupta, P., Tajik, AJ., Chandrasekaran, K., Khandheria, BK., Twist mechanics of 
the left ventricle: principles and application. JACC Cardiovasc Imaging, 2008. 1(3): 
p. 366-76. 
42. LeWinter, M., Kent, RS., Kroener, JM., Carew, TE., Covell, JW., Regional 
differences in myocardial performance in the left ventricle of the dog. Circ Res, 1975. 
37(2): p. 191-9. 
43. Copploa, B., Omens, J. , Use of Larger Species such as Dog and Pig as Model 
Systems to Study Cardiac Disease. Drug Discovery Today - Disease Models, 2009. 
5(3): p. 195-200. 
44. Maciver, D., The relative impact of circumferential and longitudinal shortening on 
left ventricular ejection fraction and stroke volume. Exp Clin Cardiol, 2012. 17(1): p. 
5-11. 
45. Tamaki N, Y.T., Leinbach R, Gold H, McKusick K, Strauss H, Spontaneous changes 
in regional wall motion abnormalities in acute myocardial infarction. American 
Journal of Cardiology, 1986. 58: p. 406-410. 
46. Bridgman, P., Earwaker, PL., The case for echocardiography in non-ST elevation 
myocardial infarction in New Zealand. N Z Med J, 2007. 120(1265): p. U2813. 
47. Visser, C., Left ventricular remodelling after myocardial infarction: importance of 
residual myocardial viability and ischaemia. Heart, 2003. 89(10): p. 1121-1122. 
48. Moller, J., Pellikka, P., Hillis, G., Oh, J, Prognostic Importance of Diastolic Function 
and Filling Pressure in Patients With Acute Myocardial Infarction. Circulation, 2006. 
114: p. 438-444. 
49. Thevenard, R., Echocardiography and diastolic function. Revista Brasileira de 
Cirurgia Cardiovascular, 2005. 20(1): p. 5-6. 
50. Senni, M., Tribouilloy, CM., Rodeheffer, RJ., Jacobsen, SJ., Evans, JM., Bailey, KR., 
Redfield, MM., Congestive heart failure in the community: a study of all incident 
cases in Olmsted County, Minnesota, in 1991. Circulation, 1998. 98(21): p. 2282-9. 
51. Redfield, M., Jacobsen, SJ., Burnett, JC., Mahoney, DW., Bailey, KR., Rodeheffer, 
RJ., Burden of systolic and diastolic ventricular dysfunction in the community: 
appreciating the scope of the heart failure epidemic. JAMA, 2003. 289(2): p. 194-
202. 
52. Bronzwaer, J., de Bruyne, B., Ascoop, CA., Paulus, W. J., Comparative effects of 
pacing-induced and balloon coronary occlusion ischemia on left ventricular diastolic 
function in man. Circulation, 1991. 84(1): p. 211-22. 
53. Carroll, J., Hess, OM., Hirzel, HO., Turina, M., Krayenbuehl, HP., Effects of 
ischemia, bypass surgery and past infarction on myocardial contraction, relaxation 
and compliance during exercise. Am J Cardiol, 1989. 63(10): p. 65E-71E. 
54. Mandinov, L., Eberli, FR., Seiler, C., Hess, OM., Diastolic heart failure. Cardiovasc 
Res, 2000. 45(4): p. 813-25. 
55. Stork, T., Mockel, M., Danne, O., Voller, H., Eichstadt, H., Frei, U., Left ventricular 
hypertrophy and diastolic dysfunction: their relation to coronary heart disease. 
Cardiovasc Drugs Ther, 1995. 9 Suppl 3: p. 533-7. 
56. Herzog, E., Chaudhry, F. , Echocardiography in Acute Coronary Syndrome2009, 
London: Spinger-Verlag Ltd. 
57. Roelandt, J., Pozzoli, MD. Non-Invasive Assessment of Left Ventricular Diastolic 
(Dys) Function and Filling Pressure 2001; Available from: 
http://www.fac.org.ar/scvc/llave/echo/roeland/roelandi.htm. 
58. Burgess, M., Atkinson, P., Ray, SG., Restrictive left ventricular filling pattern after 
myocardial infarction: significance of concomitant preserved systolic function. 
Echocardiography, 2000. 17(7): p. 659-64. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
175 
 
59. Temporelli, P., Giannuzzi, P., Nicolosi, GL., Latini, R., Franzosi, MG., Gentile, F., 
Tavazzi, L., Maggioni, AP., Doppler-derived mitral deceleration time as a strong 
prognostic marker of left ventricular remodeling and survival after acute myocardial 
infarction: results of the GISSI-3 echo substudy. J Am Coll Cardiol, 2004. 43(9): p. 
1646-53. 
60. Moller, J., Sondergaard, E., Poulsen, SH., Egstrup, K., Pseudonormal and restrictive 
filling patterns predict left ventricular dilation and cardiac death after a first 
myocardial infarction: a serial color M-mode Doppler echocardiographic study. J 
Am Coll Cardiol, 2000. 36(6): p. 1841-6. 
61. Nijland, F., Kamp, O., Karreman, A., van Eenige, MJ., Visser, CA., Prognostic 
implications of restrictive left ventricular filling in acute myocardial infarction: a 
serial Doppler echocardiographic study. J Am Coll Cardiol, 1997. 30(7): p. 1618-24. 
62. Garcia-Rubira, J., Molano, F., Espina, A., Calvo, R., Gonzalez-Valday, M., Garcia-
Martinez, JT., Cruz, JM., Abnormal filling pattern of the left ventricle and outcome in 
acute myocardial infarction. Int J Cardiol, 1997. 61(2): p. 143-9. 
63. Whalley, G., Gamble, GD., Doughty, RN., Restrictive diastolic filling predicts death 
after acute myocardial infarction: systematic review and meta-analysis of prospective 
studies. Heart, 2006. 92(11): p. 1588-94. 
64. Hee, L., Brennan, X., Chen, J., Allman, C., Whalley, G., French, J., Juergens, C., 
Thomas, L., Long Term Outcomes in Patients with Restrictive Filling Following ST-
segment Elevation Myocardial Infarction. Unpublished, 2010. 
65. Moller, J., Whalley, GA., Dini, FL., Doughty, RN., Gamble, GD., Klein, AL., 
Quintana, M., Yu, CM., Independent prognostic importance of a restrictive left 
ventricular filling pattern after myocardial infarction: an individual patient meta-
analysis: Meta-Analysis Research Group in Echocardiography acute myocardial 
infarction. Circulation, 2008. 117(20): p. 2591-8. 
66. Moller, J., Egstrup, K., Kober, L., Poulsen, SH., Nyvad, O., Torp-Pedersen, C., 
Prognostic importance of systolic and diastolic function after acute myocardial 
infarction. Am Heart J, 2003. 145(1): p. 147-53. 
67. Quintana, M., Edner, M., Kahan, T., Hjemdahl, P., Sollevi, A., Rehnqvist, N., Is left 
ventricular diastolic function an independent marker of prognosis after acute 
myocardial infarction? Int J Cardiol, 2004. 96(2): p. 183-9. 
68. Khouri, S., Maly, GT., Suh, DD., Walsh, TE., A practical approach to the 
echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr, 2004. 
17(3): p. 290-7. 
69. Ommen, S., Nishimura, RA., Appleton, CP., Miller, FA., Oh, JK., Redfield, MM., 
Tajik, AJ., Clinical utility of Doppler echocardiography and tissue Doppler imaging 
in the estimation of left ventricular filling pressures: A comparative simultaneous 
Doppler-catheterization study. Circulation, 2000. 102(15): p. 1788-94. 
70. Ritzema, J., Richards, AM., Crozier, IG., Frampton, CF., Melton, IC., Doughty, RN., 
Stewart, JT., Eigler, N., Whiting, J., Abraham, WT., Troughton, RW., Serial Doppler 
echocardiography and tissue Doppler imaging in the detection of elevated directly 
measured left atrial pressure in ambulant subjects with chronic heart failure. JACC 
Cardiovasc Imaging, 2011. 4(9): p. 927-34. 
71. Hillis, G., Moller, JE., Pellikka, PA., Gersh, BJ., Wright, RS., Ommen, SR., Reeder, 
GS., Oh, JK., Noninvasive estimation of left ventricular filling pressure by E/e' is a 
powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol, 
2004. 43(3): p. 360-7. 
72. Nagueh, S., Appleton, CP., Gillebert, TC., Marino, PN., Oh, JK., Smiseth, OA., 
Waggoner, AD., Flachskampf, FA., Pellikka, PA., Evangelisa, A., Recommendations 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
176 
 
for the evaluation of left ventricular diastolic function by echocardiography. Eur J 
Echocardiogr, 2009. 10(2): p. 165-93. 
73. Basnight, M., Gonzalez, MS., Kershenovich, SC., Appleton, CP., Pulmonary venous 
flow velocity: relation to hemodynamics, mitral flow velocity and left atrial volume, 
and ejection fraction. J Am Soc Echocardiogr, 1991. 4(6): p. 547-58. 
74. Beinart, R., Boyko, V., Schwammenthal, E., Kuperstein, R., Sagie, A., Hod, H., 
Matetzky, S., Behar, S., Eldar, M., Feinberg, MS., Long-term prognostic significance 
of left atrial volume in acute myocardial infarction. J Am Coll Cardiol, 2004. 44(2): 
p. 327-34. 
75. Moller, J., Hillis, GS., Oh, JK., Seward, JB., Reeder, GS., Wright, RS., Park, SW., 
Bailey, KR., Pellikka, PA. , Left atrial volume: a powerful predictor of survival after 
acute myocardial infarction. Circulation, 2003. 107(17): p. 2207-12. 
76. Kuhl, J., Moller, JE., Kristensen, TS., Kelbaek, H., Kofoed, KF., Left atrial function 
and mortality in patients with NSTEMI an MDCT study. JACC Cardiovasc Imaging, 
2011. 4(10): p. 1080-7. 
77. Whalley, G., Klein, A., Quintana, M., Ghio, S., Prior, D., Temporelli, P., Troughton, 
R., Poppe, K., Doughty, R., The Prognostic Signficance of E:A Ratio In Patients With 
Chronic Heart Failure: Can E:A Alone Predict Survival. Unpublished, 2012. 
78. Mottram, P., Marwick, TH., Assessment of diastolic function: what the general 
cardiologist needs to know. Heart, 2005. 91(5): p. 681-95. 
79. Hasegawa T, N.S., Maruo T, Tanaka N, Kim J, Hanatani A, Hashimura K, Yasumura 
Y, Yamagishi M, Kitakaze M, Miyatake K. , Quantitative assessment of wall motion 
using myocardial strain. Journal of Echocardiography, 2003. 1: p. 23-28. 
80. GEHealthCare. GE quantitative analysis for left ventricular function. 2007; Available 
from: 
http://www.gehealthcare.com/usen/ultrasound/docs/QuantitativeAnalysiswhitepape1.
pdf. 
81. Yalcin, F., Kaftan, A., Muderrisoglu, H., Korkmaz, ME., Flachskampf, F., Garcia, M., 
Thomas, JD., Is Doppler tissue velocity during early left ventricular filling preload 
independent? Heart, 2002. 87(4): p. 336-9. 
82. Dalen, H., Thorstensen, A., Aase, SA., Ingul, CB., Torp, H., Vatten, L. J., Stoylen, A., 
Segmental and global longitudinal strain and strain rate based on echocardiography 
of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr, 2010. 
11(2): p. 176-83. 
83. Smiseth, O., Stoylen, A., Ihlen, H., Tissue Doppler imaging for the diagnosis of 
coronary artery disease. Curr Opin Cardiol, 2004. 19(5): p. 421-9. 
84. Thomas, G., Tissue Doppler echocardiography -  A case of right tool, wrong use. 
Cardiovascular Ultrasound, 2004. 2(12): p. 1-6. 
85. Stoylen, A. Strain rate imaging. Cardiac deformation imaging by ultrasound / 
echocardiography. Tissue Doppler and Speckle tracking. 2013; Available from: 
http://folk.ntnu.no/stoylen/strainrate/. 
86. Dandel, M., Lehmkuhl, H., Knosalla, C., Suramelashvili, N., Hetzer, R., Strain and 
strain rate imaging by echocardiography - basic concepts and clinical applicability. 
Curr Cardiol Rev, 2009. 5(2): p. 133-48. 
87. Leung, D., Ng, AC., Emerging clinical role of strain imaging in echocardiography. 
Heart Lung Circ, 2010. 19(3): p. 161-74. 
88. Urheim, S., Edvardsen, T., Torp, H., Angelsen, B., Smiseth, OA., Myocardial strain 
by Doppler echocardiography. Validation of a new method to quantify regional 
myocardial function. Circulation, 2000. 102(10): p. 1158-64. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
177 
 
89. Edvardsen, T., Gerber, BL., Garot, J., Bluemke, DA., Lima, JA., Smiseth, OA., 
Quantitative assessment of intrinsic regional myocardial deformation by Doppler 
strain rate echocardiography in humans: validation against three-dimensional tagged 
magnetic resonance imaging. Circulation, 2002. 106(1): p. 50-6. 
90. Lind, B., Nowak, J., Dorph, J., van der Linden, J., Brodin, LA., Analysis of temporal 
requirements for myocardial tissue velocity imaging. Eur J Echocardiogr, 2002. 3(3): 
p. 214-9. 
91. Choi S, C.K., Lee H, Coi J, Park S, Kim H, Her J, Kim T, Diagnostic value of 
ultrasound based strain imaging in patients with suspected coronary artery disease. 
The Korean Society of Cardiology, 2008. 38: p. 398-404. 
92. Amundsen, B., Crosby, J., Steen, PA., Torp, H., Slordahl, SA., Stoylen, A., Regional 
myocardial long-axis strain and strain rate measured by different tissue Doppler and 
speckle tracking echocardiography methods: a comparison with tagged magnetic 
resonance imaging. Eur J Echocardiogr, 2009. 10(2): p. 229-37. 
93. Otto, C., Practice of Clinical Echocardiography: 4th Edition.2012, Philadelphia: 
Elsevier Saunders. 
94. Echocardiography, ed. P. Nihoyannopoulos, Kisslo, J.2009, New York: Springer. 
95. Goffinet, C., Chenot, F., Robert, A., Pouleur, AC., le Polain de Waroux, JB., 
Vancrayenest, D., Gerard, O., Pasquet, A., Gerber, BL., Vanoverschelde, JL., 
Assessment of subendocardial vs. subepicardial left ventricular rotation and twist 
using two-dimensional speckle tracking echocardiography: comparison with tagged 
cardiac magnetic resonance. Eur Heart J, 2009. 30(5): p. 608-17. 
96. Cho G, C.J., Leano R, Strudwick M, Marwick T, Comparison of two-dimensional 
speckle tracking velocity based strain and validation with harmonic phase MRI. The 
American Journal of Cardiology, 2005: p. 1661-1666. 
97. Reisner, S., Lysyansky, P., Agmon, Y., Mutlak, D., Lessick, J., Friedman, Z. , Global 
longitudinal strain: a novel index of left ventricular systolic function. J Am Soc 
Echocardiogr, 2004. 17(6): p. 630-3. 
98. Becker, M., Bilke, E., Kuhl, H., Katoh, M., Kramann, R., Franke, A., Bucker, A.. 
Hanrath, P., Hoffmann, R., Analysis of myocardial deformation based on pixel 
tracking in two dimensional echocardiographic images enables quantitative 
assessment of regional left ventricular function. Heart, 2006. 92(8): p. 1102-8. 
99. Marwick, T., Leano, RL., Brown, J., Sun, JP., Hoffmann, R., Lysyansky, P., Becker, 
M., Thomas, JD., Myocardial strain measurement with 2-dimensional speckle-
tracking echocardiography: definition of normal range. JACC Cardiovasc Imaging, 
2009. 2(1): p. 80-4. 
100. Gjesdal, O., Hopp, E., Vartdal, T., Lunde, K., Helle-Valle, T., Aakhus, S., Smith, H. 
J., Ihlen, H., Edvardsen, T., Global longitudinal strain measured by two-dimensional 
speckle tracking echocardiography is closely related to myocardial infarct size in 
chronic ischaemic heart disease. Clin Sci (Lond), 2007. 113(6): p. 287-96. 
101. Eek, C., Grenne, B., Brunvand, H., Aakhus, S., Endresen, K., Hol, P. K., Smith, H. J., 
Smiseth, O. A., , Edvardsen, T., Skulstad, H., Strain echocardiography and wall 
motion score index predicts final infarct size in patients with non-ST-segment-
elevation myocardial infarction. Circ Cardiovasc Imaging, 2010. 3(2): p. 187-94. 
102. Roes S, M.S., Lamb H, van der Wall E, Roos A, Bax J., Validation of 
echocardiographic two-dimension speckle tracking longitudinal strain imaging for 
viability assessment in patients with chronic ischemic left ventricular dysfunction and 
comparison with contrast enhanced MRI. American Journal Cardiology, 2009. 104: p. 
312-317. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
178 
 
103. Hoit, B., Strain and strain rate echocardiography and coronary artery disease. Circ 
Cardiovasc Imaging, 2011. 4(2): p. 179-90. 
104. Antoni, M., Mollema, SA., Delgado, V., Atary, JZ., Borleffs, CJ., Boersma, E., 
Holman, ER., van der Wall, EE., Schalij, MJ., Bax, JJ., Prognostic importance of 
strain and strain rate after acute myocardial infarction. Eur Heart J, 2010. 31(13): p. 
1640-7. 
105. Ingul, C., Torp, H., Aase, SA., Berg, S., Stoylen, A., Slordahl, SA., Automated 
analysis of strain rate and strain: feasibility and clinical implications. J Am Soc 
Echocardiogr, 2005. 18(5): p. 411-8. 
106. Thomas, G., Tissue Doppler echocardiography - a case of right tool, wrong use. 
Cardiovasc Ultrasound, 2004. 2: p. 12. 
107. American Society of Echocardiography Guidelines and Standards. American Society 
of Echocardiography 2013; Available from: 
http://www.asecho.org/i4a/pages/index.cfm?pageid=3317. 
108. Thygesen, K., Alpert, JS., White, HD., Universal definition of myocardial infarction. 
J Am Coll Cardiol, 2007. 50(22): p. 2173-95. 
109. Zdzienicka, J., Siudak, Z., Zawislak, B., Dziewierz, A., Rakowski, T., Dubiel, J., 
Dudek, D., Patients with non-ST-elevation myocardial infarction and without chest 
pain are treated less aggressively and experience higher in-hospital mortality. 
Kardiol Pol, 2007. 65(7): p. 769-75; discussion 776-7. 
110. Unachukwu, C., Ofori, S. Diabetes Mellitus And Cardiovascular Risk. The Internet 
Journal of Endocrinology 2012; Available from: http://www.ispub.com/journal/the-
internet-journal-of-endocrinology/volume-7-number-1/128953332diabetes-mellitus-
and-cardiovascular-risk.html#sthash.FboLzPic.CWcqXxaT.dpu. 
111. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial 
statement by the American Diabetes Association; The National Heart, Lung, and 
Blood Institute; The Juvenile Diabetes Foundation International; The National 
Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart 
Association. Circulation, 1999. 100(10): p. 1132-3. 
112. MacCallum, P., Markers of hemostasis and systemic inflammation in heart disease 
and atherosclerosis in smokers. Proc Am Thorac Soc, 2005. 2(1): p. 34-43. 
113. Stajszczyk, M., Gminski, J., [Genetic predisposition to cardiovascular diseases]. 
Przegl Lek, 2000. 57(1): p. 48-51. 
114. Ambrose, J., Barua, RS., The pathophysiology of cigarette smoking and 
cardiovascular disease: an update. J Am Coll Cardiol, 2004. 43(10): p. 1731-7. 
115. Theuma, P., Fonseca, VA., Novel cardiovascular risk factors and macrovascular and 
microvascular complications of diabetes. Curr Drug Targets, 2003. 4(6): p. 477-86. 
116. Piotrowska-Kownacka, D., Kownacki, L., Opolski, G., Krolicki, L., Rowinski, O. , 
Could TnI level on admission predict function and infarct size in STEMI patient 
treated with pPCI – CMR study. Journal of Cardiovascular Magnetic Resonance, 
2009. 11: p. 258. 
117. Thiele, H., Rach, J., Klein, N., Pfeiffer, D., Hartmann, A., Hambrecht, R., Sick, P., 
Eitel, I., Desch, S., Schuler, G., Optimal timing of invasive angiography in stable non-
ST-elevation myocardial infarction: the Leipzig Immediate versus early and late 
PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur 
Heart J, 2012. 33(16): p. 2035-43. 
118. de Winter, R., Tijssen, JG., Non-ST-segment elevation myocardial infarction: 
revascularization for everyone? JACC Cardiovasc Interv, 2012. 5(9): p. 903-5. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
179 
 
119. Sami, S., Willerson, JT., Contemporary treatment of unstable angina and non-ST-
segment-elevation myocardial infarction (part 2). Tex Heart Inst J, 2010. 37(3): p. 
262-75. 
120. Ellis, C., Gamble, G., French, J.,  Devlin, G., Matsis, P., Elliott, J., Mann, S., 
Williams, M., White, W., Patients admitted with an acute coronary syndrome in New 
Zealand in 2007: results of a second comprehensive nationwide audit and a 
comparison with the first audit from 2002. The New Zealand Medical Journal, 2010. 
123(1319): p. 25-43. 
121. Stone, P., Raabe, DS., Jaffe, AS., Gustafson, N., Muller, JE., Turi, ZG., Rutherford, 
JD., Poole, WK., Passamani, E., Willerson, JT., Prognostic significance of location 
and type of myocardial infarction: independent adverse outcome associated with 
anterior location. J Am Coll Cardiol, 1988. 11(3): p. 453-63. 
122. Nienhuis, M., Ottervanger, JP., Dambrink, JH., de Boer, MJ., Hoorntje, JC., 
Gosselink, AT., Suryapranata, H., van 't Hof, AW., Comparative predictive value of 
infarct location, peak CK, and ejection fraction after primary PCI for ST elevation 
myocardial infarction. Coron Artery Dis, 2009. 20(1): p. 9-14. 
123. Wang, B., Han, YL., Li, Y., Jing, QM., Wang, SL., Ma, YY., Wang, G., Luan, B., 
Wang, XZ., Coronary collateral circulation: Effects on outcomes of acute anterior 
myocardial infarction after primary percutaneous coronary intervention. J Geriatr 
Cardiol, 2011. 8(2): p. 93-8. 
124. Imai, S., Suzuki, T., Differences of global and regional left ventricular function in 
anterior and inferior myocardial infarction: assessment by the use of a regional 
ejection fraction. Jpn Circ J, 1984. 48(11): p. 1175-83. 
125. Lysaght, M. Cardiac Geometry. 2006; Available from: 
http://biomed.brown.edu/Courses/BI108/2006-
108websites/group05ventrestoration/Website/cardiac_geometry.htm. 
126. [New Zealand Transport Authority] Medical Aspects of Fitness to Drive. 2009. 
127. Kapila, R., Mahajan, R., Diastolic dysfunction. Contin Educ Anaesth Crit Care Pain, 
2009. 9(1): p. 29-33. 
128. Gibson, D., Francis, DP., Clinical assessment of left ventricular diastolic function. 
Heart, 2003. 89(2): p. 231-8. 
129. Diastolic dysfunction appears to worsen over time; associated with increased risk of 
heart failure. 2011; Available from: 
http://www.sciencedaily.com/releases/2011/08/110823165342.htm/releases/2011/08/1
10823165342.htm. 
130. Detry, J.M., The pathophysiology of myocardial ischaemia. Eur Heart J, 1996. 17 
Suppl G: p. 48-52. 
131. Bella, J., Palmieri, V., Roman, MJ., Liu, JE., Welty, TK., Lee, ET., Fabsitz, RR., 
Howard, BV., Devereux, RB., Mitral ratio of peak early to late diastolic filling 
velocity as a predictor of mortality in middle-aged and elderly adults: the Strong 
Heart Study. Circulation, 2002. 105(16): p. 1928-33. 
132. Poulsen, S., Clinical aspects of left ventricular diastolic function assessed by Doppler 
echocardiography following acute myocardial infarction. Dan Med Bull, 2001. 48(4): 
p. 199-210. 
133. Zile, M., Gaasch, W. Treatment and prognosis of diastolic heart failure. 2012 Jan 
2013. 
134. Paulus, W., Tschope, C., Sanderson, JE., Rusconi, C., Flachskampf, FA., 
Rademakers, FE., Marino, P., Smiseth, OA., De Keulenaer, G., Leite-Moreira, AF., 
Borbely, A., Edes, I., Handoko, ML., Heymans, S., Pezzali, N., Pieske, BI, Dickstein, 
K., Fraser, AG., Brutsaert, DL., How to diagnose diastolic heart failure: a consensus 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
180 
 
statement on the diagnosis of heart failure with normal left ventricular ejection 
fraction by the Heart Failure and Echocardiography Associations of the European 
Society of Cardiology. Eur Heart J, 2007. 28(20): p. 2539-50. 
135. Mahadevan, G., Dwivedi, G., Williams, L., Steeds, RP., Frenneaux, M., Epidemiology 
and diagnosis of heart failure with preserved left ventricular ejection fraction: 
rationale and design of the study. Eur J Heart Fail, 2012. 14(1): p. 106-12. 
136. Satpathy, C., Mishra, TK., Satpathy, R., Satpathy, HK., Barone, E., Diagnosis and 
management of diastolic dysfunction and heart failure. Am Fam Physician, 2006. 
73(5): p. 841-6. 
137. Brady, W., ST segment and T wave abnormalities not caused by acute coronary 
syndromes. Emerg Med Clin North Am, 2006. 24(1): p. 91-111, vi. 
138. Kane, G., Karon, BL., Mahoney, DW., Redfield, MM., Roger, VL., Burnett, JC., 
Jacobsen, SJ., Rodeheffer, RJ., Progression of left ventricular diastolic dysfunction 
and risk of heart failure. JAMA, 2011. 306(8): p. 856-63. 
139. Somaratne, J., Whalley, G.,  Poppe, K.,  Gamble, G., Doughty, R., Pseudonormal 
Mitral Filling Is Associated with Similarly Poor Prognosis as Restrictive Filling in 
Patients with Heart Failure and Coronary Heart Disease: A Systematic Review and 
Meta-analysis of Prospective Studies. Journal American Society Cardiology, 2009. 
22: p. 494-498. 
140. Hameed, A., Gosal, T., Fang, T., Ahmadie, R., Lytwyn, M., Barac, I., Zieroth, S., 
Hussain, F., Jassal, DS., Clinical utility of tissue Doppler imaging in patients with 
acute myocardial infarction complicated by cardiogenic shock. Cardiovasc 
Ultrasound, 2008. 6: p. 11. 
141. Wang, M., Yip, GW., Wang, AY., Zhang, Y., Ho, PY., Tse, MK., Lam, PK., 
Sanderson, JE., Peak early diastolic mitral annulus velocity by tissue Doppler 
imaging adds independent and incremental prognostic value. J Am Coll Cardiol, 
2003. 41(5): p. 820-6. 
142. Prasad, S., See, V., Brown, P., McKay, T., Narayan, A., Kovoor, P., Thomas, L., 
Impact of duration of ischemia on left ventricular diastolic properties following 
reperfusion for acute myocardial infarction. Am J Cardiol, 2011. 108(3): p. 348-54. 
143. Akasaka, T., Yoshikawa, J., Yoshida, K., Okumachi, F., Koizumi, K., Shiratori, K., 
Takao, S., Shakudo, M., Kato, H., Age-related valvular regurgitation: a study by 
pulsed Doppler echocardiography. Circulation, 1987. 76(2): p. 262-5. 
144. Klein, A., Burstow, DJ., Tajik, AJ., Zachariah, PK., Taliercio, CP., Taylor, CL., 
Bailey, KR., Seward, JB., Age-related prevalence of valvular regurgitation in normal 
subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc 
Echocardiogr, 1990. 3(1): p. 54-63. 
145. Weeks, S., Shapiro, M., Foster, E., Michaels, AD., Echocardiographic predictors of 
change in left ventricular diastolic pressure in heart failure patients receiving 
nesiritide. Echocardiography, 2008. 25(8): p. 849-55. 
146. Boyd, A., Ng, AC., Tran da, T., Chia, EM., French, JK., Leung, DY., Thomas, L., Left 
atrial enlargement and phasic function in patients following non-ST elevation 
myocardial infarction. J Am Soc Echocardiogr, 2010. 23(12): p. 1251-8. 
147. Koyama, Y., Hansen, PS., Hanratty, CG, Nelson, GI., Rasmussen, HH., Prevalence of 
coronary occlusion and outcome of an immediate invasive strategy in suspected acute 
myocardial infarction with and without ST-segment elevation. Am J Cardiol, 2002. 
90(6): p. 579-84. 
148. Hong, Y., Jeong, MH., Choi, YH., Ma, EH., Ko, JS., Lee, MG., Park, KH., Sim, DS., 
Yoon, N S., Youn, HJ., Kim, KH., Park, HW., Kim, JH., Ahn, Yl., Cho, JG., Park, 
JC., Kang, JC., Differences in intravascular ultrasound findings in culprit lesions in 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
181 
 
infarct-related arteries between ST segment elevation myocardial infarction and non-
ST segment elevation myocardial infarction. J Cardiol, 2010. 56(1): p. 15-22. 
149. Dixon, W., Wang, TY., Dai, D., Shunk, KA., Peterson, E. D., Roe, MT., Anatomic 
distribution of the culprit lesion in patients with non-ST-segment elevation myocardial 
infarction undergoing percutaneous coronary intervention: findings from the National 
Cardiovascular Data Registry. J Am Coll Cardiol, 2008. 52(16): p. 1347-8. 
150. Larson, D., Menssen, KM., Sharkey, SW., Duval, S., Schwartz, RS., Harris, J., 
Meland, JT., Unger, BT., Henry, TD., "False-positive" cardiac catheterization 
laboratory activation among patients with suspected ST-segment elevation 
myocardial infarction. JAMA, 2007. 298(23): p. 2754-60. 
151. Erikssen, J., Enge, I., Forfang, K., Storstein, O., False positive diagnostic tests and 
coronary angiographic findings in 105 presumably healthy males. Circulation, 1976. 
54(3): p. 371-6. 
152. Perugini, E., Rapezzi, C., Di Diodoro, L., Riva, L., Ortolani, P., Casella, G., Taglieri, 
N., Sangiorgio, P., Marzocchi, A., Branzi, A., Di Pasquale, G., False Positive 
Coronary Angiography Activation in a Primary Coronary Angioplasty Network: Does 
Direct Ambulance-based Access Influence The Prevalence Rate? . Circulation, 2010. 
122. 
153. Januzzie, J. Causes of Non-ACS Related Troponin Elevations. 2010; Available from: 
http://biomarkers.cardiosource.org/Hot-Topics/2010/09/Causes-of-Non-ACS-Related-
Troponin-Elevations.aspx?p=1. 
154. Medina, R., Panidis, IP., Morganroth, J., Kotler, MN., Mintz, GS., The value of 
echocardiographic regional wall motion abnormalities in detecting coronary artery 
disease in patients with or without a dilated left ventricle. Am Heart J, 1985. 109(4): 
p. 799-803. 
155. Khawaja, F., Shah, ND., Lennon, RJ., Slusser, JP., Alkatib, AA., Rihal, CS., Gersh, 
BJ., Montori, VM.,Holmes, DR., Bell, MR., Curtis, JP., Krumholz, HM., Ting, HH., 
Factors associated with 30-day readmission rates after percutaneous coronary 
intervention. Arch Intern Med, 2012. 172(2): p. 112-7. 
156. Hernandez, A., Granger, CB., Prediction is very hard, especially about the future: 
comment on "factors associated with 30-day readmission rates after percutaneous 
coronary intervention". Arch Intern Med, 2012. 172(2): p. 117-9. 
157. FujiFilm. ProSolv Cardiovascular and GE Healthcare Ultrasound Division Announce 
Affiliation 2009; Available from: http://www.prosolv.com/about/news/press_prosolv-
ge-affiliation.asp. 
158. Macron, L., Lairez, O., Nahum, J., Berry, M., Deal, L., Deux, J. F., Bensaid, A., 
Dubois Rande, J. L., Gueret, P., Lim, P., Impact of acoustic window on accuracy of 
longitudinal global strain: a comparison study to cardiac magnetic resonance. Eur J 
Echocardiogr, 2011. 12(5): p. 394-9. 
159. Marwick, T.H., Measurement of strain and strain rate by echocardiography: ready 
for prime time? J Am Coll Cardiol, 2006. 47(7): p. 1313-27. 
160. Cerqueira, M., Weissman, NJ., Dilsizian, V., Jacobs, AK., Kaul, S., Laskey, WK., 
Pennell, DJ., Rumberger, JA., Ryan, T., Verani, MS., Standardized myocardial 
segmentation and nomenclature for tomographic imaging of the heart. A statement for 
healthcare professionals from the Cardiac Imaging Committee of the Council on 
Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging, 
2002. 18(1): p. 539-42. 
161. Grenne, B., Eek, C., Sjoli, B., Dahlslett, T., Uchto, M., Hol, P. K., Skulstad, H., 
Smiseth, O. A., Edvardsen, T., Brunvand, H., Acute coronary occlusion in non-ST-
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
182 
 
elevation acute coronary syndrome: outcome and early identification by strain 
echocardiography. Heart, 2010. 96(19): p. 1550-6. 
162. Stoylen, A., Strain Rate Imaging of the Left Ventricle by Ultrasound. Fesibility 
Clinical Validation and Physiological, in Norwegian University of Science and 
Technology2001, Aspects Faculty of Medicine: Trondheim, Norway. 
163. Sagberg E, M.S., Ingul CB, Torp H, Støylen A., Feasibility of 3D reconstructed 
parametric strain rate data in recognition of myocardial infarction. . In Eur J 
Echocardiogr., 2004. 5. 
164. Maniar, H., Cupps, BP., Potter, DD., Moustakidis, P., Camillo, CJ., Chu, CM., 
Pasque, MK., Sundt, TM., Ventricular function after coronary artery bypass grafting: 
evaluation by magnetic resonance imaging and myocardial strain analysis. J Thorac 
Cardiovasc Surg, 2004. 128(1): p. 76-82. 
165. Kuznetsova, T., Herbots, L., Richart, T., D'Hooge, J., Thijs, L., Fagard, RH., 
Herregods, MC., Staessen, JA., Left ventricular strain and strain rate in a general 
population. Eur Heart J, 2008. 29(16): p. 2014-23. 
166. Waggoner, A., Bierig, SM., Tissue Doppler imaging: a useful echocardiographic 
method for the cardiac sonographer to assess systolic and diastolic ventricular 
function. J Am Soc Echocardiogr, 2001. 14(12): p. 1143-52. 
167. Maclaren, G., Kluger, R., Prior, D., Royse, A., Royse, C., Tissue Doppler, strain, and 
strain rate echocardiography: principles and potential perioperative applications. J 
Cardiothorac Vasc Anesth, 2006. 20(4): p. 583-93. 
168. Yu, C., Sanderson, JE., Marwick, TH., Oh, JK., Tissue Doppler imaging a new 
prognosticator for cardiovascular diseases. J Am Coll Cardiol, 2007. 49(19): p. 
1903-14. 
169. Palmes, P., Masuyama, T., Yamamoto, K., Kondo, H., Sakata, Y., Takiuchi, S., 
Kuzuya, T., Hori, M., Myocardial longitudinal motion by tissue velocity imaging in 
the evaluation of patients with myocardial infarction. J Am Soc Echocardiogr, 2000. 
13(9): p. 818-26. 
170. Mundigler, G., Zehetgruber, M., Tissue Doppler Imaging: Myocardial Velocities and 
Strain - Are there Clinical Applications? Journal of Clinical and Basic Cardiology, 
2002. 5(2): p. 125-132. 
171. Abraham, T., Dimaano, VL., Liang, HY., Role of tissue Doppler and strain 
echocardiography in current clinical practice. Circulation, 2007. 116(22): p. 2597-
609. 
172. Pislaru, C., Abraham, TP., Belohlavek, M., Strain and strain rate echocardiography. 
Curr Opin Cardiol, 2002. 17(5): p. 443-54. 
173. Abraham, T., Nishimura, RA., Myocardial strain: can we finally measure 
contractility? J Am Coll Cardiol, 2001. 37(3): p. 731-4. 
174. Liang, H., Cauduro, S., Pellikka, P., Wang, J., Urheim, S., Yang, EH., Rihal, C., 
Belohlavek, M., Khandheria, B., Miller, FA.. Abraham, TP., Usefulness of two-
dimensional speckle strain for evaluation of left ventricular diastolic deformation in 
patients with coronary artery disease. Am J Cardiol, 2006. 98(12): p. 1581-6. 
175. Dandel, M., Knosalla, C., Lehmkuhl, H., Hetzer, R., Non-Doppler two-dimensional 
strain imaging-clinical applications. J Am Soc Echocardiogr, 2007. 20(8): p. 1019. 
176. Artis, N., Oxborough, DL., Williams, G., Pepper, CB., Tan, LB., Two-dimensional 
strain imaging: a new echocardiographic advance with research and clinical 
applications. Int J Cardiol, 2008. 123(3): p. 240-8. 
177. Feigenbaum, H., Mastouri, R., Sawada, S., A Practical Approach to Using Strain 
Echocardiography to Evaluate the Left Ventricle. Circulation, 2012. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
183 
 
178. Geyer, H., Caracciolo, G., Abe, H., Wilansky, S., Carerj, S., Gentile, F., Nesser, HJ., 
Khandheria, B., Narula, J., Sengupta P., Assessment of Myocardial Mechanics Using 
Speckle Tracking Echocardiography: Fundamentals and Clinical Applications. J Am 
Soc Echocardiogr, 2010. 23(4): p. 351-69. 
179. Alam, M., Wardell, J., Andersson, E., Samad, B. A., Nordlander, R., Characteristics 
of mitral and tricuspid annular velocities determined by pulsed wave Doppler tissue 
imaging in healthy subjects. J Am Soc Echocardiogr, 1999. 12(8): p. 618-28. 
180. Perk, G., Tunick, PA., Kronzon, I., Non-Doppler two-dimensional strain imaging by 
echocardiography--from technical considerations to clinical applications. J Am Soc 
Echocardiogr, 2007. 20(3): p. 234-43. 
181. Korinek, J., Kjaergaard, J., , Sengupta, PP., Yoshifuku, S., McMahon, EM., Cha, SS., 
Khandheria, BK., Belohlavek, M., High spatial resolution speckle tracking improves 
accuracy of 2-dimensional strain measurements: an update on a new method in 
functional echocardiography. J Am Soc Echocardiogr, 2007. 20(2): p. 165-70. 
182. Winter, R., Jussila, R., Nowak, J., Brodin, LA., Speckle tracking echocardiography is 
a sensitive tool for the detection of myocardial ischemia: a pilot study from the 
catheterization laboratory during percutaneous coronary intervention. J Am Soc 
Echocardiogr, 2007. 20(8): p. 974-81. 
183. Gustafsson, U., Lindqvist, P., Morner, S., Waldenstrom, A., Assessment of regional 
rotation patterns improves the understanding of the systolic and diastolic left 
ventricular function: an echocardiographic speckle-tracking study in healthy 
individuals. Eur J Echocardiogr, 2009. 10(1): p. 56-61. 
184. Peng, Y., Popovic, ZB., Sopko, N., Drinko, J., Zhang, Z., Thomas, JD., Penn, MS., 
Speckle tracking echocardiography in the assessment of mouse models of cardiac 
dysfunction. Am J Physiol Heart Circ Physiol, 2009. 297(2): p. H811-20. 
185. Teske, A., De Boeck, BW., Olimulder, M., Prakken, NH., Doevendans, PA., Cramer, 
MJ., Echocardiographic assessment of regional right ventricular function: a head-to-
head comparison between 2-dimensional and tissue Doppler-derived strain analysis. J 
Am Soc Echocardiogr, 2008. 21(3): p. 275-83. 
186. Delgado, V., Sitges, M., Vidal, B., Silva, E., Azqueta, M., Tolosana, JM., Mont, L., 
Pare, C., Brugada, J., Assessment of left ventricular dyssynchrony by real-time three-
dimensional echocardiography. Rev Esp Cardiol, 2008. 61(8): p. 825-34. 
187. Olson, N., Brown, JP., Kahn, AM., Auger, WR., Madani, MM., Waltman, TJ., 
Blanchard, DG., Left ventricular strain and strain rate by 2D speckle tracking in 
chronic thromboembolic pulmonary hypertension before and after pulmonary 
thromboendarterectomy. Cardiovasc Ultrasound, 2010. 8: p. 43. 
188. Bussadori, C., Moreo, A. Di Donato, M., De Chiara, B., Negura, D., Dall'Aglio, E., 
Lobiati, E., Chessa, M., Arcidiacono, C., Dua, J. S., Mauri, F., Carminati, M., A new 
2D-based method for myocardial velocity strain and strain rate quantification in a 
normal adult and paediatric population: assessment of reference values. Cardiovasc 
Ultrasound, 2009. 7: p. 8. 
189. Hurlburt, H., Aurigemma, GP., Hill, JC., Narayanan, A., Gaasch, WH., Vinch, CS., 
Meyer, TE., Tighe, DA., Direct ultrasound measurement of longitudinal, 
circumferential, and radial strain using 2-dimensional strain imaging in normal 
adults. Echocardiography, 2007. 24(7): p. 723-31. 
190. Pereztol-Valdés, O., Candell-Riera, J., Santana-Boado, C., Angel, J., Aguadé-Bruix, 
S., Castell-Conesa, J., Garcia, EV., Soler-Soler, J., Correspondence between left 
ventricular 17 myocardial segments and coronary arteries. European Heart Journal, 
2005. 26: p. 2637-2643. 
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
184 
 
191. Bagger, T., Sloth, E., Jakobsen, CJ., Left ventricular longitudinal function assessed by 
speckle tracking ultrasound from a single apical imaging plane. Crit Care Res Pract, 
2012. 2012: p. 361824. 
192. Brown, J., Jenkins, C., Marwick, TH., Use of myocardial strain to assess global left 
ventricular function: a comparison with cardiac magnetic resonance and 3-
dimensional echocardiography. Am Heart J., 2009. 157(1): p. 1-5. 
193. Mistry, N., Beitnes, JO., Halvorsen, S., Abdelnoor, M., Hoffmann, P., Kjeldsen, SE., 
Smith, G., Aakhus, S., Bjornerheim, R., Assessment of left ventricular function in ST-
elevation myocardial infarction by global longitudinal strain: a comparison with 
ejection fraction, infarct size, and wall motion score index measured by non-invasive 
imaging modalities. Eur J Echocardiogr, 2011. 12(9): p. 678-83. 
194. Jacobs, L., Salgo, IS., Goonewardena, S., Weinert, L., Coon, P., Bardo, D., Gerard, 
O., Allain, P., Zamorano, JL., de Isla, LP., Mor-Avi, V., Lang, RM., Rapid online 
quantification of left ventricular volume from real-time three-dimensional 
echocardiographic data. Eur Heart J, 2006. 27(4): p. 460-8. 
195. Buck, T., Hunold, P., Wentz, KU., Tkalec, W., Nesser, HJ., Erbel, R., Tomographic 
three-dimensional echocardiographic determination of chamber size and systolic 
function in patients with left ventricular aneurysm: comparison to magnetic 
resonance imaging, cineventriculography, and two-dimensional echocardiography. 
Circulation, 1997. 96(12): p. 4286-97. 
196. Qin, J., Shiota, T., Asher, CR., Smedira, NG., Shin, JH., Agler, DA., Nash, PJ., 
Greenberg, NL., Lever, HM., Lytle, BW., Thomas, JD., Usefulness of real-time three-
dimensional echocardiography for evaluation of myectomy in patients with 
hypertrophic cardiomyopathy. Am J Cardiol, 2004. 94(7): p. 964-6. 
 
   
Contemporary Echocardiography in Non-ST Elevation Myocardial Infarction 
 
185 
 
 
Appendix 
 10 Appendix 
 
Table 21: Normal Values: Differences in TVI Derived Velocity, Strain and Strain Rate Values between Cardiac Walls 
 
Normal Values: Differences in TVI Derived Velocity, Strain and Strain Rate Values between Cardiac Walls 
 
Anteroseptal Anterior Anterolateral Inferolateral Inferior Inferoseptal 
TVI  velocity (cm/s) 
 
8.3 (1.9) 8.8 (1.8) 
 
8.6 (1.4) 8.0 (1.2) 
SR (s-1) -0.99 (0.27) -1.02 (0.28) -1.05 (0.28) -1.07 (0.27) -1.03 (0.26) -1.01 (0.25) 
Strain (%) -16.0 (4.1) -16.8 (4.3) -16.6 (4.1) -16.5 (4.1) -17.0 (4.0) -16.8 (4.0) 
 
‘Results from the HUNT study with normal values based on 1266 healthy individuals. Values are mean values (SD in parentheses). Velocities are taken from 
the four points on the mitral annulus in four chamber and two chamber views, while deformation parameters are measured in 16 segments, and averaged per wall’. 
 
Table and caption reproduced from Stoylen, A. [85]
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